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With conventional antibiotic therapies being increasingly ineffective, bacterial infections
with subsequent biofilm formation represent a global threat to human health and there-
fore, new strategies to fight bacteria colonization need to be found. Coimmobilization
of functional, nanosized assemblies broadens the possibility to engineer dually function-
alized active surfaces with a nanostructured texture. Surfaces decorated with different
nanoassemblies, such as micelles, polymersomes, or nanoparticles are in high demand for
various applications ranging from catalysis, biosensing up to antimicrobial surfaces. In
this thesis, I present a combination of bio-orthogonal and catalyst-free strain-promoted
azide-alkyne click (SPAAC) and thiol-ene reactions to simultaneously coimmobilize vari-
ous nanoassemblies; polymersome-polymersome and polymersome-micelle assemblies were
selected. For the first time, the immobilization method using SPAAC reaction was studied
in detail to attach soft, polymeric assemblies on a solid support. Together, the SPAAC and
thiol-ene reactions successfully coimmobilized two unique self-assembled structures on the
surfaces. Additionally, poly-(dimethylsiloxane) (PDMS)-based polymersomes were used as
“ink” for direct immobilization from a PDMS-based microstamp onto a surface creating
locally defined patterns. Furthermore, an active and a passive strategy based on polymeric
micelles were combined to fight bacterial growth. The passive strategy involved covalent
immobilization of polymeric micelles through Michael addition between maleimide exposed
micelles and thiol functionalized surfaces. Compared to the bare surface, micelle-decorated
surfaces showed reduced adherence and survival of bacteria. To extend this passive defense
against bacteria with an active strategy, the immobilized micelles were equipped with the
antimicrobial peptide KYE28 (KYEITTIHNLFRKLTHRLFRRNFGYTLR). The peptide
interacted nonspecifically with the immobilized micelles where it retained its antimicrobial
property. The successful surface decoration with KYE28 was demonstrated by a combina-
tion of X-ray photoelectron spectroscopy and quartz crystal microbalance with dissipation
monitoring. The initial antimicrobial activity of the nanostructured surfaces against Es-
cherichia coli (E. coli) was found to be increased by the presence of KYE28.
Combining immobilization reactions has the advantage to attach any kind of nanoassembly
pairs, resulting in surfaces with “desired” interfacial properties. Different nanoassemblies
that encapsulate multiple active compounds coimmobilized on a surface will pave the way
for the development of multifunctional surfaces with controlled properties and efficiency.
Additionally, the combination of our active and a passive strategy represents a straight-
forward modular approach that can easily be adapted, for example, by exchanging the
antimicrobial peptide to optimize potency against challenging bacterial strains, and/or to
simultaneously achieve antimicrobial and anti-infection properties.
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This chapter is tightly based on the following review articles and book chapter I partic-
ipated in writing: ’Nanoscience-Based Strategies to Engineer Antimicrobial Surfaces’,1
’Enzymatic reactions in polymeric compartments: nanotechnology meets nature’,2 and
’Battling bacteria with free and surface-immobilized polymeric nanostructures’.3
1.1 Device associated infections
Bacteria play an important role in our health. The microbes of the skin are fundamental
to skin physiology and prevent pathogens from entering the body.4,5 Another well-known
example is the 500–1,000 unique bacterial strains in the human colon.6 This personal com-
munity of bacterial strains is referred to as the gut microbiota and is vital for many aspects
of health, including physiology,7 resistance to disease and digestion,8 among others. In
addition, there is a tight link between the human gut microbiota and the host central ner-
vous system. The microbiome or genetic content of these bacteria changes in individuals
with disease, such as irritable bowel syndrome,7 obesity or diabetes8 when compared to
unaffected individuals. Advances in sequencing technology enabled the exploration of the
role of the gut microbiota in a broad range of neurological and psychiatric disorders and
diseases including Alzheimer’s disease9 and depression.10 In addition, evidence to a causal
role for the microbiota in disease acquisition is increasing.
Besides probiotics, there are numerous pathogenic bacteria which, when they prolifer-
ate uncontrolled in or on our body, cause a lot of distress, harm and in the worst case
death. With the discovery of the first antibiotics, some of these deadly infections could fi-
nally be treated.11 Following their inital discovery, numerous different classes of antibiotics
were developed with different mechanisms of action. However, the antibiotic era was soon
marred by the emergence of antibiotic-resistance. The world health organisation (WHO)
in 2018 has highlighted antibiotic resistance as a serious global problem concerning ev-
eryone.12 Besides improving the discovery models for new antimicrobial agents that are
successful in the combat of antibiotic resistance, the need for developing new strategies
such as the design of more effective preventive measures is urgent.
In today’s life, medical devices play an important role in extending and/or improving
life quality. Bone fractures can be repaired using metal screws, pins, and plates, hip
and knee joints can be replaced, pacemakers can control the heartbeat, implants help
reconstructing breasts after mastectomy, and different catheters are used in diagnosis
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and treatment. Despite all medical progress, there is always the risk of infection following
surgery. Pathogenic bacteria may spread within the body and proliferate on the implanted
device, possibly leading to device associated infections (DAI) which account for a quarter
of all health care associated infections in the USA.13 Of particular concern is the threat of
bacterial biofilm development, since these infections are difficult to diagnose and effective
treatments are lacking.14 Moreover, biofilm formation not only occurs on the implant, but
also affects adjacent soft tissues and bone.15 In order to keep the infection risk during
surgery on an absolut minimum, preventive antibacterial treatment is essential to reduce
possible bacteria contamination in the wound.16 With the dramatic increase in the emer-
gence of antibiotic resistant bacterial strains, there is an urgent need for more efficient
antibiotic treatments to reduce DAI. Antimicrobial surfaces which actively or passively
prevent bacteria colonialization by reducing the bacteria’s ability to adhere and grow into
a biofilm on implants, is an important research field in the fight against DAI.1
1.1.1 Biofilm
Bacterial species can cause DAI if they colonize on the device and grow into biofilms.13
Biofilm formation is a dynamic and multifaceted process where cell to cell communication
between the bacteria within the biofilm allow products essential for its development and
survival to be actively shared and exchanged.17–21 It is referred to as quorum sensing and
relies on autoinducers, extracellular signalling molecules produced and detected by the
bacteria.22 Communication through electrical signals between bacteria is also possible.23
The microorganisms within a biofilm are embedded into and protected by the biofilm
matrix, which usually accounts for more than 90% of the dry mass of a biofilm.24 The
matrix consists of self-produced extracellular polymeric substances (EPS) which contain
polysaccharides, proteins, glycoproteins, and other natural polymers.25,26 The EPS of the
matrix create a microenvironment with local heterogeneity. To protect the bacteria from
dessication the matrix contains a lot of water due to which biofilms become slimy and are
therefore often referred to as slime. Nevertheless, the mechanical stability is important
and mostly provided by polysaccharides embedded in the matrix.23,24
Biofilms develop in many different environments and on many different surfaces always
following the same sequence of events (Figure 1.1). On a surface in aqueous solution
where organic molecules are present (e.g. seawater, blood, or urine) a conditioning film
will form immediately by the adsorption of proteins and other organic molecules. First
planktonic bacteria adhere reversibly to the surface and eventually attach irreversibly be-
coming sessile bacteria. These bacteria then start to divide and grow into microcolonies
on the surface, where they produce EPS for the extracellular matrix, which anchors them
further to the surface. The biofilm grows by cell division and by further attracting still
freely suspended planktonic bacteria. Single bacteria can disperse actively and change
back to a planktonic lifestyle when they decide that living within the biofilm community
is no more beneficial for them (e.g. upon environmental changes). Bacteria aggregates
can also detach passively by shear stress or mechanical forces.25,27–29
Treating DAI is not simple since the bacteria in a biofilm are not easily accessable, and
the efficacy of antibiotic treatments is low due to their higher resistance to antibiotics
compared to the same planktonic bacteria. Deep within the biofilm, so called dormant
variants or persister cells, are living. These bacteria are not growing and antibiotics are
ineffective as most antibiotics are only effective against growing bacteria. Therefore, such
5
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Figure 1.1: Schematic representation of biofilm formation. a) free swimming planktonic
bacteria. b) reversible and c) irriversible attachment to the surface. d) microcolony with
extracellular matrix formation. e) mature three dimensional biofilm. Detachment of f)
single bacteria and g) bacteria aggregates.27
persister cells are able to survive antibiotic treatment and cause further relapse infections
possibly leading to chronic infections.13,23,30,31 The minimal biofilm eradication concen-
tration (MBEC) is significantly higher than the minimal inhibition concentration (MIC)
of the planktonic counterpart. Up to 1000 times the concentration of antibiotics has to be
used to kill biofilm forming bacteria than planktonic ones.17,31,32 Therefore, conventional
treatments of DAI with antibiotics have several limitations, such as support of biofilm for-
mation when the concentration of the antibiotic is lower than the MIC,33,34 or ineffective
treatment against non-multidrug resistant bacteria strains.21 An effective way to prevent
DAI would be the prevention of biofilm formation, hence the bacterial attachment to the
surface as a first step of biofilm formation.
1.1.2 Bacteria attachment
Surface roughness and micro structures play an important role in deterring bacterial at-
tachment. By directly mimicking the topography of biointerfaces and exploring the fac-
tors that are responsible for the antibiofouling properties, researchers have been guided
towards the necessity to find relationships between surface microstructure and bacteria
colonization.35–38 Improving the understanding of the interactions between bacteria and
micro-/nanostructures will help the development of more effective antibacterial surface
designs. Several mechanisms, such as the contact area reduction (attachment point the-
ory),39 showing that species with few attachment points to a surface envisage reduced
adhesion forces compared to species with enlarged contact area to the surface,39,40 has
been proposed as being responsible for controlling interactions between bacteria and hosts.
In order to gain a better understanding, the physical properties of microstructured sur-
faces have been further divided into sub-groups, such as size, shape, spacing distance, or
organization of the microstructures,41 and different levels of interactions between surface
patterns and bacteria have been identified. A surface possesses a universal bactericidal
effect when patterns are smaller than the bacteria, probably because of mechanical defor-
mation stresses leading to the rupture of the bacteria on the structured surface.40 When
surface patterns and cell size are similar, attachment of individual bacteria is hampered by
6
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Figure 1.2: Interactions between device,14 host, and pathogens44 are the deciding fac-
tors for successful insertion of the device. Tissue integration should be promoted while
preventing biofilm formation.1
the limited number of attachment points. However, it is inappropriate to attempt to iden-
tify a single physical factor that determines the effect of surface topography on bacterial
attachment,41 because other factors, such as surface chemistry, charge state,42 and wet-
tability, as well as the individual morphology of the bacteria40 influence bacteria-surface
interactions. Such complications might also be the explanation for some of the controver-
sial conclusions that have been published. Therefore, all of these ideas and findings must
be taken into consideration in order to create novel surfaces that combat bacterial growth.
1.1.3 Race for the surface
Interactions between the device, the host, and the bacteria are important for successful
implantation and implant survival (Figure 1.2). They influence the ease with which
an implant integrates into the biological environment of the host’s body and the ability
to prevent bacterial growth. To this end, there are various parameters that need to be
considered; i) the surface and material properties of the device, ii) the type of pathogen,
and iii) the strength of the host’s immune system, which is decreased around synthetic
material due to frustrated phagocytosis.43 These interactions are critical factors in choos-
ing the appropriate device-surface for a specific treatment. Competition between bacteria
and cells for the implant surface is crucial, and the risk of DAI decreases dramatically as
soon as the implant is completely colonized by the host’s cells, since then there is no free
surface remaining for the attachment and proliferation of bacteria.
Studies to test viability and metabolism of host cells separately from the capability of
bacteria to form biofilms on implant surfaces represent a good first step for predicting
weather host cells or bacteria will be able to first colonize the implant surface. To this
end, silver-releasing hydroxyapatite coatings with fibronectin on titanium alloy (Ti-6Al-
4V) surfaces have shown a high bacteria killing property likely due to the silver. On the
other hand this surface was nontoxic to host cells probably assisted by the fibronectin.
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These two separate findings indicate that the tested fibroblasts could win the race for
the surface over Staphylococcus aureus (S. aureus).19 However, biofilms were able to grow
on surfaces of titanium, titanium-zirconium alloy, and zirconium-oxides with comparable
roughness/smoothness,45 and although the roughness or hydrophobicity did not have a
decisive influence, the lowest biofilm formation was observed on the roughest titanium sur-
face. To better understand this effect, co-culture studies are needed to reliably predict the
chances of host cells winning the race for the surface. Such studies with human-gingival-
fibroblasts (HGF) revealed that bacteria decreased the amount of HGF cells on all, but
the smooth titanium surface, which supported the best soft tissue integration.45 However,
other works observed no significant differences between rough and smooth surfaces for
implant survival,46 and even significantly higher survival rates for rough surfaces.47 A co-
culture study compared the antimicrobial behavior of untreated titanium surface (Un-Ti)
with sulfuric acid treated surface (SA-Ti) leading to a higher surface roughness, and sulfu-
ric acid treated titanium surfaces with immobilized chitosan (SA-CS-Ti), whereas chitosan
is known to decrease bacteria attachment. SA-CS-Ti surfaces showed the lowest bacteria
adhesion both after 30 min and 4 hours (when S. aureus were incubated together with os-
teoblasts). This could be a consequence of the increased roughness due to the sulfuric acid
treatment enhancing the attachment of cells and bacteria, while chitosan only minimized
bacterial attachment, or at least minimized bacteria attachment stronger than osteoblast
attachment. However, from 30 min to 4 h the amount of osteoblasts only increased on
Un-Ti surfaces.48 Such co-culture studies49,50 provide important data for predicting the
chances of successful osseo- or soft tissue integration. The combination of surface treat-
ment and release of bactericidal agents seems to be the most promising strategy to prevent
DAI, although studies over longer periods of time are still needed.
1.2 Antimicrobials
Antimicrobials are substances that act against microbes (e.g. bacteria, fungi, virus, par-
asite) either by killing them or stopping their growth. Antibiotics are active against
bacteria, fungicide against fungi, antiviral drugs against virus, and antiparasitics against
parasites. However, a drug of one of these classes of drugs is not active against the whole
class of the specific microbes. Cephalexin, an antibiotic for instance, is not active against
all bacteria.
1.2.1 Different classes of antibiotics
Bacteria can be divided into two groups regarding their cell wall composition. The cell
wall of both groups is composed of an inner, cytoplasmic membrane containing proteins
followed by a peptidoglycan layer, which is thick for the gram-postive bacteria and thin
for the gram-negative ones. Additionally, the gram-negative bacteria possess an outer
membrane. Gram-negative and gram-positive bacteria can be distinguished by the gram
test from which they obtained the name. The gram positive bacteria retain the violet dye
in the thick peptidoglycan layer and are stained violet. The gram negative bacteria do
not retain the dye and get stained pink by the counter dye (Figure 1.3).
This difference in cell type affects the way that antibiotics effect the bacteria. Gram
negative bacteria with the outer membrane, providing them further protection, are more
resistant to antibodies and antibiotics than Gram positive bacteria which are lacking the
8
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Figure 1.3: Schematic representation of gram-negative and gram-positive cell walls. Gram
positive bacteria are stained purple while gram-negative ones pink by the gram test.51,52
outer membrane. Antibiotics act by either killing bacteria (bactericidal antibiotics), or by
preventing bacteria from growing and reproducing (bacteriostatic antibiotics). To achieve
the best treatment outcome, it is important to know the bacteria causing the infection
in order to choose a suitable antibiotic out of the vast numbers of antibiotics on the market.
Penicillin, discovered by Alexander Fleming in 1928, started the antibiotic era. It is a β-
lactam antibiotic and contains a β-lactam ring like all β-lactam antibiotics. Cephalosporins
such as cephalexin, belong to them as well. β-lactam antibiotics are bactericidal and in-
hibit cell wall biosynthesis, precisely the formation of the peptidoglycan layer, which is
important in bacteria, especially in gram-positive bacteria being the outermost layer of
the membrane. Bacteria can develop resistances by producing enzymes (e.g. β-lactamase)
which break down the β-lactam ring.
Tetracyclines, first discovered in the mid 1940’s, contain four six-membared rings fused
linearly together and are broad– spectrum antibiotics active against several gram-negative
and gram-positve bacteria. However, they are used less due to increasing resistance. They
are bacteriostatic and inhibit the biosynthesis of proteins on bacterial ribosome.
Another bacteriostatic antibiotic discovered the same time as tetracyclines is Chloram-
phenicol. It inhibits bacterial growth and protein synthesis by preventing protein chain
elongation. It is a braod-spectrum antibioitc but only used in cases where infections are
life-threatening due to the possibility of serious toxic effects. In developing countries how-
ever, it is a much more common antibiotic due to its low cost and high availability.
Quinolones are broad-spectrum antibiotics widely used in hospital acquired infections
where resistance to older classes of antibiotics is suspected. Quinolone antibiotics were
introduced in the 1960s and have a core structure related to 4-quinolone with an attached
carboxylic acid group. Many contain a fluorine atome due to which they are then referred
to as fluoroquinolones. They are bactericidal and interfere with the deoxyribonucleic acid
(DNA) replication and transcription. Unfortunately, resistances to quinolones can be par-
ticularly rapid in its development.
Lipopeptides were discovered in the late 1980s. This class of antibiotics contains a lipid
bonded to a peptide. They are bactericidal and disrupt several aspects of the cell mem-
brane function. This seems to be advantageous as resistance to these antibiotics are rare,
although have been reported.
9
PhD Thesis Serena Rigo
Several metals such as selenium,53 zinc,54,55 Gallium,54 copper55 or silver55 are used
in antimicrobial treatment strategies due to the intrinsic antimicrobial properties of the
elements. These elements are applied in the form of salts, nanoparticles (NPs) or ions to
fight and prevent antimicrobial infections. The use of silver ions in their most common oxi-
dation state (Ag+) is the predominant inorganic approach that has been developed.20,56,57
AgNPs offer the advantage of reducing possible precipitation and therefore inactivation of
free silver ions,58 as well as inhibiting the toxic effect of free silver ions by storing them
in the zero oxidation state (Ag0).20 It was demonstrated that AgNPs have slower in vitro
antimicrobial activity (at the same total silver concentration) than free silver ions, because
of the release kinetics of Ag+ from the AgNPs.59
Gramicidins were the first antimicrobial peptides (AMPs) discovered in 1939 and later also
commercially used as antibiotics. However, it lasted until the 1980s, with the descriptions
of cecropins and magainins, for the research of AMPs to get popular. Since then a vast
amount of new AMPs were discovered and characterized.60 They are ubiquitous in multi-
cellular organisms from plants, bacteria, insects, amphibians, birds, and mammalians.60,61
AMPs exhibit excellent biocompatibility and are less prone to create resistance in bacte-
ria due to their mechanism of attacking the cell membrane rather than specific targets.62
They selectively rupture bacteria but not mammalian cells. No cytotoxicity was observed
in mammalian cells for the release of short cationic AMPs when covalently attached,63 em-
bedded in polysaccharide films,64 or physically adsorbed on titanium-oxide nanotubes.65
Various modes of actions for AMPs were proposed, mostly aiming the bacterial plasma
membrane in which pores are formed, the membrane is thinned, or completely lysed and
assembled into micelles. The peptide membrane interactions are typically driven by elec-
trostatic forces.66,67 Some peptides also penetrate into the bacteria manipulating intracel-
lular targets like inhibiting the synthesis of proteins, DNA, or ribonucleic acid (RNA).66
With these characteristics, AMPs are a promising alternative to conventional antibiotics,
because they possess broad antibiotic effects, but supposedly induce less resistance than
conventional antibiotics.62,68
1.2.2 Resistance: strategies needed
Bacteria have developed many different resistance strategies to survive in antibiotic set-
tings. The great genetic flexibility allows bacteria to adapt quickly and survive in changing
environments. Genes are not only classically transferred from one bacteria generation to
the next one but also horizontally, meaning from one bacteria to an already living one
from the same or a different species. Genes responsible for certain resistance mechanisms
can through this horizontal gene transfer spread quickly to different bacteria and envi-
ronments globally.69 Resistance against certain antibiotics were already identified shortly
after the discovery or introduction to clinical use of the antibiotic itself. Resistance genes
(R-genes) are also found in people living far from the modern civilisation without contact
to antibiotics. R-genes are up to 600 million years old. Many Bacteria are producing
antibiotic compounds them self. These bacteria developed resistance strategies to protect
themselves from their own produced antibiotic. Resistance is inevitable but spread dra-
matically since the introduction of antibiotics to the market during the last century. The
selection of resistant bacteria strains was accelerated due to the overload of antibiotics in
the environment as a consequence of the over- and misuse of the antibiotics in the society.
The production of antibiotics is cheap. Less than half of the antibiotics produced are used
10
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for therapeutic applications in humans.70 However, the same antibiotics are also used in
animal breeding and in agriculture to optimize health and growth of animals and crops,
leading to a high abundance of antibiotics in the environment. Therefore, the ecological
equilibrium between antibiotic susceptible and resistant stains shifted towards resistant
bacteria strains.69 To slow down the emergence of new resistances or the spread of al-
ready established resistance mechanisms, it is important to regulate the use of antibiotics
and only apply an appropriate one when needed against species susceptible to that spe-
cific antibiotic applied. The design and development of niche antibiotics instead of broad




Amphiphilic molecules are composed of both hydrophilic and hydrophobic parts. A promi-
nent example in nature are lipids with a hydrophilic head group and a hydrophobic tail
which together with membrane proteins, make up the membrane boundary of natural vesi-
cles which store, transport, produce, or protect molecules such as enzymes by generating
compartmentalized reaction spaces. A large variety of biological vesicles with different
functions exists such as extracellular vesicles for long and short distance communication
between celles,72,73 endosomes that encapsulate extracellular material and cell surface
proteins and thereby transport them within the cell for recycling or degradation,74 or
lysosomes that enclose many degradative enzymes.75
The high specificity and complexity of biological membranes limits their industrial and
technological application. Therefore, natural or synthetic lipids are used to design more
simple systems that mimic biological membranes.76 Due to their amphiphilic character,
lipids are able to self-assemble into various structures, such as micelles or vesicles (lipo-
somes) that are often applied as delivery systems in the cosmetic and pharmaceutical
industries.77,78 However, one major drawback of liposomes and other lipid-based struc-
tures is their instability in the body. Functionalizing lipids with polymers, for example by
PEGylation79 was found to improve liposome stability and stealthiness, meaning avoid-
ing major biological reaction or interactions that would lead to degradation and removal
of the structure from the blood. This prompted the development of membrane mimics
composed purely of amphiphilic polymers80,81 that contain at least one hydrophilic and
one hydrophobic block. Depending on how many blocks are used, these amphiphilic poly-
mers are referred to as di- or tri block copolymers; AB or ABA, respectively, with A
being the hydrophilic and B the hydrophobic block.82,83 Triblock copolymers with differ-
ent hydrophilic blocks A and C on either side of the hydrophobic block B are designed to
create asymmetric membranes with different properties.84–86 Like lipids, amphiphilic poly-
mers can self-assemble into structures allowing mimicking biological compartmentalization
strategies;2 however, block copolymers are much more versatile than lipids because they
can be composed of a wide range of building blocks synthesized from chemically distinct
monomers, and lend themselves to chemical modifications. In addition to the possibility of
functionalization, which allows for tuning the surface properties, polymer-based nanocarri-
ers are usually more stable than lipid-based systems.83,87–91 These features are particularly
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important for in vivo applications because they help to prolong circulation time in the
body.92 The robust polymer membrane also protects the cargo from adverse effects from
the environment as exemplified by a poorly soluble and unstable antimalarial compound,
which in a polymer formulation showed increased solubility while retaining activity.93
Amphiphilic bock-copolymers with specific molecular weight and dispersity (D) can be
synthesized by different approaches such as (1) reversible addition–fragmentation chain
transfer (RAFT) polymerization, (2) atom transfer radical polymerization (ATRP), (3)
anionic living polymerization, or (4) ring-opening polymerizations (ROPs), each one hav-
ing its own advantages and disadvantages also regarding their further application. In living
polymerization, the reaction stops once the monomer in solution has been consumed and
restarts upon addition of fresh monomer. Because it offers precision and control over
molar mass and end-groups, living polymerization is a popular method for synthesizing a
variety of distinct block copolymers (ABA, ABC, ABCA, etc.).94
(1) RAFT polymerization is a versatile polymerization technique where many differ-
ent vinyl monomers and different solvents including water can be used and reaction
conditions are moderate. Besides, it is effective for the synthesis of block and hyper-
branched copolymers. For example, thermoresponsive poly[(glycerol monomethacrylate-
stat-glycidylmethacrylate)]-block-poly(2-hydroxypropyl methacrylate) block copolymers
were synthesized via RAFT.95 It is a controlled polymerization, however, re-initiation
is required once monomer is completely consumed. One major advantage of RAFT poly-
merization is its tolerance of functionality including introduced substituents that can be
used in ’click’ reactions.96,97
(2) ATRP is another method that can be applied to synthesize polymers from a wide
selection of vinyl monomers. For example, the positively charged, photosensitive poly(2-
dimethylaminoethyl methacrylate) (PDMAEMA) was synthesized by ATRP. Under UV
irradiation, PDMAEMA changes to its neutral form, which as a constituent of a self-
assembled nanocompartment enables the slow release of a compound from the compart-
ment.98 However, ATRP typically requires a transition metal catalyst, albeit metal-free
catalyst are emerging.99,100 The possible toxicity associated with the metal catalyst and
its ligands makes careful purification necessary and limits the potential of polymers syn-
thesized via ATRP in biomedical applications.97
(3) In anionic living polymerization, the variety of possible vinyl monomers for polymer
synthesis is reduced as the negative charge needs to be stabilized and delocalized with the
help of stabilizing substituents.
(4) ROP are other living polymerization techniques94 with which biodegradable polymers
can be synthesized.97,101 ROPs are sensitive to impurities including water and oxygen. As
the name suggests, cyclic monomers are used and react with the reactive polymer end by
opening its ring system and turning itself into the reactive end. Depending on the nature of
the propagation center they are referred to as radical-, anionic-, or cationic ROP. Anionic
ROP can be used for the synthesis of polyesters, polyamides like nylon 6, polycarbonates,
polyurethanes, and polyphosphates in a controlled fashion. Also polydimethylsiloxane
(PDMS), which is the hydrophobic block of the block copolymer used for the research
described in this thesis, can be synthesised by anionic ROP.102,103 PDMS is biocompat-
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ible and widely used in biomedical applications such as breast implants, contact lenses
or pacemakers.104 Cationic ROP is one of the techniques used for the synthesis of poly-
oxazolines like the poly(2-methyl-2-oxazoline) (PMOXA),82,105 which is the hydrophilic
block of the block copolymer used for the research described in this thesis. PMOXA is a
biocompatible and bioinert polymer, which decreases blood clotting, protein adsorption,
and bacteria colonization.104,106 Furthermore, PMOXA is a peptidomimetic but is known
to be more stable towards degradation.106,107
The polymerization techniques mentioned above result in a statistical distribution of dif-
ferent chain lengths. This variation is described by the dispersity D (Equation 1.1),
defined by the ratio between the weight average molecular weight (Mw) (representing the
molecular weight above and below which there is an equal mass of polymer chains) and
the number average molecular weight (Mn) (representing the molecular weight above and
below which there is an equal number of polymer chains) for the polymer. A narrow mass
distribution of the polymer gives a low D, which is always greater than one because Mw
is always bigger than Mn, as Mn is more sensitive to lower mass molecules. Thus, if all






Amphiphilic block copolymers can self-assemble in aqueous diluted solution into various
nano- or micrometer sized structures such as spherical micelles, cylindrical micelles, tubes,
lamellar structures, or vesicles (polymersomes) (Figure 1.4).83 There are different pro-
cedures to form such self-assembled structures: In the cosolvent,86 solvent switch,109 and
the water addition/solvent evaporation86 procedure, the amphiphilic block copolymer is
dissolved in an organic solvent. During the solvent switch and water addition/solvent
evaporation procedure the ultimately desired solvent system in which only the hydrophilic
block is soluble, i.e., an aqueous buffer, is added to the polymer solution. Alternatively, the
polymer solution is added dropwise to the aqueous solvent during the cosolvent method.
Monodispersed vesicles mostly in the micrometer range with high encapsulation efficiencies
can be obtained by double emulsions using microfluidics. Water droplets are kept within
an oil layer surrounded by water. In this technique, the organic solvents together with the
high complexity of the set up, are the main disadvantages. The evaporation of the organic
solvent after vesicle formation is not yet efficient.110,111 One disadvantage of all these
mentioned methods is that traces of organic solvent might remain in the system which
might be toxic for downstream applications. This is not the case in the film rehydration
method,86,112 where the polymer dissolved in the organic solvent is first completely dried
to a thin film, whose subsequent rehydration with aqueous buffer results in self-assembly
without residual organic solvents. A very similar method is the solid rehydration, where
the polymer is directly rehydrated from a bulk powder instead of a thin film.113
The type of polymer, the solvent(s), and the method applied for self-assembly affect what
structure will be obtained. The nature of the polymer, its molecular weight (Mw), its
hydrophilic fraction f (Equation 1.2), and the packing parameter P (Equation 1.3)
are crucial parameters that determine the structures resulting from self-assembly (Figure
1.4).
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Figure 1.4: Different structures self-assemble from amphiphilic block cpoppolymers in di-
lute solutions. The hydrophilic fraction (soluble fraction) of amphiphilic block copolymers









v describes the volume occupied by the hydrophobic, water insoluble block, and lc its
length. a0 is the optimum area between the volumes occupied by the soluble and insoluble
blocks. All these parameters (v, lc, and a0) are defined in an equilibrated state where the
interactions between the two blocks are balanced. The curvature which arises due to the
relative size ratio of the two blocks is reflected in P , and is an important determinant for
the ensuing structure.
Self-assembly is based on intramolecular and intermolecular interactions, mostly driven by
non-covalent hydrophobic interactions. In order to initiate self-assembly, the dilute poly-
mer concentration in solution needs to exceed the critical micelle concentration (CMC).
In aqueous media, the hydrophobic blocks tend to align and are protected by the hy-
drophilic blocks, in order to minimize the total free energy. To obtain polymersomes, the
hydrophilic, water-soluble, fraction of the block copolymer should be around 35% and 1/2
≤ P ≤ 1. Polymers with hydrophilic fraction of 40 – 50% and 1/3 ≤ P ≤ 1/2 tend to
self-assemble into rod-like aggregates. Theoretically, the most stable condition for self-
assembled structures would be infinitely long cylinders and infinitely large membranes.
However, in order to avoid contact between the insoluble fraction and the solvent, the
cylinders bend and form cylindrical micelles while the membranes close to polymersomes.81
Block copolymers with a hydrophilic fraction larger than 50% and P ≤ 1/3 tend to form
spherical micelles. Along with the polymer nature, the solvent properties (including pH,
polarity, viscosity, osmolarity, temperature) and the concentration also have an impact on
which structure is preferentially formed.115 In concentrated polymer solutions, different
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structures (i.e. hexagonally packed cylinders, cubes, inverse structures, or lamellae) can be
formed. With increasing copolymer concentration spherical micelles transform into cubic
phases, then hexagonally packed cylinders and finally lamellae while cylindrical micelles
directly form hexagonally packed cylinders. Vesicles first form hexagonally packed vesi-
cles, then bicontinuous phases and finally also lamellea, whereas at high concentration also
inverse structures have been observed. Generally, with increasing concentration, spherical
assemblies change into cylinders and eventually membrane like structures.115
An important parameter to characterize the self-assembled structures is the shape fac-
tor (ρ), which is the ratio of the radius of gyration (Rg) and the hydrodynamic radius
(Rh) (Equation 1.4). Rg and Rh are obtained by static light scattering (SLS) and dy-
namic light scattering (DLS) measurements, respectively. For homogeneously spherical
structures, like micelles, Rg is smaller than Rh and therefore, ρ < 1. For a hollow sphere,
ρ equals 1, since there is no mass in the cavity. For extended structures such as worms,
ρ > 1. The combination of SLS/DLS is very useful, because it gives precise information





Micrographs obtained by transmission electron microscopy (TEM) also provide informa-
tion on the morphology of self-assembled structures. However, the harsh conditions of
sample preparation might interfere with structure preservation. In particular, depending
on the stiffness of their membrane some polymersomes collapse and will appear as deflated
balls in negatively stained TEM images.
1.3.3 Polymersomes and micelles
Hollow polymer self-assemblies where the aqueous cavity is surrounded by a polymer mem-
brane are called polymersomes (Figure 1.4). They can host a wide range of hydrophilic
molecules including some antibiotics in their cavity116 and hydrophobic compounds in their
membrane. Polymersomes are very robust and thus, protect the integrity and activity of
encapsulated compounds.89 Micelles on the other hand have no aqueous cavity. Their hy-
drophobic core consists of the hydrophobic block(s) and is surrounded and shielded from
the aqueous media by the hydrophilic block(s) (Figure 1.4). Micelles can be loaded with
hydrophobic compounds.93
Depending on the polymers used, these polymeric self-assembled structures are usually
biocompatible and have low toxicity.117,118 In addition, the diversity of polymer building
blocks allows them to be chemically tuned to respond to various stimuli, either internal
(i.e. pH, enzymes, oxidative stress, etc.) or external (i.e. temperature, magnetic field,
light, ultrasound).119
Some polymeric self-assemblies exhibit antibacterial activity in the absence of antibiotic
cargos. Such intrinsic antibacterial activity has been reported for polymersomes based
on the thermoresponsive block copolymer Poly[2-(2-methoxyethoxy)ethyl methacrylate]-
Poly[2-(tert-butylaminoethyl) methacrylate] (PMEO 2 MA-b-PTA).120 The PTA amino
groups bear a positive charge and thus can interact with Ca2+ and/or Mg2+ ions of the
bacterial membrane and consequently damage it. These polymersomes were tested on both
Gram-negative E. coli and Gram-positive S. aureus at neutral pH 7.4 When solutions of
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polymersomes were added to bacterial cultures, counting of the resulting colonies led to
the conclusion that bacterial growth was prevented by the presence of PMEO 2 MA-b-
PTA polymersomes. In another study, the conjugation of a synthetic, biodegradable block
copolymer poly(ε-caprolactone) (PCL) with the antibacterial block poly[phenylalanine-
stat-lysine-stat-(lysine-folic acid)] (Phe12-stat-Lys9-stat-(Lys-FA)6) resulted in a polymer
able to form antibacterial polymersomes in aqueous solution.121 Similar to what was re-
ported for the PTA amino groups, lysine residues that become positively charged in water
mediate attachment to the bacterial membrane, enabling membrane penetration by the
phenylalanine residues and the subsequent death of E. coli and S. aureus.
1.3.4 Nanoreactors and membrane permeability
Polymersomes can function as compartments or carriers for antimicrobial agents. They
are considered catalytic nanocompartments, so called nanoreacters, when they host en-
capsulated enzymes or catalysts for the in situ produciton of active agents and enable
the exchange of educts and products across the polymer membrane (Figure 1.5A).122
Compared to lipid membranes, polymeric membranes are composed of heavier amphiphiles
and their membranes are thicker. Due too this increased thickness,89,123 they benefit from
greater stability but are also known to be less permeable (Figure 1.5B).91 PMOXA-
Figure 1.5: A) A schematic representation of a nanoreactor with two enzymes (C and E)
encapsulated and able to conduct a cascade reaction from A to D and further to F. These
substrates and products are able to pass through the membrane due to the insertion of
protein channels (B).124 B) Schematic plot of physical properties of vesicles versus the
molecular weight of the corresponding amphiphiles.91
PDMS based block copolymer membranes, for example, are even impermeable to many
ions and small molecules125 except for dithiothreitol126 or oxygen species, i.e. O2
•−.127
However, in order for nanoreactors to be functional, the substrates, and products must
be able to pass through the membrane, either into the cavity where the enzyme or cata-
lyst resides or out of the cavity to keep concentration dependent inhibition of the enzyme
from occurring. This can be achieved by several existing permeabilization techniques such
as: (i) The use of block copolymers, which naturally form a porous membrane.128 (ii)
Chemical modification to create pores into the membrane.129 (iii) Mixing polymerizable
diblock copolymers, with nonpolymerizable phospholipids which can be removed from the
membrane after self-assembly.130
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(iv) The insertion of channel proteins, biopores, or ionophores131–133 that allow the pas-
sage of specific reactants (e.g. divalent ions through ionomycin,134 protons and monova-
lent cations through gramicidin,135 electrons through the photosynthetic reaction center
membrane protein,136 or protons through proteorhodopsin137) or the passive diffusion
of molecules up to a certain size through the membrane. The outer membrane pore F
(OmpF, MWCO: 600Da)138 is an example and the molecular weight cut-off (MWCO) can
be reduced by using OmpF mutants (OmpF G119D, MWCO: 300Da).139 Polymeric mem-
branes are thicker than natural lipid membranes (Figure 1.5B) which then create for all
natural biopores and membrane protein a hydrophobic mismatch between the hydrophobic
domain of the synthetic membrane and the length of the biopore or membrane protein.
However, due to the flexibility of the membrane, membrane pores and proteins can still be
successfully reconstituted. Ionomycin for example could successfully transport Ca2+ across
polymeric membranes which were up to 8.9 times thicker than the length of the pore.140
Several factors (e.g. type of detergent and concentration, pH, membrane composition and
membrane pore) and a combination thereof play a role in successful channel protein recon-
stitution. The design of experiment method, using a mathematical framework to keep the
numbers of needed experiment low while still modeling results matching the experiments,
has been successfully applied for the optimized insertion of proteorhodopsin, a light driven
proton pump.137 The channel proteins, biopores, or ionophores are inserted and reconsti-
tuted into the polymer membrane either already during the self-assembly process or by
the external addition to the polymersome.
Furthermore, triggered passage across the membranes are possible such as by the insertion
of modified OmpF rendering it pH responsive.141 Similarly, responsive block-copolymers
can be used for self-assembly to turn the membrane porous upon a certain trigger (pH,
temperature, light, or enzyme degradation) by changing the hydrophobicity of one of the
blocks to reversibly destabilize the membrane allowing the passage of small molecules or
by degrading the whole membrane allowing the release of the encapsulated cargo.116,119,142
To further improve the efficacy of such compartmentalized structures, membranes can be
functionalized for targeting. This allows them to release their cargo close to the place or
inside the cells needed.143
1.4 Nanoscience based delivery of Antibiotics
1.4.1 Polymersomes loaded with antimicrobial agents
An example of applying polymersomes to battle bacteria is the efficient treatment of
Porphyromonas gingivalis (P. gingivalis) infected oral keratinocytes with drug-loaded
polymersomes.144 Specifically, metronidazole and doxycycline antibiotics have been en-
capsulated in poly[2-(methacryloyloxy) ethyl phosphorylcholine] (PMPC) - poly[2-(diiso-
propylamino) ethyl methacrylate] (PDPA) polymersomes. The PMPC block interacts
with specific plasma membrane receptors that promotes endocytosis. The PDPA block
is pH-responsive, which is very important and serves as a trigger for antibiotic release.
Accordingly, polymersomes disintegrate at the acidic pH of the endosomal-lysosomal com-
partment (pH 6.5-4.5) releasing their cargo. The effect of antibiotic loaded PMPC-PDPA
polymersomes was tested in vitro. H357 and TR146 human oral squamous cell, carcinoma-
cells, and NOK cells (immortalized oral keratinocytes) were infected with P. gingivalis and
then incubated with antibiotic loaded polymersomes. Apart from these three cell lines, a
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tissue-engineered oral mucosa that more closely represents the physiological conditions of
a living organism was used as a test model. Even though P. gingivalis were not completely
eradicated from either of the test systems, the results strongly indicate that metronida-
zole and doxycycline loaded polymersomes were uptaken by the cells, disintegrate in the
endosomal compartment and show antibacterial activity. Subsequently, pH responsive
PMPC-PDPA polymersomes were loaded with a number of antimicrobial drugs includ-
ing gentamicin, lysostaphin, vancomycin, rifampicin, and isoniazid.145 Their potential to
reduce intracellular pathogens was tested both in vitro and in vivo, in monocyte-derived
macrophages (THP-1 cells) and embryos of zebrafish (Danio rerio), respectively. Both
THP-1 cells and the zebra fish embryos were infected with either S. aureus, Myobacterium
bovis-attenuated Bacillus Calmette–Guérin (M. bovis-BCG), Myobacterium tuberculosis
(M. tuberculosis), or Myobacterium marinum (M. marinum) bacteria. After screening all
possible combinations of cargoes and infected model systems, antimicrobial loaded poly-
mersomes were found to inhibit the bacterial growth both in vitro and in vivo in all the
cases.
Moreover, copolymerisation of 2-hydroxyethyl methacrylate (HEMA) and poly(ethylene
glycol) methyl ether methacrylate (O950) yielded a library of block copolymers. Selected
copolymers were found to spontaneously form polymersomes and to be pH responsive.146
Loaded with the hydrophilic antibiotic drug ceftazidime, these pH responsive polymer-
somes were incubated with RAW 264.7 murine macrophages previously infected with
Burkholderia thailandensis (B. thailandensis). In order to evaluate the impact of the
ceftazidime containing polymersomes on the bacterial growth, treated RAW 264.7 cells
were examined by fluorescence microscopy and colony forming units (CFUs) were counted.
Similar to the findings described above for PMPC-PDPA polymersomes, ceftazidime was
released when pH-responsive polymersomes had reached the endosomal compartment and
inhibited bacterial growth to a noticeable extent.
A different approach is based on the co-assembly of polymersomes derived from poly(ε-
caprolactone)-block-poly(lysine-stat-phenylalanine) PCL-b-P(Lys-stat-Phe) block copoly-
mers and hydrogels made from dibenzaldehyde-functionalized PEG (DF-PEG) block co-
polymers that appear to show “quick” and “long-term” antibacterial function.147 Here,
both the polymersomes and the hydrogels contain the antibiotic penicillin G from Penicil-
lium chrysogenum. The porous structure of the hydrogels allows for the release of penicillin
G as well as the release of antibiotic containing polymersomes. The presence of penicillin
G within the hydrogels allows for fast antibacterial action (“quick” release). However, the
half time of penicillin G is rather short, up to 30 min. By incorporation into polymer-
somes, penicillin G is protected and its activity is extended through a long-term release.
At the same time, these specific polymersomes exhibit intrinsic antimicrobial activity: the
positively charge lysine residues of the surface-exposed P(Lys-stat-Phe) corona can bind
to the negatively charged bacterial membranes and disrupt them. In addition, the inter-
action of the polymer membrane with the bacteria facilitates the release of the antibiotic
cargo. The hydrogel-polymersome system was tested in S. aureus (Gram-positive) and E.
coli (Gram negative) bacteria cultures and was shown to effectively reduce their viability.
Furthermore, these studies revealed that the coexistence of hydrogels and polymersomes
was critical to significantly extend the duration of penicillin G release.
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1.4.2 Inorganic NP delivery
Inorganic NPs were introduced as promising antibacterial agents but they face the limita-
tion of low specificity and high toxicity in eukaryotic cells.148 Conceivably, these limitations
can be overcome by encapsulating NPs in polymer-based assemblies such as polymersomes
or micelles. Hence, the antibacterial activity of inorganic NPs is combined with the en-
hanced stability and biocompatibility of polymer nanostructures.
In a fundamental study, silver nanoparticles (AgNPs) were incorporated into the mem-
brane of polymersomes and the resulting nanostructures were tested for antimicrobial ac-
tivity in vitro.149 Specifically, PEO-b-P(DMA-stat-tBA) block-copolymer was synthesized
and was shown to self-assemble into polymersomes in aqueous solution. The polymersome
solution was then mixed with an AgNO3 solution and solid NaBH4 was added under stir-
ring. As a result, AgNPs formed within the polymersome membrane. The Ag-decorated
polymersomes were evaluated for their antibacterial efficacy in vitro. When Gram-negative
E. coli were exposed to the Ag-decorated polymersomes, MIC and Minimum Bactericidal
Concentration (MBC) were low, and the inhibition of bacterial growth was rather high.
In a next step, methoxypoly(ethelyne glycol)-poly(D)-(L)-lactic acid (mPEG-PDLLA), a
biodegradable block copolymer, was used to produce polymersomes with AgNPs incorpo-
rated into the hydrophobic part of the membrane. Additionally, the hydrophilic cavities
of the mPEG-PDLLA polymersomes were loaded with ampicillin. The potential antimi-
crobial activity of the AgNPs and antibiotic containing mPEG-PDLLA polymersomes was
tested by monitoring the proliferation (CFU mL−1) of a suspension of ampicillin-resistant
E. coli.150 The optical density at 600 nm (OD 600) was measured for 24 hours following
their treatment with free ampicillin, Ag containing polymersomes without ampicillin, and
ampicillin containing polymersomes without silver nanoparticles. From this study resulted
that the combination of Ag and ampicillin in polymersomes was able to significantly in-
hibit the bacterial growth, whereas with the other treatments, the bacteria were able to
proliferate.
Other examples of inorganic NPs on the membrane and antibiotic in the aqueous cav-
ity include mPEG-b-PDLLA based polymersomes hosting the antibiotic methicillin in the
hydrophilic core and hydrophobic superparamagnetic iron oxide nanoparticles (SPIONs)
in the membrane bilayer.151 These assemblies are called iron oxide-encapsulating poly-
mersomes (IOPs). Biofilms formed by Staphylococcus epidermidis (S. epidermidis) grown
on glass cover slips were incubated with IOPs. Taking advantage of the magnetic proper-
ties of SPIONs, a magnet placed underneath the coverslip was used to attract the IOPs
and make them penetrate the biofilm. The unique combination of SPIONs and antibiotic
within polymersomes exposed to a magnet resulted in a uniform penetration and sub-
sequent eradication of the biofilm, making it a weapon of great potential against drug
resistant bacteria.
1.4.3 Antimicrobial producing Nanoreactors
Nanoreactors assembled from the amphiphilic block copolymer poly(2-methyloxazoline)-
block-poly(dimethylsiloxane-block-poly(2-methyloxazoline) (PMOXA-b-PDMS-b-PMOXA)
that were loaded with the enzyme penicillin acylase (PA) were able to locally produce an-
tibiotics.152 To obtain these vesicular catalytic nanocompartments, the polymer was dried
together with the bacterial porin OmpF to a thin film which was then rehydrated in a
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buffer containing PA. This way, OmpF was inserted in the membrane of the resulting poly-
mersomes, forming a protein gateway that allows the diffusion of molecules up to around
600 Da. In parallel, PA was encapsulated in the hydrophilic cavity of the nanoreactors.
When the externally added substrates 7-aminodesacetoxycephalosporanic acid (7-ADCA)
and phenylglycine methyl ester (PGME) diffused into these catalytic nanocompartments,
an enzymatic reaction took place in the cavity and cephalexin was produced. Cephalexin
is a well-known antibiotic disrupting the growth of the bacterial cell wall of S. aureus, S.
epidermidis, E. coli and Proteus mirabilis (P. mirabilis).153,154 To confirm the antibiotic
activity of the produced cephalexin, the effects of PA-loaded nanoreactors on the growth
of E. coli were monitored in the presence and absence of substrate. Notably, the growth
of E. coli was inhibited by the presence of the antibiotic producing nanoreactors which
remained active (i.e. they kept producing cephalexin) for seven days under physiological
conditions.
Similarly, a light-sensitive, water-soluble tetraalkylpyridinium porphyrin (TpyCP) was
encapsulated into PMOXA-b-PDMS-b-PMOXA polymersomes and evaluated for its an-
timicrobial activity against E. coli.112 TpyCP is a photosensitizer, that upon irradiation
(e.g., LED light of 660 nm wavelength) is able to induce reactive oxygen species (ROS)
production and cause oxidative stress in target cells in vitro. The particular advantage
of this system is that only the ROS produced in the aqueous cavity of the polymersomes
diffuse across the polymer membrane and reach the bacteria of interest, whereas TpyCP
remains encapsulated. This compartmentalization allows for a selective and controlled
process. The antimicrobial activity of light-induced ROS was demonstrated by irradiating
E. coli cultures that were incubated with porphyrin containing polymersomes. Counting
CFUs and imaging of corresponding E. coli cultures by confocal laser scanning microscopy
(CLSM) strongly indicated that TpyCP-polymersomes caused a significant decrease of the
E. coli population only when irradiated (Figure 1.6).
1.4.4 AMP delivery
To target AMPs to specific sites and protect them from untimely degradation, they were
combined with different nanocarriers.155 A cationic AMP, for example, was mixed with
an anionic block copolymer and based on electrostatic interaction self-assembled into neg-
atively charged polyion complex micelles. After one day 50% of the peptide was released.
Afterwards, the release slowed down and reached 80% of cumulative release after 3 days
where it then stagnated. Compared to free AMP, the hemolytic toxicity could be reduced
while the antimicrobial activity was preserved.156 The loading and release of positively
charged human model AMP LL-37 was influenced by the surface charge and surface area
of silica NP carriers. Higher amounts can be loaded into negatively charged mesoporous
silica NPs compared to positively charged mesoporous or non-porous silic NPs. Further-
more, the peptide was protected from degradation due to its preferred location within the
mesopores of the mesoporous silica NPs.157 The same peptide self-assembled with oleic
acid into cylindrical micelles leading to pH responsive nanocarriers which were antimicro-
bial active at pH 5 and inactive at pH 7.158 Furthermore, among other AMPs, this peptide
was also loaded on anionic poly(ethyl acrylate-co-methacrylic acid) microgels, which pro-
tected these peptides from degradation. Under physiological salt concentration the loaded
peptide was released and could efficiently act against several bacteria.159,160 When formu-
lated with PEGylated phospholipid micelles, the aggregation of an aurein derived peptide
could be decreased as well as the cytotoxicity eased.161 Importantly, molecular dinamics
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Figure 1.6: Left panel, schematic of porphyrin containing polymersomes. Right panel, E.
coli bacteria incubated in presence of 200 µM TPyCP loaded polymersomes were stained
with SYTO 9 (considered alive, green) and propidium iodide (considered dead, red) after
0 min (A) 30 min (B) 120 min (C) and 360 min (D) of illumination with red LED light
(λmax = 660 nm).Scale bars: 10 µm.112
simulations of the AMP magainin2 indicated that the peptide preserved its secondary
structure when encapsulation in PEG, PLGA, or copolymer micelles.162
1.5 Antimicrobial surface strategies
1.5.1 Passive Strategy - micro- and nanostructured surfaces
Whereas the production or release of specific chemicals provides mechanisms for active de-
fense against bacteria and the formation of biofilms, surface micro-structures represent pas-
sive mechanisms, which are non-toxic since no biocides or inhibiting agents are released to
the environment. In nature, various organisms use such passive defense strategies against
bacterial colonization, and these have inspired the development of biomimetic antibac-
terial surfaces.170–172 Models of surface textures from sea organisms, such as sharks,165
pilot whales,164 sea stars166 and mussels,167 have been investigated because these animals
have few problems with fouling organisms. The skins of these different animals are pat-
terned with special microstructures (Figure 1.7a),163 and the spacing between them is
regarded as a key property for inducing antifouling performance.173 Studies on the re-
lationship between feature size and antifouling property indicated that the lowest level
of attachment was for structures of the order of 2 µm (similar to the feature size of the
skin of pilot whales and smaller than zoospores).168 The textures of pilot whale skin have
been tested for their non-fouling properties, and nano- and micro-structure coatings that
mimic whale skin have been fabricated by multilayers of spray-coated polyacrylic acid and
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Figure 1.7: (a) Surface topography of various natural models that resist fouling:163 pilot
whale,164 shark,165 sea stars,166 and mussels167 (from top to bottom; the scale bars are
1 µm, 100 µm, 100 µm, and 10 µm, respectively). (b) SEM images of polyacrylic acid-
polyethylene imine multilayers inspired from pilot whale skins. Scale bars: 1 µm.168 (c)
SEM images of shark skin inspired surfaces with engineered patterns on PDMS elastomers
with a spacing of 2 µm.169
polyethyleneimine (Figure 1.7b).168 The ridged platelet structures on shark skin,165 are
considered to be a key factor in the prevention of biofouling,174 and hierarchically wrinkled
surfaces remained free of fouling for more than a year in field tests.175 Various patterns,
such as pits, pillars, ribs, channels and ridges, that mimic natural surface structures have
been produced using photolithography with a constant spacing of 2 - 20 µm between or-
ganized nanosized features (Figure 1.7c).169,174 Attachment of Cobetia marina, a gram
negative bacterium larger than these surface features, was two orders of magnitude lower
on the structured surface than on smooth polydimethylsiloxane (PDMS).169 SharkletTM,
a product inspired by shark skin is already being marketed, and has been shown to reduce
settled microorganism density by 86% compared to a smooth surface.174
An approach for preventing biofilm formation is the modification of surfaces with syn-
thetic organic compounds, often biocompatible polymers (Figure 1.8a) which directly
reduce bacteria adhesion to the device.176 For example, polyamide reverse osmosis mem-
branes are protected from the attachment of bacteria through a phosphorylcholine block
copolymer coating.176 This is sufficient to reduce bacterial growth by at least a factor of
10. Atifouling strategies, preventing protein adsorption being the first step in the forma-
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tion of biofilms, have been developped with polymer brushes.177,178
Another example of bioinspired synthetic surface pattern was obtained by replicating the
structure of macroalgae. A macroalgae mold in PDMS was filled with epoxy doped with
furanone to obtain artificial microstructured surfaces, which showed 40% less biofouling
than pure epoxy blanks, and thus demonstrated that both the chemistry and topography
affect antifouling properties.179 Using microwave plasma chemical vapour deposition on
a silicon surface, diamond nanocones have been engineered to mimic the topography of
cicada fly wings (Figure 1.8b). Although this structure did not inhibit the development
of bacteria, it killed up to 18% of them at the surface.180
Nanostructured surfaces for instance can be created via direct addition of patterned nano-
objects to kill bacteria once they reach the surface. High-aspect-ratio surfaces have been
produced with silicon nano-pillars patterned by the deep reactive ion etching technique
with SF6 and O2 gases in the etch cycle and C4F6 gas in the deposition cycle. These sili-
con nano-pillars, with random interspaces, increased the contact angle of a silicon surface
from 75◦ to 154◦ and led to up to 86% death of bacteria on their surfaces.181 This strategy
modifies surface topography so that the attachment and growth of pathogens is avoided,
but without mimicking natural surfaces.182 By creating micro- or/and nano-structured
roughness, such surfaces can decrease bacterial growth by being very hydrophobic.183 The
topography can be shaped with biocompatible polymers, such as PDMS, polystyrene,
polycarbonate or polyethylene to obtain a desirable roughness and hydrophobicity with
contact angles increasing from 60-90◦ before, to 150◦ after restructuring.184 These struc-
tured surfaces massively decrease bacteria adherence to <0.1% of biofilm compared to
unstructured surfaces. Surfaces have also been patterned with different microscale mo-
tifs (e.g., pillars, cross pillars, hexagonal pillars, and hexagonal pits) to inhibit bacterial
growth to 11% of coverage compared to the control surface.185 The topographical ap-
proach to preventing biofilm formation by i) controlling surface-roughness and -pattern to
prevent bacteria adherence, or by ii) adding patterned nano-pillars to kill bacteria shows
promising results in antifouling and bactericidal properties, and thus represents a solution
with high potential for protecting medical devices from pathogen infections.
1.5.2 Active Strategy - surface releasing active agents
Most developed solutions for coatings against DAI are based on layers that entrap an-
timicrobial agents44,186 to provide controlled release of drugs (Figure 1.8c). Antibiotics
directly incorporated in polymer coatings resulted in a controlled and constant release of
the drug during 7 days, and induced a decrease in DAI in animal models.187
Another possible active strategy is to load the surface with AMPs. They have been
immobilized on metal-,188,189 nanoparticle-,190 polymer-,191,192 polymer/ lipid-based-,62
or microgel-surfaces,193,194 by various physical or chemical methods.195 For example, two
AMPs have been coupled to polycarbolactone. 4 mol% of this AMP-Polymer mixed into a
polymer film was enough to completely kill Methicillin-Sensitive s. aureus (MSSA).191 Ma-
gainin II was covalently bound to stainless steel surfaces, decreasing bacteria attachment
and showed biofilm resistant abilities.189 A cationic AMP was electrostatically anchored
on titanium nanostructured surfaces from where it was released over several hours to ac-
tively kill bacteria.188 Another AMP, cecropin-melittin, was immobilized with high density
on gold nanoparticle-coated surfaces. Conceivably, the high density of the AMP could be
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achieved through the increase in surface area from the nanoparticles.190 KYE28, another
AMP was incorporated in surface immobilized microgel multilayers, thereby improving an-
timicrobial effects compared to untreated glass surfaces or peptide-loaded monolayers.194
Peptides, immobilized on polydopamine coatings have been used to prevent bacteria ad-
hesion,196 or entrapped in polymer matrix coatings to increase the antimicrobial effect of
free peptides and to keep them at the interface of devices with their biological environment
for up to one month. This controlled their release without producing possible toxicity to
mammalian cells.197 Using compounds that are degraded by pathogens to release drugs
to inactivate bacterial growth is a very interesting approach;198 for example, the destruc-
tion of polysaccharide multilayer films with entrapped AMPs by secretions of bacteria
and yeast led to peptide release and resulted in the destruction of the pathogens.64 Since
sterilization of surfaces, for example by autoclaving, is prerequisite for most biomedical
applications, some of the immobilized peptides were tested for heat stability and the sur-
faces were shown to retain their bactericidal efficacy.199
Biofilm formation can also be prevented by directly using the properties of metallic ele-
ments incorporated in or grafted on the surface of medical devices (Figure 1.8d). Ag-
NPs can be synthesized in an eco-friendly way200 and are nowadays the main inorganic
nanoscience-based surface modification of medical devices.201,202 These NPs have the ad-
vantage of being a stable store of silver and thus having longer use than classical Ag+.20,203
AgNPs are usually functionalized with chemical agents to improve their aqueous stabil-
ity and dispersion20,26,59 before being linked to device surfaces that have been previously
functionalized with polymers,201 hydrogels,20 or chitosan.26 These strategies allow entrap-
ment of AgNPs at the interface between the medical device and the biological environment,
and the release of Ag+, the active bactericide state of silver.203 AgNPs have shown very
high antimicrobial properties by decreasing bacteria present on chitosan gel26 or polymer
brushes201 by > 99.8% 24 hours after exposure. Ag+ release was demonstrated to be
an important parameter in long-term antibiofilm activity, reducing bacteria adhesion and
proliferation in vitro,26 and even leading to an in vivo decrease of DAI in rats.203 AgNPs
have not shown yet any direct toxicity because of prior coating of the NPs with chemical
agents or of the biocompatible surfaces onto which they were entrapped,20,203,204 although
a study has shown that AgNPs can cause hemolysis.205
A recent development has been the use of drug encapsulated vesicles,144 or surface immo-
bilized nanoreactors.206 Micro- or nano-spheres of polylactic acid-polyvinyl alcohol were
loaded with usnic acid, the release of which prevented biofilm formation by reducing the
amount of bacteria by > 10,000 times after 72 hours incubation with S. aureus.207 Im-
mobilized nanoreactors loaded with enzymes are able to produce antibiotics “on demand”
(Figure 1.8e).152,206 They act as self-defending surfaces which allow locally controlled
drug production at a specific rate for long periods of time by adding the required amounts
of substrate to the outer medium.
1.5.3 Techniques to immobilize self-assembled nanostructures
Various methods exist to immobilize nanostructures, including covalent and non-covalent
strategies. In most cases, the nanostructures are equipped with surface modifications
complementary to those of the surface onto which they are immobilized. Non-covalent in-
teractions include the receptor ligand pair biotin-streptavidin, where different immobiliza-
tion strategies are employed. For example, streptavidin is added to a biotinylated surface
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Figure 1.8: A summary of possible synthetic surface nano-functionalization approaches
for preventing DAI. 1) Antifouling properties: surfaces can be (a) coated with organic
compounds or (b) patterned (scale bar = 1 ρm)180 to avoid growth of bacteria. 2) An-
timicrobial properties are provided via (c) peptides/drugs or (d) nanoparticles entrapped
in the organic coatings. Another antimicrobial solution could be (e) the direct grafting of
a nanoreactor onto the surface to control drug release.206
and biotinylated polymersomes are then immobilized on the surface by binding to step-
tavidin.208–211 Using a plasma-polymerized acrylic acid surface that exposes strepdavidin
to interact with biotinylated polymersomes also leads to successful immobilization.212
Another non-covalent immobilization method is based on the adamantane-β-cyclodextrin
host-guest complexation. Here the adamantane moiety on polymersomes fits tightly into
the cavity of β-cyclodextrin which is accessible on the substrate surface.213 Electrostatic
interactions enable the reversible immobilization of polymersomes via Mg2+ bridges214
or the immobilization of negatively charged (COO-) polymersomes on positively charged
(NH3
+) surfaces.215
Covalent interactions include the prominent Schiff-base formation between aldehyde func-
tionalized surfaces and amine functionalized polymersomes216 or vice versa217 with pos-
sible further reductive amination.206 In the thiol-ene click reaction, the double bond
of methacrylate exposed on polymersomes covalently binds to thiol functionalized sur-
faces.218 Another covalent immobilization mehtode is based on the Copper (I) catalyzed
alkyne azide cycloadditon (CuAAC). Azide functionalized polymersomes can covalently
bind to alkyne functionalized surfaces, forming a stable triazole linker.219 However, the
cytotoxicity of Cu(I) represents a significant limitation of this well-established reaction
in biological applications. With the strain promoted azide alkyne click (SPAAC) reac-
tion, a catalyst free reaction pathway was developed that overcomes this limitation,220,221
which was then optimized for polymersome immobilization described in detail in chap-
ter 3.222 Another covalent immobilization technique developed in chapter 4 is based on
the thiol-maleimide Michael addition,223 which was used to covalently link proteins to
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polymersomes.224
1.5.4 Functional surfaces due to immobilized nanostructures
Specialized surfaces (e.g., hydrophilic, hydrophobic, reflective, non-adhesive, anti-fouling,
drug releasing surfaces) play an important role in everyday life such as in cars, windows,
displays, or medicine. Their properties and behavior is tuned towards their function
and desired application. Especially for medical application such as implants, stents, or
catheters optimized surfaces are crucial and can decide over the outcome of a surgery for
instance. Active molecules can be immobilized on the surface. However, free compounds
can get degraded fast by the complex environment, which keeps the surface active for
only a short period of time. Nanostructures (e.g., Polymersomes, liposomes, micelles,
particles) are able to protect such active agents by shielding them from the harsh envi-
ronment.93 Furthermore, the nanostructures can be designed to release the active agent
when needed.92,93,225 Therefore, immobilized self-assembled nanostructures have gained a
lot of interest in recent years. If such nanostructures are immobilized permanently on the
surface, not only would the active agent be released at the site of interest, but its lifetime
would be prolonged, and it would even be possible to control the release of the active
substance over longer periods of time. These benefits have made immobilized polymeric
nanostructures hot topics in recent years.
The described immobilization techniques can be applied to the nanoreactors or drug car-
riers. For polymersomes to be functional on a surface, i.e. create an active surface, it is
crucial that despite being immobilized they remain responsive to redox state, light, pH
etc. To show that immobilized vesicles with a disulfide cross-linked polymer shell maintain
their redox responsive release properties, polymersomes with encapsulated carboxyfluores-
cein (CF) were exposed to the reducing agent tris(2-carboxyethyl)phosphine (TCEP).210
The resulting change in redox potential triggered the release of CF as visualized by a 10
hour increase of fluorescence. To evaluate pH responsiveness, polymersomes were loaded
with pyranine, a pH sensitive dye, and immobilized on a glass substrate.226 Depending on
the pH of the surrounding buffer, the fluorescence was either increased (pH 8) or quenched
(pH 6). Compared to free polymersomes, the immobilized ones retain their responsiveness
although their physical behavior may change. If polymersomes are free in solution, their
swelling, which is induced by a change of pH, occurs equally in all directions. Interestingly,
immobilization causes them to swell more in z direction than in the lateral direction.213
This indicates that immobilization of nanostructures on a surface has an influence on the
physical properties.
Surface-immobilized nanostructures also have great potential in biosensing applications.227
In particular, surfaces coated with catalytic nanocompartments can be used as detecting
platform. For example, ribitol, a model sugar alcohol was detected by means of surface
immobilized polymersomes loaded with the enzyme ribitol dehydrogenase (RDH).227 To
allow selective diffusion of sugar alcohols across the membrane into the cavity where RDH
was encapsulated, the E. coli glycerol facilitator (GlpF) had been incorporated into the
membrane of these polymersomes. Nanoreactors can also be immobilized in a distinct
pattern as demonstrated for polymersomes encapsulating acid phosphatase.208 To obtain
the patterned nanostructures, the surface was first micro-contact printed with biotin and
then strepdavidin was added to immobilize the biotinylated catalytic nanocompartment.
These patterned catalytic nanocompartments successfully dephosphorylated the fluoro-
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genic substrate ELF 97.
Intriguingly, it has been shown that immobilized cationic NPs are more effective in killing
bacteria than free NPs in solution.228 This could be due to the lack of movement of the
NPs during the interaction with the bacteria. Poly(L-lactic acid) (PLLA) nanoparticles
containing AgNPs and the detergent polyvinyl alcohol (PVA) as a stabilizer were im-
mobilized through electrostatic interactions between negatively charged COO- groups on
the PLLA nanoparticles and positively charged NH3
+ groups on the substrate (Figure
1.9a).229 This surface was able to reduce biofilm formation up to 98% compared to im-
mobilized PLLA nanoparticles which are lacking the AgNP. PLLA itself is not having any
influence on biofilm growth. However, it might facilitate silver ion availability as lactic
acid, a degradation product of PLLA, enhances the permeabilization through the bacte-
rial cell wall. Additionally, the decrease in local pH due to lactic acid might enhances the
oxidation and dissolution of the AgNP.
Figure 1.9: Schematic representation of various strategies to design antimicrobial surfaces
by immobilization of different active nanostructures. (a) PLLA-AgNP nanoparticles are
immobilized on an Allylamine plasma polymer thin film. The large grey spheres repre-
sent the PLLA nanoparticles, the yellow dots the AgNP, the red squiggles the detergent
PVA.229 (b) Catalytic nanocompartments encapsulating the enzyme PA are immobilized
on silica wafers. OmpF is used to create pores in the polymersome through which the
educts 7-ADCA and PGME (yellow and green dots) as well as the product cephalexin
(red dots) can diffuse.206 (c) CVC are modified with APTS to obtain amino-functionalized
surfaces on which iron oxide NPs containing the AMP clavA are immobilized. An 808 nm
wavelength laser causes local hyperthermia and ablation.230
The previously discussed nanoreactors that are able to produce the antibiotic cephalexin152
have been immobilized through Schiff-base formation with further reductive amination on
a silica surfaces (Figure 1.9b).206 After immobilization, the nanoreactors stayed active
and were able to produce and release the antibiotic over up to 7 days. This is a strong
indication for a prolonged activity of immobilized nanocompartments in comparison to
nanocompartments that are free in solution. Surfaces with immobilized nanoreactors were
able to reduce bacteria attachment and proliferation.
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AMPs, which often are natural peptides, obtained a lot of attention in recent years.61,66 On
the one hand, they do not seem to evoke resistance, on the other hand, they are able to se-
lectively destroy bacterial membranes. The AMP clavanin A (clavA) was attached on iron
oxide (Fe3O4) NPs functionalized with dimercaptosuccinic acid (DMSA).
230 These Fe3O4-
DMSA-clavA NPs were then immobilized on the inner wall of a central venous catheter
(CVC) which was previously functionalized by aminopropyl trimethoxysilane (APTS) to
create an amino surface (Figure 1.9c). The clavA on the immobilized NPs was able to
disrupt bacterial membranes. The CVC modified with the Fe3O4-DMSA-clavA NPs re-
duced gram negative bacteria attachment by nearly 90% compared to non-modified CVC.
Furthermore, 808 nm wavelength laser irradiation causing a local hyperthermia and ab-
lation which promotes adhered bacterial annihilation, was able to reduce already formed
biofilms.
1.5.5 Key requirements for efficient antimicrobial surfaces
We are surrounded by specialized surfaces in our everyday life. Depended on the applica-
tion of the surface, different requirements have to be fulfilled. Antimicrobial surfaces have
to be able to efficiently kill bacteria and thereby decreasing the bacteria population over
time or prevent bacteria from attachment. Furthermore, when such potent surfaces are
applied in the biomedical field strict requirements have to be met. Antimicrobial coatings
need to withstand any mechanical stresses exposed during application while maintaining
long term stability and specific mechanical and physical properties.1 For example, the
mechanical stability the AMP GL13K coating, has been shown to be unaffected by ul-
trasonication which simulates in vivo fluid forces.63 Coatings need to be resistant toward
any kind of degradation, as well as have mechanical and thermochemical stability for the
long-term retention of the coated substance thereby ensuring the antimicrobial effective-
ness. No possible toxic or harmful compounds are allowed to be released at any time
during application, neither through passive release or mechanical abrasion. Therefore, it
is advantageous to reduce as much as possible toxic compounds throughout the production
of the surface. Destructive factors leading to abrasion like shear forces or yield stresses
are different for each environment; thus the antimicrobial surface needs to be designed
specifically for the desired application in order to achieve required mechanical stability
and minimize the amount of wear particles as much as possible.231,232
The antimicrobial surface needs to maintain its function over a lengthy time period under
defined conditions without excessive expenditure on maintenance or repair. It is important
to test the surfaces in relevant biological fluids (e.g. blood) due to the presence of macro-
molecules (e.g.proteins in blood) that can cover antimicrobial surfaces eliminating their
antimicrobial activity. In drug delivery systems the finite release property of antimicro-
bial compounds limits their use in implants due to the release of antibiotic concentrations
below the MIC after a certain time point. For short-term implants (e.g., catheters), the
finite release property is not a problem as the implant is removed before full release of
the antibiotic. However, for long-term implants, continuous strong release of antibiotics is
crucial within the first few hours postimplantation, while the immune system is weakened
and the implant is most susceptible to bacterial colonization.1 To circumvent the finite re-
lease problems, surfaces which regenerate the antimicrobial activity have been studied.201
An alternative solution is to use “smart antimicrobial surfaces” based on immobilized
nanoreactors that produce antibiotics “on demand.” This strategy is very promising as
they are only active when needed and can be designed to be sensitive and responsive to
28
PhD Thesis Serena Rigo
specific stimuli, such as enzymes198 or external substrates.206
The antimicrobial surface should not be toxic, injurious, or physiologically reactive or
cause unwanted immune responses. It is crucial that the material is compatible with tis-
sue and biological fluids of a living system. Testing the biocompatibility of coatings is
generally performed in vitro by evaluating the interactions between the surface and recog-
nized cell culture lines.1 However, such in vitro conditions do not adequately address the
acceptability of antimicrobial surfaces in environments with blood contact for a prolonged
time (e.g., central venous catheters). Interactions of these coatings with blood are critical
for the functioning of the device. Therefore, the hemocompatibility of such surfaces needs
to be studied. This can be done by determining platelet activation and adhesion and
haemolysis in human blood,65 even under high pressure and high-shear arterial flow.233
The antimicrobial action of the surface should act on specific targets rather than using a
wide spectrum of antibiotics in order to avoid or slow down bacterial resistance. AMPs are
a promising alternative to conventional antibiotics, because they possess broad antibiotic
effects, but supposedly induce less resistance than conventional antibiotics.62,68
Depending on their locations, medical devices can be classified as: i) totally external,
ii) percutaneous and permucosal, or iii) totally internal implanted devices. Totally exter-
nal devices as for example contact lenses usually do not present serious risks of infection to
the patient because they can either be designed for single use or allow sterilization during
the utilization if necessary. Percutaneous and permucosal devices (e.g., dental implants,
central venous catheters) are invasive, being partially internal to the body tissues, and
therefore with high risks of infections. Ideal surfaces of percutaneous and permucosal
devices have to support osseointegration and perimucosal sealing, because it is important
to resist periimplant infections, for example, periimplantitis.63 Totally internal implant
devices are usually contaminated because of specific reasons in restricted circumstances,
for example, implant surface contamination before or during surgery, or hematogenous
seeding from a distant infected site.14 Short-term totally internal implant devices might
not require a permanent coating and they can be used together with release of antimicro-
bials into the surrounding tissue. For long-term totally internal implant devices (e.g.,heart
valves or joint replacements), stable coatings which do not dissipate over time are needed
to protect against DAI.1 The race for the surface (Chapter 1.1.3) is especially important




The aim of the research conducted and described in this thesis is the design of an antibac-
terial surface by the combination of an active and a passive strategy. Antibiotic resistance
is a continuously increasing threat to human health, as previously curable bacterial in-
fections are again becoming life-threatening. Bacteria are able to rapidly adapt to new
environments by the evolution of new mutations. Using less antibiotics is crucial to slow
down the creation of antibiotic resistance. Therefore, research must be performed to de-
velop strategies in which potent, available antibiotics can be reduced as much as possible.
On the other hand new antibiotics to which bacteria are not yet resistant and strategies
to fight bacteria in which bacteria are less prone to develop resistances need to developed.
The scope of this thesis addresses the concept of a new design for antibacterial surfaces
by the combination of a passive strategy to reduce bacteria attachment and an active
strategy to kill bacteria locally. To do this, self-assembled polymeric nanostructures serve
as the basis for either the passive strategy by creating a nanostructured surface or the
active part as micelles decorated with an antimicrobial peptide (AMP) or by designing
an antibiotic producing nanoreactor. Anyhow, these polymeric nanostructures need to be
immobilized to create a nanostructured surface or to serve as a local source of antibiotic
activity. Research showed that AMPs create less resistances due to their mode of action
and immobilized nanoreactors have the advantage to be able to locally produce antibi-
otic when needed. Therefore, they are believed to reduce the amount of antibiotics used,
slowing down the creation of antibiotic resistance. These surfaces are designed with the
final goal of using them as possible implant materials. Therefore, it is crucial to minimize
toxic components to an absolute minimum during production to minimize possible con-
taminants in the final product.
The studies presented in this thesis aim to contribute to the future development and




via SPAAC reaction and
coimmobilization of self-assembled
polymeric nanostructures
This chapter is based on published work entitled: Surfaces with Dual Functionality through
Specific Coimmobilization of Self-Assembled Polymeric Nanostructures.222
3.1 Introduction
Chemo-selective copper catalysed azide alkyne click (CuAAC) reaction is a popular cova-
lent immobilization technique. However, using this well-established reaction in biological
samples, is limited by the cytotoxicity of Cu(I). The strain promoted Azide-Alkyne click
(SPAAC) reaction, inspired by the CuAAC reaction, is another, simple one-pot reaction
without the need of any catalysts due to the high strain (18 kcal/mol) of the reactive triple
bond in an 8-membered ring.220,221 Due to its high selectivity, rapid kinetics, and low tox-
icity, this bio-orthogonal copper-free click reaction attracted a lot of interest in different
fields.234–237 Accordingly, SPAAC reactions were successfully applied to post-functionalize
various nanostructures like liposome membranes,238,239 nanoparticles,240 quantum dots,241
or self-assembled polymersome membranes.242 Various cyclooctynes with high ring strain
were designed to increase the reactivity and apply SPAAC reactions in biological en-
vironments, in vitro as well as in vivo.243,244 The bio-orthogonal SPAAC reaction is a
promising precedure for immobilizing nanostructures on surfaces in order to engineer and
to ultimately optimize surfaces for biomedical applications.
The thiol-ene click reaction can proceed via the radical or nucleophilic Michael addi-
tion.245 With the radical addition, the thiol group might be added non-selectively to all
types of vinyl groups. Besides the radical initiator, an external source of energy is needed
to generate radicals. On the other hand, the nucleophilic Michael addition profits from
mild reaction conditions between the thiol as the nucleophile and the double bond of
an α, β-unsaturated carbonyl compound, an acryl moiety. Different amine or phosphine
based catalysts activate and promote the Michael addition between thiols and acrylates
(Figure 3.1).245 The latter has been applied to create nanostructured surfaces through
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Figure 3.1: Proposed mechanism of the thiol-ene click reaction between an acryl group
and a thiol moiety catalysed by a phosphine compound.245
the immobilization of methacrylate terminated PMOXA-b-PDMS-b-PMOXA based nano-
assemblies. The architecture of the vesicles and micelles in solution stayed stable in the
presence of tris(2-carboxyethyl)phosphine (TCEP), but changed when triethylamine, or
propylamine was used.218
A number of soft lithography techniques can be used to immobilize vesicles in spatially de-
fined patterns. For example, micro-molding in capillaries takes advantage of the capillary
forces that are induced by pressing a micro-stamp on the surface which creates channel-
like spaces between the surface and the stamp. Lipid vesicles were locally immobilized by
adding a solution of vesicles in front of the stamp and subsequently, the capillary forces led
to an influx of the solution into the defined space between the stamp and the surface.215,246
Classical micro-contact printing (µCP) is another soft lithography technique that also uses
a PDMS micro-stamp. However, here no connected pattern on the stamp are needed to
create channels. Instead, the substrate to be immobilized is directly inked on the pat-
terned side of the stamp and then brought in contact with the surface thereby transferring
the pattern onto the surface of interest.247 Corresponding solutions of nanostructures were
directly inked on the PDMS stamps to immobilize liposomes,246,248 inorganic nanoparti-
cles,249–251 or, as described in this chapter, polymersomes222 in a defined pattern by µCP.
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3.2 Scope of this chapter
The aim of the research presented in this chapter was to coimmobilize polymeric self-
assembled nanostructures like polymersomes and micelles. These structures are known to
provide protection for encapsulated biologically relevant molecules.93 Coimmobilizing two
distinct structures could allow the future design of new antimicrobial surfaces which are
able to fight bacteria colonization with two active component protected by the polymeric
nano-assemblies until further usage. The scope of this chapter addresses the study of a
new immobilization technique which allows the immobilization of poylmersomes without
the need of toxic additives. Furthermore, it is combined with an already known immobi-
lization technique to study coimmobilization. This chapter aims to further advance the
research and knowledge in the field of immobilizing self-assembled nanostructures and to
achieve following goals:
(i) Preparation and characterization of polymersomes and micelles.
(ii) Optimizing a biocompatible immobilization technique.
(iii) Simultaneous coimmobilization of two distinct structures using two differ-
ent immobilization techniques.
(iv) Immobilization of nanostructures creating a distinct pattern.
The approach developed in this chapter is based on the creation and careful characteriza-
tion of surfaces with immobilized nanostructures. There is an interest to find new ways to
immobilize and spatially control the immobilization of nanostructures to further develop
and design new smart surfaces.
3.3 Experimental Procedures
3.3.1 Materials
PMOXA6-b-PDMS43-b-PMOXA6 and azid terminated PMOXA7-b-PDMS40-b-PMOXA7
were obtained by Dr. Samuel Lörcher;82 Methacrylate-terminated PMOXA25-b-PDMS54-
b-PMOXA25 (Mn = 8400 g mol
−1) and PMOXA19-b-PDMS67-bPMOXA19 (Mn = 8000
g mol−1, D= 1.3) were purchased from Polymer Source Inc.; bodipy630/650, alexa fluor
488 azide, and Menzler glass coverslips (22 x 32 mm2) from Thermo Scientific Inc.; silica
wafers (P〈100〉) from Si-Mat Germany; the microstamp from Research Micro Stamps; (3-
aminopropyl)triethoxysilane (APTES) from Acros organics; ethyltrimethoxysilane from
Alfa Aesar; dicyclohexylcarbodiimide (DCC) and ethyl acetate from Fluka Analytical;
1-hydroxy-6-chloro-benzotriazole (6-Cl-HOBt) from Iris Biotech GmbH; sodium chloride
(NaCl) and sodium phosphate dibasic (Na2HPO4) from Merck; potassium chloride (KCl)
and potassium dihydrogen phosphate (KH2PO4) from PanReac AppliChem; dichloro-
methane (DCM) from VWR chemical; DBCO-Cy5, DBCO-acid, trimethylamine, toluene,
ethanol, (3-mercaptopropyl)- trimethoxysilane, sodium hydroxide (NaOH), and tris(2-
carboxyethyl)phosphine (TCEP) from Sigma-Aldrich. All chemicals were used as received
unless stated otherwise.
3.3.2 Self-assembly
Five different triblock copolymers composed of poly(2-methyl-2-oxazoline) (PMOXA) and
poly(dimethylsiloxane) (PDMS) were used in this study:
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(1) PMOXA6-b-PDMS43-b-PMOXA6 in combination with
(2) azide terminated PMOXA7-b-PDMS40-b-PMOXA7.
(3) Methacrylate terminated PMOXA25-b-PDMS54-b-PMOXA25 and
(4) methacrylate terminated PMOXA19-b-PDMS67-bPMOXA19 in combina-
tion with
(5) sulforhodamine B (SRB) labeled PMOXA18-b-PDMS76-b-PMOXA18.
Polymersomes containing 0.1, 1.0, and 10 mol% of azide terminated polymers were formed
by thin film rehydration. A total of 0.5 µmol polymer were dissolved in 100 µl ethanol and
dried into a film on a rotary evaporator. The polymer film was rehydrated with 1 mL PBS
(137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.8 mM KH2PO4, pH 7.4) and stirred
overnight at room temperature (rt). The turbid solution was extruded 13 times through
a 200 nm membrane (Nuclepore Trac-Etch membrane, Whatman R©) using a 1 ml syringe
extruder and purified by size exclusion chromatography (SEC) on a self-filled Sepharose
2B column (length: 25 cm, diameter: 1 cm) that was connected to an ÄKTAprime system
for detecting the polymersome elution at 280 nm.
Polymersomes and micelles with methacrylate groups were formed by thin film rehydration
in the dark.218 To obtain approximatly 0.5 mol% SRB-labeled polymer, 1 µmol polymer
was dissolved in 2 mL DCM (0.5 µmol ml−1) and a drop (ca. 5 µl) of a 0.9 mM solution
of SRB labeled polymer was added. The polymer solution was dried to a film prior to its
rehydration with 2 mL PBS (pH 7.4) by stirring at rt over night.
3.3.3 Physical characterization of the nanostructures
Dynamic Light Scattering (DLS) was performed on a Zetasizer nano ZSP (Malvern In-
struments) at 25◦C. The scattering was recorded at a backscattering angle of 173◦. 20
µL of polymersome solution was diluted in 500 µL PBS. Static light scattering (SLS)
(LS instruments) was performed with a 30 mW HeNe laser at 23◦C and target scattering
intensity of 40 kHz. Nanostructures containing 1 mol% azide terminated polymers were
diluted to solutions of 0.3, 0.2, and 0.1 mg mL−1 polymers (0.5 µmol ml−1 =̂ 2.25 mg
mL−1, dilution after purification: 3.4-fold). Each concentration was measured at scatter-
ing angles between 40◦ and 110◦ with an angular step of 10◦ for 20 s each. For the lowest
concentration, DLS data was recorded on the same instrument at 90◦ for 60 s.
Transmission electron microscopy (TEM) images were recorded on a Phillips CM100 at
an acceleration voltage of 80kV. 5 µL nanostructure solution diluted in PBS (1:7) were
deposited on a glow discharged formvar and carbon coated copper grid. After 1 min ad-
sorption, excess samples was blotted off, and the grids washed twice with 5 µL H2O, once
with 5 µL 2% uranyl acetate before being negatively stained with 5 µL 2% uranyl acetate
for 10 s.
Fluorescent correlation spectroscopy (FCS) experiments (Zeiss LSM880) were performed
with a Dibenzocyclooctyne (DBCO) labeled fluorophore, DBCO-Cy5 as the fluorescent
dye and a HeNe laser (λ = 633 nm). A main beam splitter (MBS 488/561/633) was used.
The pinhole diameter was set to 90 µm and calibrated using PBS containing 100 nM of
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DBCO-Cy5. For each kind of polymersome with a different amount of azide groups, three
independent polymersome preparations were stirred with DBCO-Cy5 overnight at 37◦C
at 100 rpm, and measured at 1% laser power. The amount of DBCO-Cy5 added was equal
to the concentration of azide terminated block copolymer. For samples without azide ter-
minated polymers, the same amount of DBCO-Cy5 was added as for the polymersome
samples containing 1 mol% azide terminated polymers. Each measurement represents an
average of 30 recordings of 10 s duration. The obtained autocorrelation curves were fitted
by a 3-D diffusion model (Equation 3.1) either for a single-component, when analyzing
the free dye, or for two-components when analyzing the polymersomes reacted with the
dye, where the parameters for one component were constrained according to the recorded
values of the free dye.88
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Where N is the average number of particles in the confocal volume, Gt(τ) (Equation
3.2) describes the molecules in the triplet state, Tt represents the triplet fraction, and
τt represents the triplet relaxation time. The term Gd(τ) (Equation 3.3) describes the
diffusion of 1 component (n=1) or for two components (n=2) in three dimensions. Finally,
τd represents the diffusion time, Φ the fractional intensities, S the structural parameter,
and α the anomaly parameter. τt was fixed to 3 µs and S to 5. τd of DBCO-Cy5 was
determined applying the one component system model to the measurements recorded of
the free dye solution, the solution which was also used to calibrate the pinhole diameter.
Then the average τd of the polymersomes interacting with the dye was determined using
the two component system where the first component τd was fixed to the average of free
DBCO-Cy5 (100.59 µs).
3.3.4 Preparation of functionalized substrates
The surfaces of silicon wafers or glass slides were activated by oxygen plasma (Plasma
Cleaner, Harrick Plasma) for 5 min before being immersed in toluene (anhydrous, 25 mL)
containing APTES (4.3 µL), ethyltrimethoxysilane (4.3 µL), and triethylamine (42 µL).218
The surfaces were constantly shaken (80 rpm) overnight at rt. Subsequently, the surfaces
were rinsed with toluene followed by ethanol and dried under a gentle stream of com-
pressed air. Dried surfaces were further functionalized with DBCO as follows. 2 µmol of
DBCO-acid, DCC, and 6-Cl-HOBt were separately dissolved in 1 mL ethyl acetate before
being mixed together and stirred at 0◦C for 1 h. The APTES functionalized surfaces were
immersed in 20 mL ethyl acetate and the cooled reaction mixture was added. The surfaces
were shaken horizontally at 80 rpm overnight at rt, to allow the peptide bond formation
between the amine on the surface and the acid on the DBCO linker. Subsequently, the
derivatized surfaces were rinsed with ethyl acetate, water, and ethanol, and then dried
under a gentle stream of compressed air.
Bifunctionalized surfaces were prepared similarly. After plasma treatment, the glass slides
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were immersed in a 0.4% (w/w) of silanes in toluene (1:1:1 weight% APTES, (3-Mercapto-
propyl)trimethoxysilane, and ethyltrimethoxysilane) to achieve a 33% relative density of
each silane. Subsequently, the surfaces were washed and the amine groups of the APTES
served to further functionalize the surface with an acid-DBCO linker via peptide bond
formation as described above, but with a reduced reaction time of 1.5 h in order to mini-
mize any potential side reactions.
DBCO functionalized surfaces were characterized by various methods and compared to
non-functionalized and amino (APTES) functionalized surfaces. Static water contact
angles (KSV, instruments, CAM100 Version 2.1.1) were measured on at least 3 inde-
pendently prepared surfaces. Attenuated total reflection – Fourier transformed infrared
(ATR-FTIR) spectroscopy (Bruker Alpha, platinum-ATR) measurements consisting of 24
recorded scans were performed on the surfaces. DBCO-functionalized surfaces were im-
mersed in 3.5 mL Alexafluor488-azide (900 nM in PBS) to react overnight at 37◦C, 20 rpm.
The surfaces were washed with PBS to remove uncoupled dye. The surfaces were visual-
ized by confocal laser scanning microspcopy (CLSM) (Zeiss LSM510 META/ConfocoCor
2 FCS microscope) using an Argon2 (λ = 488 nm) laser and a water immersion objective
(C-Apochromat 40x/1.2 W). The pinhole diameter was set to 70 µm and a main beam
splitter (HFT488), a secondary beam splitter (NFT490) and a band pass filter (BP 505-
550) where used throughout all experiments. All images were recorded with a detector
gain fixed to 679. The brightness adjustments by ImageJ of all recorded images were
treated identically.
3.3.5 Immobilization of self-assembled nanostructures
An aliquot of 10 mM bodipy in dimethylsulfoxid (DMSO) was diluted in water to obtain
a 25 µM bodipy stock solution. The appropriate volume (end concentration 50 nM) was
added to azide functionalized polymersomes in PBS. Bodipy interacts with the PDMS
block of the membrane due to non-specific hydrophobic interactions and therefore allows
the visualization of the vesicles. 400 µL of the bodipy-stained polymersome solution were
added onto DBCO-functionalized surfaces of approximately 1 cm2. The SPAAC immo-
bilization reaction was allowed to proceed overnight at rt with horizontal shaking at 80
rpm. The surface was washed 3 times by immersion in 2 mL fresh PBS while shaking
horizontally at 80 rpm for 5 min at rt.
To immobilize nanostructures on bifunctionalized surfaces, a bifunctional surface contain-
ing DBCO and thiol moieties as well as two different nanostructures were used. Bodipy
(50 nM) was utilized to visualize the azide exposing polymersomes through hydrophobic
interactions, while the methacrylate nanostructures were visualized by the addition of
SRB labeled polymers during the self-assembly process.
A microstamp of parallel stripes (5 µm width, 5 µm spacing, 10 µm tall) was inked with
a polymersome solution (azide or methacrylate exposing polymersomes) by spreading the
solution with a Q-cotton tip on the stamp. The stamp was brought in contact with the
bifunctionalized DBCO/thiol surface for 10 min and weighted with a glass petri dish lid
(ca. 18 g). The stamp was removed and the surface was rinsed with PBS. The stamp was
then washed by rinsing it with water, ethanol and sonication in ethanol for 10 min before
reuse.
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The SRB labeled methacrylate nanostructure (polymersome and micelle) solution ob-
tained after self-assembly was diluted 1:1 with PBS. TCEP (20 mg mL−1), the catalyst
for the thiol-ene reaction was added at least 2 h prior to adjusting the pH to 7.0 with
2 M NaOH. Afterwards, this methacrylate nanostructure suspension was mixed 1:1 with
bodipy containing, azide exposing polymersomes, and 400 µL of the mixture was applied
to approximatly 1 cm2 of the bi-functionalized surfaces. The immobilization reactions was
allowed to proceed overnight while horizontally shaking at 80 rpm at rt. Afterwards the
surfaces were washed by removing the reaction solution, followed by 3 immersions in 2 mL
fresh PBS, while shaking horizontally at 80 rpm for 5 min at room temperature.
Atomic force microscopy (AFM) (JPK Nanowizard 3, Version 6.0.63) was used to char-
acterize the surfaces of immobilized polymersomes containing varying ratios of azides. A
Tap150 Al-G cantilever (Budget Sensors, resonance frequency 150 kHz, force constant
5 N m−1) was used for AC mode measurements in PBS buffer. Images were analyzed
with the JPK data processing software (Version spm 6.0.63). For further characteriza-
tion, platinum-sputtered surfaces were examined by scanning electron microscopy (SEM)
(Hitach S-4800) with an acceleration voltage of 5000 V at a working distance of 3.4 mm.
CLSM (Zeiss LSM880) was performed to visualize immobilized nanostructures. The bod-
ipy containing azide-polymersomes and the SRB labeled methacrylate polymersomes and
micelles were visualized after immobilization by CLSM in the airyscan mode. A HeNe
laser (λ = 633 nm) was used to visualize bodipy containing vesicles, and a DBSS 561-10
Laser (λ = 561 nm) for SRB labeled nanostructures. The images were recorded with an
oil immersion objective (Plan Apochromat 63x/1.4 oil DIC M27), a mean beam splitter
(MBS 488/561/633) and an airyscan detector. The laser power was kept as low as pos-
sible (0.2% for λ = 561 nm, 2 – 20% for λ = 633 nm) to minimize bleaching, the gain
was always below 800, and the pinhole diameter around 110 nm to be slightly above the
minimal pinhole diameter for airyscan, which corresponds to 2.5 airy units and 2.7 airy
units for λ = 633 nm and λ = 561 nm, respectively. The images were airyscan processed
with the Zeiss software ZEN 2.3 SP1 and imageJ software for brightness adjustments.
3.4 Results and Discussion
3.4.1 Self-assembly of PDMS-b-PMOXA-b-PDMS with different ratios
of azide terminated polymers
Nanostructures equipped with either azide or methacrylate funcional groups were cre-
ated by self-assembly of PDMS-b-PMOXA-b-PDMS via thin film rehydration. In order
to expose different concentrations of azide groups on the surface, the nanostructures were
self-assembled from mixtures of PMOXA6-b-PDMS43-b-PMOXA6 copolymers and azide-
terminated PMOXA7-b-PDMS40-b-PMOXA7 copolymers at different ratios (0.0, 0.1, 1.0,
and 10 mol%). Extrusion and size exclusion chromatography were applied to obtain a
narrow, specific size distribution of the resulting assemblies (Figure 3.2 ).
The assemblies prepared with increasing percentages of azide terminated block-copolymer
were characterized by a combination of light scattering (LS), specifically DLS and SLS,
and TEM. DLS measurements of all azide containing assemblies revealed an overall aver-
age diameter of 140 ± 15 nm according to the number particle size distribution (PSD) and
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Figure 3.2: Size exclusion chromatograms (UV-vis absorption at 280 nm) of polymersomes
prepared from polymer mixtures with 0.0, 0.1, 1.0, and 10 mol% of azide-functionalized
polymer. Injection volumes were 880, 850, 860, and 860 µL, respectively. Arrows indicate
the time point of injection. The polymersomes were eluted in PBS and collected as a
single fraction indicated by the grey shading.
polydispersity indices (PDI) ranging from 0.03 to 0.23. Diameters that are all in a similar
range indicate that the different ratios of azide derivatized polymers in the polymer mix
did not affect the size of the resulting nanostructure. (Figure 3.3).
Therefore, for further characterization of the nanostructure architecture, only the assem-
bly containing 1 mol% azide-terminated block-copolymer was considered. Specifically, the
shape factor was calculated according to Equation 1.4: a hydrodynamic radius (Rh) of
84 ± 7 nm and a radius of gyration (Rg) of 76 ± 1 nm was obtained (Figure 3.4). The
resulting shape factor (ρ=Rg/Rh) of 0.9 indicated a hollow, spherical architecture.
140 Con-
sistently, TEM micrographs of the different assemblies revealed a morphology that is char-
acteristic of hollow spherical structures, independent of the amount of azide-terminated
block-copolymer (Figure 3.5).
3.4.2 Self-assembly of methacrylate terminated polymers
In order to promote the formation of nanostructures that expose fluorescently labeled
methacrylate, two different methacrylate terminated PMOXA-b-PDMS-b-PMOXA copoly-
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Figure 3.3: DLS of polymersomes with different ratios of azide terminated polymers re-
vealed similar diameters for the number average PSD. Three independent samples per
type of polymersomes were measured three times each (black, red, and blue curves).
Figure 3.4: LS data of self-assembled structures containing 1 mol% azide terminated
polymers. Previously extruded polymersomes were diluted with filtered PBS (Millex-
LCR syringe filters, hydrophilic, polytetrafluoroethylene - PTFE, 0.45 µm; Millipore) to
a final polymer concentration of; 0.3, 0.2, and 0.1 mg mL−1. Left: Zimm Plot of SLS
data acquired every 10◦ from 40◦ to 110◦. Right: DLS measurement of the 0.1 mg ml−1
solution recorded at 90◦
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Figure 3.5: TEM images of polymersomes self-assembled from PMOXA6-b-PDMS43-b-
PMOXA6 with different ratios of azide-terminated polymers. Scale bars: 1 µm.
mers (PMOXA19-b-PDMS67-b-PMOXA19 to form polymersomes, or PMOXA25-b-PDMS54-
b-PMOXA25 to form micelles)
218 were mixed with traces of SRB labeled PMOXA18-b-
PDMS76-b-PMOXA18.
The full characterization of the methacrylate functionalized polymers and the assemblies
formed can be found in reference.218 Methacrylate terminated PMOXA19-b-PDMS67-b-
PMOXA19 copolymers self-assembled into polymersomes with a diameter of 180 ± 95 nm
by number PSD (Figure 3.6A) which is slightly larger than the size of azide functional-
ized polymersomes, and a PDI of 0.32 to 0.51 as determined by DLS. The higher PDI is
in agreement with the respective TEM analysis, which revealed spherical morphologies of
different sizes (Figure 3.7A). The presence of the shoulder indicated the presence of some
bigger particles or aggregates. Micelles formed by methacrylate terminated. PMOXA25-
b-PDMS54-b-PMOXA25 copolymers appeared as round structures in TEM micrographs
(Figure 3.7B) with a diameter of 80 ± 50 nm obtained by number PSD (Figure 3.6B)
(maximal PDI 0.43). Methacrylate terminated nanostructures could not be purified by
SEC due to interactions with the chromatography resin. Hence, they were examined with-
out SEC, which explains the higher PDI compared to that of polymersomes assembled
from azide terminated polymer.
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Figure 3.6: DLS measurements of A) two identically prepared methacrylate polymersome
samples (black and blue traces), which were self-assembled from methacrylate terminated
PMOXA19-b-PDMS67-b-PMOXA19 block copolymer. The plot shows the number average
PSD versus size for each measurement. Each sample was measured 3 times. B) methacry-
late micelles self-assembled from PMOXA25-b-PDMS54-b-PMOXA25. The number average
PSD of three measurements are displayed.
Figure 3.7: TEM images of A) polymersomes self-assembled from methacrylate termi-
nated PMOXA19-b-PDMS67-b-PMOXA19 block copolymer, scale bar: 500 nm, and B)
micelles self-assembled from methacrylate terminated PMOXA25-b-PDMS54-b-PMOXA25,
scale bar: 200 nm.
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3.4.3 Azide accessibility on polymersomes
Accessibility of the azide moieties exposed on polymersomes was assessed by FCS, which
allows the study of the diffusion time of fluorescent molecules and their interactions with
bigger assemblies, such as nanoparticles, liposomes, or polymersomes.88,93,252 Fluores-
cently labeled DBCO (DBCO-Cy5) was reacted with azide functionalized polymersomes.
The diffusion time (τd), was then determined by a two component fit where the first com-
ponent’s diffusion time was fixed to the one obtained for free DBCO and compared to
free DBCO-Cy5 in solution determined by the one component fit (Figure 3.8 and Table
3.1). The increase of two orders of magnitude in τd confirms that the DBCO-Cy5 molecule
Figure 3.8: FCS measurements of DBCO-Cy5 interaction with polymersomes containing
different amounts of azide-terminated polymers. DBCO-Cy5 was added to the outside of
the polymersomes and after overnight reaction the normalized autocorrelation curves for
azide containing polymersomes showed a strong shift to higher diffusion times compared
to azide free polymersomes (red line) or free DBCO-Cy5 (black line).The samll step (?) in
the autocorrelation curve is indicative of the presence of some clusters of polymersomes.
was bound to the azide-exposing polymersomes, which diffuse significantly slower through
the confocal volume than the free fluorescent molecules. Additionally, the Rh calculated
through the diffusion time is in accordance with the expected size of the polymerosomes
(Table 3.1). The calculated sizes are all in a similar range, however the FCS measure-
ments seem to clearly indicate that polymersomes with 1 mol% azide terminated polymers
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are bigger than the ones with 1 mol% azide terminated polymers. This might be due to
some in-homogeneity of the sample as also some clusters of polymersomes are present,
indicated by the small step in the autocorrelation curve (noted by ?). Polymersomes
without azide groups were reacted with the same amount of DBCO-Cy5 as used for the
polymersomes containing 1 mol% azide terminated polymers and a similar autocorrelation
curve as the free dye was observed (Figure 3.8). The fit of this autocorrelation curve
resulted in a 73% population of free DBCO-Cy5 and a 27% fraction of slow diffusing par-
ticles, which has been associated to a fraction of DBCO-Cy5 non-specifically interacting
with unfunctionalized polymersomes, probably due to hydrophobic interactions with the
polymeric membrane. The measured τd ≈ 10’000 µs, corresponding to a calculated Rh of
54 ± 7 nm is smaller than for the azide containing polymersome samples. However, in
the case of azide exposing polymersomes, the slow diffusion fractions were close to 100%,
whereas here the slow diffusion fraction accounted only for about one third. The signif-
icant increase of the slow diffusing fraction in azide containing polymersomes confirms





PMOXA6-b-PDMS43-b-PMOXA6 polymersomes formed with
x% azide-terminated PMOXA7-b-PDMS40-b-PMOXA7
0.0% 0.1% 1% 10%
diffusion
time [µs]
100 ± 4 9390 ± 1200 17630 ± 1050 21920 ± 3830 12580 ± 3410
Polymersome
fraction [%]
N/A 27 ± 9 95 ± 1 95 ±3 87 ±9
Rh [nm] 54 ± 7 101 ± 6 126 ± 22 72 ± 20
Table 3.1: FCS parameters for each ratio of azide containing polymersomes.
3.4.4 Surface functionalization
To immobilize azide containing polymersomes through the SPAAC reaction, surfaces were
functionalized with DBCO in a two-step procedure (Figure 3.9). First, surfaces were
functionalized with primary amines using silane chemistry. A 50% relative density of
amines on the surface was achieved by mixing the functional amine silane APTES and
non-functional ethyl silane prior to the reaction with the surface.218 Secondly, DBCO
functional groups were introduced via a peptide bond formation using a carboxylic acid-
functionalized DBCO.
Figure 3.9: Schematic presentation of surface modification steps to obtain DBCO-
functionalized surfaces.
To evaluate the functionalization of the surfaces we analyzed the changes in surface hy-
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drophobicity and ATR-FTIR spectroscopy. Amine modified surfaces possess an increased
hydrophobicity (87 ± 2◦) compared to non-functionalized surfaces (67 ± 1◦). Further func-
tionalization with DBCO (86 ± 1◦) did not affect the hydrophobicity (Figure 3.10A).
ATR-FTIR spectroscopy was performed after each functionalization step. A non-func-
tionalized silicon wafer was used as background. DBCO functionalized surfaces show an
inverted peak around 2200 cm−1 indicating the presence of the triple-bond253 compared
with the non-functionalized or amine functionalized surface (Figure 3.10B).
Figure 3.10: A) Water contact angles of non- functionalized (non), amino functionalized
(NH2) and DBCO functionalized surfaces. C) ATR-IR of non- functionalized (non), amino
functionalized (NH2) and DBCO functionalized surfaces.
Importantly, only surfaces functionalized with DBCO showed fluorescence after reaction
with an azide functionalized fluorescent dye (Figure 3.11). Therefore, the surfaces were
successfully functionalized with DBCO, rendering them reactive towards azide containing
molecules.
Figure 3.11: LSM micrographs after reacting the surface during the different functional-
ization steps with Alexafluor488-azide: non-functionalized surface (A), NH2 functionalized
surface (B), DBCO functionalized surface (C). Images were recorded with the same set-
tings and processed equally. Scale bars: 10 µm.
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3.4.5 Immobilization of azide-functionalized polymersomes on surfaces
The SPAAC reaction was conducted to immobilize the azide exposing polymersomes to the
DBCO functionalized surface. The obtained surfaces after polymersome immobilization
were characterized by a combination of CLSM, SEM, and AFM. A hydrophobic fluores-
cent dye (Bodipy630/650) was entrapped inside the polymersomes to allow their detection
by CLSM. Numerous round fluorescent objects were observed in the expected size range
confirming the immobilization of fluorescent structures and indicating successful polymer-
some immobilization on solid support by SPAAC (Figure 3.12).
Figure 3.12: CLSM of immobilized polymersomes with different ratios of azide-terminated
polymers: A) 0 mol%, B) 0.1 mol%, C) 1 mol%, and D) 10 mol% on DBCO-functionalized
surfaces. Scale bar: 1 µm
A clear difference in immobilization density was detected between the azide-free (0 mol%)
polymersome where only one polymersome per 100 µm2 was found, compared to the azide-
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exposing polymersomes (0.1, 1.0 , or 10 mol%) where 20-40 polymersome per 100 µm2
were visualized. The polymersomes were counted using particle count on Fiji. However,
no significant difference between the polymersomes containing 0.1, 1.0, or 10 mol% azide
terminated polymers was observed (Table 3.2).
Azide ratio 0 mol% 0.1 mol% 1 mol% 10 mol%
1.6 40.7 4.4 31.3
Polymersomes 1.2 33.5 5.3 23.6
(= red dots) 1.2 43.5 9.4 26.3
per 100 µm2 0.9 36.8 37.0 6.1
2.7 46.8 44.1 13.9
Average ± standard deviation 1.5 ± 0.6 40.3 ± 4.7 20.0 ±17 20.2 ±9.1
Table 3.2: Polymersomes were mixed with Bodipy prior immobilization to be able to
visualize them on the surface by airyscan LSM as red dots. Several images of each kind
of immobilized polymersomes were taken. The round fluorescent dots were counted by
analyze particles on Fiji by ImageJ. The size of the image was calculated to put in relation
with the immobilized polymersomes.
Figure 3.13: SEM of immobilized polymersomes with different ratios of azide-terminated
polymers: A) 0 mol%, B) 0.1 mol%, C) 1 mol%, and D) 10 mol%, Scale bar: 500 nm
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The images obtained by SEM (Figure 3.13), are in agreement with the CLSM micro-
graphs, and provide further evidence of the immobilization of azide containing polymer-
somes on solid support.
In addition, surfaces reacted with azide containing polymersomes showed round struc-
tures on the surface of 70 – 120 nm in height when imaged by AFM while immersed in
PBS buffer (Figure 3.14), supporting the previously obtained findings.
Reaction with azide-free polymersomes and the DBCO functionalized surface only revealed
very few fluorescent dots by CLSM (Figure 3.12A and Table 3.2), few immobilized vesi-
cles by SEM (Figure 3.13A) and no structures of the expected heights by AFM (Figure
3.14A). Together, this data strongly suggests that the immobilization was due to the
azide functional groups on the polymersome exterior. Therefore, polymersomes exposing
azides on their surface have been successfully immobilized by SPAAC reaction on DBCO
functionalized silica wafers.
Figure 3.14: AFM of immobilized polymersomes with different ratios of azide-terminated
polymers: A) 0 mol%, B) 0.1 mol%, C) 1 mol%, and D) 10 mol% on DBCO-functionalized
surfaces. Scan size was 2.5 µm x 2.5 µm each and the height scale bars were 70 nm (A),
120 nm (B), 70 nm (C) and 20 nm (D), respectively.
3.4.6 µCP of polymersomes to obtain patterned surfaces
In order to equip surfaces with different functionalities, it is attractive to create patterns
of one of the functionality of interest. Hence, µCP was used to immobilize self-assembled
nanostructures. Polymersomes exposing azide groups and containing bodipy entrapped in
their membrane were used as ink on the PDMS microstamp, transferred to the with DBCO
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and thiols bifunctionalized surface, and visualized by CLSM. A clear striped pattern alter-
nating between fluorescence and background every 5 µm was observed (Figure 3.15A),
indicating successful surface patterning. Further, the distinct fluorescent spots observed
in the patterned lines indicate that the polymersomes remained intact throughout the
printing process and were transferred from the stamp to the surface. Similarly, polymer-
somes exposing methacrylate groups and labeled with SRB were successfully micro-contact
printed onto the surface (Figure 3.15B). The methacrylate exposing nanostructures cova-
lently bind to the thiol moieties on the surface through the thiol-ene reaction using TCEP
as a phosphine catalyst (Figure 3.1).218 Our results further underline that also PDMS-
based nanostructures can be printed from a PDMS based stamp onto a functionalized
surface.
Figure 3.15: Polymersomes are immobilized within a pattern by µCP and visualized by
CLSM: A) Azide functionalized polymersomes visualized through entrapped fluoresencent
dye (bodipy, red) and B) SRB (yellow) labeled methacrylate functionalized polymersomes.
Scale bars: 5 µm.
3.4.7 Coimmobilization of two different structures
In order to obtain multifunctional surfaces we were interested to coimmobilize differ-
ent types of nanostructures with different functional groups on the same solid support.
Surfaces were functionalized with both, thiols, to perform the thiol-ene reaction with
methacrylate nanostructures,218 and DBCO, to perform the SPAAC reaction with azide
containing polymersomes. Therefore, plasma activated silica wafers were reacted simulta-
neously to thiol and amine containing silanes prior to the condensation reaction between
the amine and the DBCO-acid. In order to avoid any unwanted side reactions between thi-
ols and alkynes, the condensation reaction time was reduced to 1.5 h. The immobilization
of the azide containing polymersomes was visualized through bodipy (red) interacting with
the membrane while the immobilization of the methacrylate nanostructures was visualized
by SRB (yellow). Traces of SRB labeled polymer was mixed with methacrylate terminated
polymer during self-assembly to obtain fluorescent nanostructures. A mixture of the two
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differently functionalized polymersomes was added on the bifunctionalized surface. How-
ever, prior mixing the two nanostructures, the SRB labeled methacrylate nanostructures
were reacted to TCEP while the azide exposing polymersomes were separately mixed with
bodipy.
CLSM micrographs showed successful coimmobilization of the polymersomes due to the
presence of both fluorescent signals associated to SRB in the methacrylate polymersomes
and bodipy in the azide exposing polymersomes. (Figure 3.16A). To go one step fur-
ther in obtaining nanostructured bifunctional surfaces we simultaneously immobilized two
different assemblies: azide-exposing polymersomes (containing bodipy) and methacrylate-
exposing micelles labeled with SRB. Azide exposing polymersomes containing bodipy were
mixed equally with SRB labeled micelles exposing methacrylate groups and added on
the bifunctionalized surface. After overnight reaction, the immobilized structures, visi-
ble as round fluorescent dots for the polymersomes and micelles were observed by CLSM
(Figure 3.16B). Furthermore, bodipy-stained, azide-exposing polymersomes were micro-
contact printed onto a bifunctionalized surface followed by a second µCP immobilization
of SRB-labeled methacrylate-exposing micelles with the stamp rotated 90◦ to create a
checkerboard pattern (Figure 3.16C). After patterning single nanoassemblies, it was
shown that different nanoassemblies could be not only randomly coimmobilized on the
same surface, but also in a distinct pattern.
Figure 3.16: CLSM micrographs of azide-functionalized polymersomes containing bo-
dipy (red dots) coimmobilized with SRB-labeled methacrylatefunctionalized nanostruc-
tures (yellow dots) on DBCO and thiol bifunctionalized surfaces. (A) Coimmobiliza-
tion of azide-exposing polymersomes and methacrylate-exposing polymersomes; (B) azide-
exposing polymersomes and methacrylate-exposing micelles; and (C) checkerboard pattern
obtained by first printing azide-exposing polymersomes and then methacrylate-exposing
micelles with the stamp rotated by 90◦. Scale bars: (A, B) 2 µm; (C) 5 µm. ∗Hollow
structure in the inset represents polymersomes and filled structures micelles.
3.5 Conclusions
Surfaces with nanostructured architecture and bifunctionality were successfully generated
by the coimmobilization of azide containing polymersomes together with methacrylate
exposing polymersomes or micelles on a solid support. To support simultaneous immo-
bilization of the nano-assemblies, surfaces were bi-functionalized by using SPAAC and
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thiol-ene reactions, each of them serving to specifically bind nano-assemblies exposing
appropriate functional groups (azide and methacrylate, respectively). The SPAAC re-
action was analyzed in detail as it was used for the first time to immobilize polymeric
nanostructures, while the thiol-ene immobilization reaction has been used in conditions
already reported.218 A comparison between polymersomes containing different ratios of
azide terminated polymers (0.1 - 10 mol%) revealed that the ratio does not influence the
polymersome immobilization, suggesting that only a few attachment points are required
for their successful immobilization via the SPAAC reaction. Additionally, µCP was ap-
plied to immobilize polymersomes in a spatially defined pattern onto surfaces. Coimmo-
bilization of different functionalized nano-assemblies to engineer multifunctional surfaces
represents a general approach to induce a nanostructured architecture on a solid support
and a dual functionality through the active compounds that can be entrapped inside these
nano-assemblies. Indeed, different cargos (as shown here by using dyes as models for bio-
logically active low weight molecules) can be protected either in micelles or polymersomes.
Such nanostructured surfaces with dual functionality are expected to improve the surface
efficacy in applications, such as antimicrobial surfaces, or biosensing.
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Chapter 4
AMP decorated and immobilized
micelles
This chapter is based on published work entitled: Decorating nanostructured surfaces with
antimicrobial peptides to efficiently fight bacteria.223
4.1 Introduction
Micro and nanostructured surfaces have evolved in Nature as broadly occurring passive
strategies to prevent bacteria colonization with resulting host infections.163,166 Features
of surface structures, including, size and geometry, hamper bacterial attachment and
survival.40,254,255 The underliying principles of these naturally occurring passive defense
strategies are key to mimicking their anti-biofouling efficiency by surfaces designed to
fight bacterial infections without additional antimicrobial compounds. Antimicrobial or
antifouling surfaces are important in many medical and industrial contexts.1,256
To improve the antimicrobial performance of microstructured surfaces in terms of function-
ality and biological efficacy, active surfaces have been developed by including antimicrobial
agents.1,20,62,257 The active agents can be either released from the surface or be effective
upon contact.258 The advantages of such surfaces include a high local concentration of
the agent193 and time-controlled release profiles.206 In this respect, antimicrobial peptides
(AMPs) are particularly appealing since they can be designed to display broad-spectrum
antimicrobial activity, even against bacteria resistant to conventional antibiotics, besides
excellent biocompatibility.62,66,259 The amphipathic structure of AMPs, characterized by
hydrophilic, cationic and hydrophobic domains,61 allows for a multitude of effects, the
most important being bacterial membrane lysis.66,259
KYE28 (KYEITTIHNLFRKLTHRLFRRNFGYTLR) is a particularly appealing AMP be-
cause it displayed improved antimicrobial effects when incorporated in surface-immobilized,
microgel-based multilayers compared to when bound to plane glass surfaces or presented
in peptide-loaded monolayers.194 KYE28 is part of the helix D of human heparin cofactor
II.194 The antimicrobial action of KYE28 is based on bacterial cell membrane disruption
which induces leakage and eventually leads to cell death.260–262 Apart from broad spec-
trum antimicrobial activity, this peptide also exhibits potent anti-inflammatory effects by
binding to circulating endotoxins and suppressing cytokine production.260,263
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4.2 Scope of this chapter
There is a huge interest in surfaces that hinder bacterial attachment and proliferation
on them. Therefore, the aim of the research presented in this chapter was to combine a
passive antimicrobial strategy with an active antimicrobial strategy. The passive strategy
involves the immobilization of micelles to create a microstructured surface and the ac-
tive strategy the addition of the AMP KYE28 to the micelle-immobilized surface (Figure
4.1). The PMOXA-b-PDMS-b-PMOXA block copolymers used for micelle self-assembly
are not only biocompatible, PMOXA is also known to decrease blood clotting and protein
adsorption.106 These features are advantageous for medical applications as they possibly
suppress an immune response and/or bacterial colonization.104,106 In addition, PMOXA
is a peptidomimetic polymer known to be stable towards degradation.106,107
Figure 4.1: Schematic presentation of the combination of the passive (immobilized mi-
celles) and active (AMP decoration) approach to create antimicrobial surfaces.
This chapter focuses on the design of a new antibacterial surface by combining a passive
strategy, which reduces bacterial attachment, with an active strategy by the addition of an
active AMP to kill bacteria and further reduce the bacteria load on the surface. Further-
more, a new immobilization technique which allows the immobilization of micelles without
the need to self-assemble already functional group exposing nanostructures is studied. The
aim is to further advance the research and knowledge in the field of antimicrobial surfaces
by achieve following goals:
(i) Micelle preparation and characterization.
(ii) Optimizing micelle immobilization to create nanostructured surfaces.
(iii) AMP synthesis and characterization.
(iv) Characterization of AMP decorated nanostructured surfaces.
The approach developed in this chapter is based on the creation and careful physical char-
acterization of surfaces with immobilized and AMP-decorated nanostructures. There is
an interest to find new designs to successfully fight bacterial colonization.
52
PhD Thesis Serena Rigo
4.3 Experimental Procedures
4.3.1 Material
The block copolymer PMOXA18-b-PDMS69-b-PMOXA18 was obtained by Dr. Samuel
Lörcher;82 Si-wafers (〈P100〉) were obtained from Si-Mat Germany, silicon dioxide Quartz
crystal microbalance (QCM) sensor chips (5 MHz quartz crystal, q-sense) from Biolin Sci-
entific, p-maleimidophenyl isocyanate crosslinker (PMPI) and Atto-647 maleimide from
Atto-Tec GmbH, dimethyl-sulfoxide (DMSO), anhydrous toluene, piperidine, N,N’-Diiso-
propylcarbodiimide (DIC), Diisopropylethylamine (DIEA), 3-(mercaptopropyl)trimethoxy-
silane, KI, diethyl ether, carboxyfluorescein (CF), and α-cyano-4-hydroxycinnamic acid
from Sigma Aldrich. 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE), and 1,2-
dioleoyl-sn-glycero-3-phosphoglycerol, monosodium salt (DOPG) were purchased from
Avanti Polar Lipids. Ethyltrimetoxysilane was from Alfa Aesar, Bodipy630/650 from
Thermo Scientific Inc., NaCl from Merck, and D-glucose monohydrate, and Triisopropy-
lsilane (TIS) from Fluka. Milli-Q water (resistivity of ≥ 18 MΩ·cm) used was obtained
from a Purelab Option-R 7/15 system (ELGA), henceforth referred to as H2O. 0.9 % NaCl
solution in Milli-Q is henceforth referred to as NaCl solution. Bacterial tryptone, yeast
extract, agar, and soytone were from Becton Dickinson, potassium phosphate from Ap-
pliChem, and KYE28-Cys from Bio Peptide. Cl-MPA ProTide resin (0.2 mmol g−1, 200
mesh), and OxymaPure were obtained from CEM, N,N-dimethylformamide (DMF) from
J.T. Baker, Dichloromethane (DCM), and trifluoroacetic acid (TFA) from VWR, HPLC
grade acetonitrile (ACN) from Scharlau. 9-fluorenylmethyloxycarbonyl (Fmoc) protected
amino acids Ile, Lys(Boc), Tyr(tBu), Asn(Trt), Leu and Phe were purchased from Nov-
abiochem and Gly, Thr(tBu), Arg(Pbf), His(Boc) from Iris Bio. All chemicals were used
as received unless stated otherwise.
4.3.2 Micelle self-assembly and characterization
Micelle self-assembly was achieved using solvent evaporation. Briefly, a 10 mM stock solu-
tion of PMOXA18-b-PDMS69-b-PMOXA18 was prepared in ethanol. 50 µL of the polymer
solution was added to 1 mL of H2O in a glass vial. The colloid was stirred at 350 rpm
overnight at rt and stored at 4◦C until further usage. The procedure to functionalize
preformed micelles with maleimide moieties was modified from Kiene et al.224 as follows:
A stock solution of PMPI (1 mM) was prepared in DMSO and further diluted with H2O
to the corresponding concentrations (1 mM, 200 µM, 50 µM, and 19 µM) immediately
before functionalization. Micelles (0.5 mM) were diluted (1:1 v/v) with the different PMPI
concentrations resulting in 200, 40, 10, and 4 mol % PMPI. The reactants were mixed for
at least 6 h at rt. Subsequently, the mixture was ultra-filtrated (5 min at 11,000 g) with
a 30 kDa membrane filter to remove unreacted PMPI. The filtrate was washed with H2O
and filtered again (2x). Then, the filter cake was resuspended in H2O to obtain a micelle
suspension corresponding to 0.25 mM polymers.
For transmission electron microscopy (TEM), 5 µL micelle suspension were adsorbed to
a glow discharged formvar-coated copper grid (400 mesh) for one minute. Excess sample
was blotted off and the grid washed twice with water and once with 2 % uranyl acetate
before being negative stained with 2 % uranyl acetate for 10 s. Dry grids were imaged
with a Philips CM100 at an acceleration voltage of 80 kV.
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Dynamic light scattering (DLS) was performed in triplicates on a Zetasizer Nano ZSP
(Malvern Instruments) at 25◦C. The micelle suspension (20 µL) was diluted with 480 µL
H2O and the scattering recorded at a backscattering angle of 173
◦. The zeta-potential (ζ)
was measured in 10 mM NaCl on the same instrument at 25◦C.
4.3.3 Peptide-Micelle interaction
KYE28 with an additional cysteine at the C-terminus (KYE20-Cys) was reacted to Atto-
647-maleimide overnight at 4◦C. The labeled peptide was purified by column purification
(PD Minitrap sephadex G-25, GE Healthcare) to remove free Atto-647-maleimide.
Peptide-Micelle interactions were analyzed by fluorescence correlation spectroscopy (FCS)
on a commercial Zeiss LSM 510 META/Confocor2. The micelles were mixed with Atto-
647 labeled KYE28 or free dye overnight at 4◦C. A 10 µL aliquot was then placed on a
glass coverslip (0.16-0.19 mm thickness) and excited at 633 nm with a HeNe laser with
a pinehole of 90 µm and a power of 5mW. Autocorrelation curves were recorded using
a 40x water-immersion objective (Zeiss C/Apochromat, NA 1.2) and appropriate filter
sets. The FCS autocorrelation curves were fitted with either a one component curve or
a two-component curve where the diffusion time of the first fraction was fixed to the one
obtained for free dye. The fitting was conducted as previously described.93
Anionic bacterial model liposomes were self-assembled from a 75/25 mol/mol mixture
of DOPE / DOPG. The lipid mixture was dissolved in chloroform and dried to a thin film
under vacuum. The thin film was rehydrated with 0.1 M CF dissolved in 10 mM Tris
buffer, pH 7.4. The hydrated lipid mixture was treated with eight freeze-thaw cycles in
liquid nitrogen followed by one minute heating in a 60◦C water bath and 30 s vortexing.
The sample solution was extruded 30 times through polycarbonate filters (pore size 100
nm) mounted in a LipoFast miniextruder (Avestin, Ottawa, Canada) to obtain unilamellar
liposomes. Non encapsulated CF was removed by two subsequent gel filtrations (Sephadex
G-50, GE Healtcare, Uppsala, Sweden) with Tris buffer as eluent. CF leakage was mon-
itored on a SPEX-fluorolog 1650 0.22-m double spectrometer (SPEX Industries, Edison,
U.S.A.) through emitted fluorescence at 520 nm. Liposomes were diluted with Tris buffer
to obtain a 10 µM lipid sample for the leakage assay. After 10 min the substrate (peptide
or micelle) was added and after another 30 min 0.8 mM Triton X-100 (Sigma-Aldrich, St.
Louis, U.S.A.) was dropped into to disrupt the liposomes and obtain 100% leakage while
the emitted fluorescence was monitored for another 5 min. Micelles were decorated with
KYE28-Cys by mixing micelles and peptide together and keeping them at 4◦C until gel
filtration was conducted to remove non-attached peptide.
4.3.4 Synthesis of AMP KYE28
The peptide KYE28 (KYEITTIHNLFRKLTHRLFRRNFGYTLR) was synthesized by
microwave-assisted automated solid phase peptide synthesis (Liberty Blue, CEM Cor-
poration). Cl-MPA ProTide resin (0.2 mmol g−1, 200 mesh) was used for the synthesis
with DMF as the solvent. Fmoc protected amino acids were deprotected with piperidine
(20% v/v, 3 mL) followed by coupling the next amino acid by amide bond formation in
the presence of DIC (0.25 M, 1 mL), and a mixture of OxymaPure and DIEA (0.5 M and
0.05 M, 0.5 mL). The microwave power was set to reach 90◦C (50◦C for Histidine) during
deprotection and coupling. The first amino acid was coupled to the resin in a more basic
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environment, in a mixture of DIEA and KI (1 M and 125 mM, 1 mL). After microwave
assisted synthesis of the complete sequence, the peptide bound resin was transferred to
a syringe vessel, rinsed with DCM, and allowed to dry in air. Resin cleavage and amino
acid side chain deprotection was accomplished by adding 4 mL cleavage solution (95 %
TFA, 2.5 % H2O, and 2.5 % TIS) and stirring for 4 h at rt and 80 rpm. After collection of
the TFA mixture containing the cleaved peptide, the resin was washed several times with
cleavage solution and the supernatants were combined with the peptide solution. The
peptide was precipitated in ice cold diethyl ether (40 mL) and pelleted by centrifugation
(5 min, 2300g). The supernatant was removed and the precipitated peptide resuspended
in ice cold diethyl ether (repeated 3x). The precipitated peptide was finally dissolved in
H2O containing 0.1 % TFA and lyophilized.
The peptide was purified by semi-preparative reverse phase high-performance liquid chro-
matography (HPLC) (Shimadzu) on a Proto 300 (Higgins Analytical) C18 column (250
mm x 10 mm) with 5 µm particle size at a flow rate of 4 ml min−1. The mobile phase was
a mixture of ACN and H2O each acidified with 0.1 % v/v TFA. The run started with 5
% ACN increasing linearly to 25 % over the first 4 min. Then, up to minute 26 a linear
gradient from 25 % to 38 % ACN was applied to collect KYE28 around minute 24. After
this, the column was washed with 95 % ACN up to minute 30 and decreased again back
to 5 % over half a minute where it stayed until the end of the run at minute 37. UV-Vis
absorbance was simultaneously measured focusing on λ = 214 nm. The solvents were
evaporated in a rotary evaporator, followed by lyophilization.
Matrix-assisted laser desorption/ionization time of flight mass spectrometry (MALDI-Tof-
MS) analysis of the peptide was performed on a Bruker Microflex system. A saturated
α-cyano-4-hydroxycinnamic acid solution (1:1, v/v, H2O:ACN, 0.1 % TFA) was mixed
with 100 pmol µL−1 of purified peptide solution in H2O at a sample to matrix ratio of
1:20 and 1 µL of the mixture was dropped onto the target plate and allowed to air dry.
4.3.5 Antimicrobial Activity of KYE28 - MIC and MBC
Minimal inhibitory concentrations (MICs), defined as the lowest concentration of an an-
timicrobial that will inhibit the visible growth of a microorganism after overnight incu-
bation, were determined using JM101 K12 Escherichia coli (E. coli). Overnight cultures
of E. coli grown in LB medium (LB, 5 g bacterial tryptone, 2.5 g of yeast extract, 5 g
NaCl, 500 mL H2O) were pelleted and resuspended in 10 % tryptic soy broth (TSB) (1.7
g bacterial tryptone, 0.3 g soytone, 0.25 g of D-Glucose monohydrate, 0.5 g NaCl, 0.25
g potassium phosphate, 100 mL H2O) in NaCl at a concentration of 10
7 colony forming
units (CFU) mL−1. KYE28 was diluted in H2O at concentrations ranging from 125 µg/L
to 64 mg/L as described in the NCSLA guidelines.264 90 µL of each KYE28 concentration
were combined with 10 µL of E. coli (107 CFU mL−1) per well in a 96-well plate and
incubated overnight at 37 ◦C. MIC was determined.
The minimal bactericidal concentration (MBC), i.e. the lowest concentration of antimi-
crobial that will prevent the growth of an organism after subculture on to antibiotic-free
medium was determined by plating 10 µL spots of undiluted samples from wells without
visible growth of E. coli and from the lowest KEY28 concentration with visible E. coli
growth on LB-agar plates (7.5 g agar/500 mL LB). The LB-agar plates were incubated
overnight at 37 ◦C and quantitatively assessed the next day.
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4.3.6 Production and characterization of surfaces with KYE28 deco-
rated micelles
QCM sensor chips and 64 mm2 squares cut from Si-wafers were functionalized with thiol
groups. Therefore, the supports were activated for 5 min in an oxygen plasma218 fol-
lowed by being submerged in anhydrous toluene containing 0.3 % of silanes ((w/w); 3-
(mercaptopropyl)-trimethoxysilane:ethyltrimetoxysilane, 1:1). Supports were shaken hor-
izontally at 80 rpm overnight at rt, rinsed with toluene and ethanol and dried under a
gentle stream of compressed air.222
For micelle immobilization, thiolated Si-wafer squares were placed in a 24-well plate and
450 µL of resuspended maleimide-micellar solution were added to each well. After shaking
the plates at 80 rpm overnight at rt the surfaces were washed twice with H2O and placed
in a dry well.
To decorate the immobilized micelles with KYE28, 400 µL of a KYE28 stock solution
(640 µg/mL in H2O) were carefully applied to each well containing a surface. Alterna-
tively, micelle-coated surfaces were placed in a Petri dish and 40 µL of KYE28 stock
solution was added to each square. Squares were then covered with a sterile parafilm so
that the droplet evenly spread over the whole surface and the KYE28 was left to adsorb
overnight. Wet tissue was placed in the Petri dish to prevent drying of the protein solution.
Atomic force microscopy (AFM, JPK Nanowizard 3, Version 6.0.63) was used to charac-
terize surfaces with immobilized micelles before and after peptide adsorption. Dry surfaces
were measured in amplitude-modulation mode using a Tap300 Al-G cantilever (Budget
Sensors, resonance frequency 280 kHz, force constant 40 N m−1) for measurements in air,
and a Tap75 Al-G (Budget Sensor, resonance frequency 75 kHz, force constant 3 N m−1)
for measurements in H2O. The phase was always set to 0 deg. All images were recorded
at a pixel resolution below the tip radius (< 10 nm). Images were further processed and
analyzed with Gwyddion (version 2.51).
The thickness of the modified surfaces was determined by spectroscopic ellipsometry (Ac-
curion, Cauchy model). Three separate measurements on each surface were averaged.
Static water contact angles were measured with a drop shape analyzer (KRÜSS). De-
pending on the surface area 2-4 drops were analyzed per surface.
Confocal laser scanning microscopy (CLSM) was performed at 20◦C on a ConcfoCor
(ZEISS LSM 880, inverted microscope ZEISS Axio Observer, Carl Zeiss). Bodipy (10
mM in DMSO) was diluted in H2O to a concentration of 25 µM and subsequently added
to maleimide-micelles in H2O to a final concentration of 50 nM. Bodipy-stained, surface-
attached micelles were imaged using an oil-immersion objective (Plan Apochromat 63x/1.4
oil DIC M27) and a mean beam splitter (488/561/633). For images recorded in airyscan
mode, a He-Ne laser at 633 nm wavelength was used as an excitation source (5 % laser
power), with the pinhole set at 103 µm and the gain to 800. Intensity values were calcu-
lated with ZEN software and then normalized.
XPS measurements were carried out with a VG ESCALAB 210 spectrometer, using
monochromatized AlKa (1486.6 eV) as radiation source. 20 eV pass energy was applied for
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all narrow scan measurements while 100 eV was applied for wide scans. Normal electron
escape angle and a step size of 0.05 eV were applied. The Gaussian broadening of the spec-
trometer was calibrated for the 20 eV analyzer pass energy to 0.55 eV. The binding energy
scale was calibrated with reference to the 4f7/2 level of clean gold sample at 84.0 eV binding
energy. Fitting of the core level lines was performed applying the Doniach-Sunjic (asym-
metrical Lorentzian) function265 with Shirley background subtraction,266 using UNIFIT
for Windows (Version 2016) software.267 The individual peaks were fitted by a convolution
of an asymmetric function with Lorentzian and Gaussian line shapes. The intensities were
then estimated by calculating the integral of each peak. Scofield sensitivity factors were
used to derive the atomic concentrations.268
Quartz crystal microbalance with dissipation monitoring (QCM-D) was performed with
a Q-Sense E1 system (Biolin Scientific, Sweden). All measurements were performed on
14 mm diameter, 5 MHz quartz crystal with a sputter-coated silicon oxide (model no
QSX303) surface coating. Prior to experiments, each sensor crystal was rinsed with wa-
ter, ethanol and then subjected to oxygen plasma (Harrick Plasma, Ithaca) to remove
undesired contaminants. The clean sensors were functionalized with thiol moieties as de-
scribed for the Si-wafers. All QCM-D measurements were conducted under continuous
flow conditions, with a flow rate of 50 µL min−1, and controlled by an IPC pump from
Ismatec. The measurements were recorded at multiple odd overtones (5th, 7th, 9th) and
the data shown was obtained at the seventh overtone (n=7). The viscoelastic modelling
was done with the Qtools software package assuming a film density of 1000 kg m−3 and
a bulk aqueous solution viscosity of 0.001 Pa s−1. For the viscoelastic modelling, data
produced from 5th, 7th, and 9th overtones were used. The data are expressed as the mean
± standard deviation of the mean where appropriate. All measurements were performed
in triplicates.
4.3.7 Antibacterial Activity of Micelle Modified Surfaces
Functionalized Si-wafer squares were placed in a 24-well tissue culture plate and infected
with 1 mL of E. coli (5·104 CFU mL−1,269 1 % TSB in NaCl). E. coli were allowed
to adhere for 90 min at 37◦C without agitation. Non-adherent cells were removed by
washing with NaCl. Surfaces were placed in a fresh well, covered with 10 % TSB in
NaCl and incubated for 20 h at 37◦C. Subsequently, planktonic cells were removed by
washing with NaCl and modified surfaces were stained with the LIVE/DEAD BacLight
stain (ThermoFisher Scientific). Stained surfaces were visualized with the CLSM using
a water immersion objective (C-Apochromat 40x/1.2W Korr FCS M27) with excitation
at 488 nm and 561 nm wavelengths (each 1.5 % laser power) and a mean beam splitter
(488/561/633) at 20 ◦C. The pinhole was set to 47 µm and the gain to 600. Fluorescence
was tracked from 500-550 nm and 610-718 nm. Fluorescence images were processed with
Fiji.270 In parallel, corresponding surfaces were transferred to 15 mL falcon tubes and
sonicated for 5 min with 2 mL 1 % TSB in NaCl to disperse adherent bacteria. The
bacteria suspension was serially diluted (10−1, 10−2, 10−3, 10−4, 10−5, 10−6) in NaCl and
50 µL of each dilution were spotted in triplicate on LB-Agar plates. After an overnight
incubation at 37◦C, the CFUs were counted on the 10−3 dilution if numbers were adequate,
or back calculated for this dilution from a countable dilution (n = 3). Further on, Welch’s
t-test was applied.
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4.4 Results and Discussion
4.4.1 Micelle Self-Assembly
Micelles were formed by self-assembly of PMOXA18-b-PDMS69-b-PMOXA18 block copoly-
mer82 and characterized by a combination of DLS, TEM, and ζ-potential measurements.
TEM analysis revealed single particles with a homogenous micellar morphology (Figure
4.2). A mean radius of 15 ± 6 nm was determined by measuring over 100 micelles on
several TEM micrographs. Consistently, DLS measurements yielded a unimodal peak as-
sociated with a hydrodynamic radius (Rh) of 19 ± 5.5 nm (Figure 4.3). A ζ-potential of
5 mV indicated that the surface charge of the micelles was neutral.
Figure 4.2: TEM micrographs with inlets of the size distribution histogram measured by
image processing of A) micelles assembled from PMOXA18-b-PDMS69-b-PMOXA18 and of
B) assembled micelles reacted to p-Maleimidophenyl-isocyanate (PMPI). Scale bars: 200
nm.
4.4.2 Peptide-Micelle interaction
Amphiphilic molecules including AMPs are known to interact with polymeric nanostruc-
tures162 and the adsorption of KYE28 to the micelles was investigated. Therefore, the
peptide was fluorescently labeled with Atto-647 maleimide, and its interaction with the
micelles studied by FCS. FCS auto-correlation curves were recorded for free Atto-647-
maleimide in solution, the Atto-647-KYE28 in solution, and micelles mixed either with
free dye or Atto-647-KYE28 (Figure 4.4). The auto-correlation curves for free dye (black
curve) and micelles incubated with the dye (blue curve) overlapped, and similar diffusion
times of 56 ± 2 µs and 62 ± 3 µs, respectively, were calculated. This data indicated that
the dye is freely moving in solution and not interacting with the micelles. In contrast, a
shift to a higher diffusion time (157 ± 35 µs) was obtained for the labeled KYE28 (green
curve). The calculated Rh based on the diffusion time increased from 0.9 nm for free dye
to 2.3 nm for labeled KYE28. The auto-correlation curve was fitted with a two component
model, where one diffusion time was fixed to the one previously measured for the free dye.
This fitting showed that 34 % of the dye was still free in solution while 66 % was attached
to the peptide. Mixing the micelles with the labeled peptide (red curve) lead to a signifi-
cant shift toward longer diffusion times (747 ± 63 µs). This shift to slow diffusion reflects
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Figure 4.3: DLS measurements of micelles without PMPI (black) and after reaction to
PMPI (red) revealed similar number particle size distributions (PSD). The two samples
were measured each three times.
that the labeled peptide was interacting with the micelles to yield KYE28-decorated mi-
celles. An Rh of 11 ± 1 nm was calculated from the diffusion time obtained for micelles
interacting with labeled peptide, which is in good agreement with the size of the micelles
previously determined by TEM and DLS. The counts per molecules (CPMs) recorded for
free dye, labeled peptide, and micelles interacting with labeled peptide indicate an average
of one dye molecule per peptide and one to two labeled peptides per micelle (Table 4.1).
τD [µs] Fraction [%] CPM [kHz] CR [kHz]
Atto 647 maleimide (dye) 56 ± 2 100 30.6 ± 0.6 22.5 ± 0.3
Micelle + dye 62 ± 3 100 33.4 ± 0.4 222 ± 3
Labeled Peptide 157 ± 35 66 29.5 ± 1.0 688 ± 143
Micelle + labeled peptide 747 ± 63 99 49.4 ± 1.4 1796 ± 75
Table 4.1: FCS fitting parameters of the micelle-peptide interaction study.
To test whether KYE28 decoration conferred antimicrobial properties upon micelles, CF
encapsulating DOPE/DOPG (75/25 mol/mol) liposomes were mixed with micelles. These
liposomes are mimicking the anionic bacterial membrane and are extensively used in AMP
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Figure 4.4: Normalized FCS auto-correlation curves of Atto-647 maleimide (black), dye
mixed together with micelles (blue), Atto-647 labeled KYE28 peptide (green), and micelles
mixed with Atto-647 labeled KYE28 peptide (red). Raw data are represented by squares
while the fitted autocorrelation curves by a colored line.
studies. Importantly, the DOPE/DOPG membranes gave similar results on AMP inter-
action, as membranes prepared from E. coli lipid extracts. Furthermore, these liposomes
agreed with bacterial lysis experiments.271 CF is a fluorescent dye which is self-quenched at
high concentrations, thus showing increased fluorescence when diluted.272 CF was encap-
sulated in bacterial membrane mimicking liposomes to monitor the ability of the peptide
and micelles to induce leakage and therefore, destroying the integrity of the anionic mem-
brane mimicking DOPE/DOPG liposomes (Figure 4.5). The detergent Triton X was
added in the end to determine 100 % leakage. In the self-leaking experiment, the stability
of the liposomes was confirmed. The peptide free in solution caused leakage in a dose-
dependent manner. With a high concentration of 1 µM 100 % leakage was caused, while
with a lower concentration of 0.1 µM partial leakage of 45 % was was reached (Figure
4.5A). The micelles (10 µM polymer) alone did not result in any detectable liposome lysis.
In contrast, micelles decorated with 1 µM peptide before purification by gel filtration, led
to 67 % leakage (Figure 4.5B). These results suggest that the bare micelles free in solu-
tion will not harm bacteria, but should be able to kill them when decorated with KYE28.
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Figure 4.5: Leakage experiments on CF-containing DOPE/DOPG liposomes. After 10
min, the sample was added to the liposome solution and after an additional 30 min Triton-
X was added to cause 100 % leakage. A) Peptide alone in two different concentrations: 1
µM Peptide led to 100 % leakage while 0.1 µM led to 45 % leakage. B) Micelles alone did
not cause any leakage; the leakage was in the range of the self-leaking of liposomes. The
AMP decorated micelles caused nearly 70 % leakage.
4.4.3 Surface functionalization
Micelles and surfaces were functionalized with opposite moieties to enable the immobi-
lization. To obtain a surface with a 50 % relative density of thiol groups for further
coupling, Si-wafers were functionalized by silane chemistry with a 1:1 mixture of thiol
and ethyl functionalized silanes.218,222 The functionalized surfaces were analyzed by am-
plitude modulation AFM to characterize material properties by height and phase. No
significant height difference across the surface was expected as the silane functionalization
is known to result in self-assembled monolayers.273 Therefore, to study non-functionalized
and functionalized Si-Wafers the focus has to be put on the phase, indicating if the in-
teraction between the AFM tip and the surface is attractive (positive phase) or repulsive
(negative phase). Compared to non-functionalized Si-wafers where the phase was negative
and homogeneous (Figure 4.6A and C), phase imaging of the functionalized surface
revealed material differences that indicate the presence of thiol and ethyl groups. The
yellow ellipsoidal patches of 10-50 nm in diameter (Figure 4.6B and C) are likely to
reflect thiol groups due to increased attractive behavior towards the tip than other regions
as the hydrophilicity of the thiols is higher compared to the ethyl groups.
The surfaces were further analyzed by ellipsometry and static water contact angle (Figure
4.7). The functionalization of the Si-wafer with thiol groups led to a decrease in hydropho-
bicity from 67◦ ± 1◦ to 58◦ ± 1◦ water contact angle due to the polarity of the thiol groups.
An increased thickness from 4.3 to 5.0 nm was modeled by ellipsometry, representing the
added silane layer composing of 50 % thiol functionalized silanes.
4.4.4 Immobilization of Micelles on Functionalized Surfaces
To covalently attach micelles to the thiol functionalized Si-wafers by means of thiol-
maleimide Michael addition, maleimide exposing micelles were produced by functional-
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Figure 4.6: AFM micrograph showing the phase (◦) channel of A) untreated Si-wafer and
B) thiol functionalized Si-wafer. Scale bars are shown in white: 200 nm. C) Measured
profile lines in black (300 nm, A, B) of the phase are displayed.
izing already preformed micelles with different concentrations of PMPI-crosslinker in an
easy one pot reaction. Due to possible hydrolysis up to 200 mol % PMPI was reacted to
micelles. TEM (Figure 4.2) and DLS analysis (Figure 4.3) before and after PMPI ad-
dition demonstrated that shape and diameter of the micelles remained largely unaffected
by functionalization with maleimide. Specifically, a radius of 16 ± 5 nm was obtained
from TEM and an Rh of 23 ± 6 nm by DLS for micelles after their reaction to PMPI .
Low ζ-potentials of 5, 5, and 4 mV were measured for 4, 40, and 200 mol % PMPI. The
corresponding surface charge was comparable to that of non-functionalized micelles, with
all samples having a solvent conductivity of 0.7 Sm−1.
Thiol functionalized surfaces were reacted overnight with maleimide exposing micelles
to create surfaces with immobilized micelles. To trace the micelles by fluorescence, Bod-
ipy630/650, a hydrophobic dye adsorbing non-specifically to micelles,88 was added prior
immobilization. The fluorescent intensities of immobilized micelles that were maleimide-
functionalized with different concentrations of PMPI (0 - 200 mol %) were examined by
CLSM (Figure 4.8) to compare immobilization efficiencies between the different micelles
added to the surface. Surfaces reacted with Bodipy-stained maleimide-functionalized mi-
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Figure 4.7: In situ assessment of thickness by ellipsometry (red bars) and static water
contact angles (blue bars) during different stages of surface fabrication. Error bars were
calculated by a standard deviation for all samples (n=3).
celles showed higher fluorescent intensities and therefore more micelles on the surface, than
those treated with Bodipy-stained micelles lacking maleimide. The different amounts of
PMPI used for maleimide functionalization did not have a significant influence on the
fluorescent intensities, suggesting a similar extend of immobilization. This data cor-
roborated that maleimide-functionalized micelles can be covalently immobilized on thiol-
functionalized surfaces by the Michael addition and that only little maleimide functional-
ities were needed to achieve stable immobilization of micelles. The surface roughness was
calculated from AFM micrographs. It showed that the less PMPI was used for maleimide
grafting the rougher was the final surface. However, the complete absence of maleimide
resulted in the lowest roughness (Figure 4.8). The surface corrugation is indicative of
individual micelles being immobilized, as individual micelles are larger and stick out from
the surface. Together, these results show that for the successful immobilization on thiol-
functionalized surfaces, maleimide-exposing micelles are crucial.
As PMPI is sensitive to moisture, a tenfold excess is suggested to overcome hydrolysis.
Therefore, the 10 mol% PMPI presumably corresponds to 1 mol% functional groups, which
has previously been used for polymersome immobilization.222 Based on these considera-
tions, a concentration of 10 mol% PMPI was chosen for all further experiments. Moreover,
the fluorescent intensity study showed that this concentration was sufficient for successful
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Figure 4.8: Confocal laser scanning microscopy intensities (red) comparison and AFM cal-
culated roughness (blue) comparison between immobilized micelles treated with different
mol% PMPI (0-200) prior immobilization.
immobilization.
AFM micrographs recorded in liquid (H2O) (Figure 4.9A and B) and in air (Figure
4.10A-C) revealed immobilized micelles in the phase and height channels. The micelles
were detected with a higher phase than the surrounding, which was indicative of an in-
creased attractive regime. This was likely due to the higher hydrophilicity of the polymer
micelles attached to the thiol patches compared to the surrounding surface. When recorded
in liquid the micelles displayed a lower height than when recorded in air.
When assessed by ellipsometry(Figure 4.7), the thickness was found to be increased by
12 nm due to the immobilized polymeric micelles. The final thickness for a surface with
surface-attached micelles was therefore 17.0 nm. The water contact angle of 63◦ (Figure
4.7) indicates that the hydrophobicity stayed similar to thiol-functionalized surfaces.
4.4.5 Synthesis of the antimicrobial peptide KYE28
The AMP KYE28 was synthesized by Fmoc solid-phase peptide synthesis with microwave
heating having the advantage of reduced synthesis time and chain aggregation.274 This
peptide was chosen as a model peptide due to its antimicrobial and anti-endotoxic prop-
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Figure 4.9: AFM images recorded in H2O of surfaces before and after adsorption of KYE28.
A) Phase-contrast image and B) height image of surfaces with immobilized micelles lacking
KYE28. C) Phase-contrast image and D) height image of surfaces after KYE28 adsorption.
On the right side are displayed 3D images of the height with phase as overlay of immobilized
micelles (top), and of the surface after KYE28 adsorption (bottom). Scale bars: 200 nm.
erties.261 The main peak in the HPLC elugram of the raw peptide corresponds to KYE28
and was collected during the depicted time around minute 24 (Figure 4.11A). The mass
was confirmed by MALDI ToF-MS, where the single and double charged species are ob-
served at 3591 m/z and 1792 m/z, respectively (Figure 4.11B). A yield of up to 22 %
after HPLC purification was achieved. The peptide was purified successfully as visible by
the HPLC elugram of the purified KYE28 solution (Figure 4.12).
First, we assessed the antimicrobial potential of the purified KYE28 peptide in solution,
the MIC and MBC were measured and determined to be both 32 µg/mL corresponding
to 8.9 µM. This was in the range of the MICs that have been reported for KYE28 using
different bacteria species and strains.261
4.4.6 Modification of Surface-Attached Micelles with the antimicrobial
peptide KYE28
KYE28 was dissolved in water (640 µg/mL) and adsorbed to the surface-immobilized mi-
celles by overnight immersion of the surface in the peptide solution (450 µL). An HPLC
elugram of the KYE28 solution was recorded before and after immersion of the surface to
estimate the amount of adsorbed peptide (Figure 4.12). The concentration of KYE28 in
the solution was reduced by 28 %, corresponding to a possible maximum of 80 µg KYE28
on the surface, comparable to findings by Nyström et al.193 The surface was either used in
dry state for AFM, ellipsometry or static water contact angle measurements, immersed in
water for liquid AFM studies or immersed in bacteria medium for antimicrobial testing.
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Figure 4.10: AFM micrographs recorded in air of immobilized micelles. A and D) Phase
contrast images, B and E) height images, and C and F) 3D images of the height with
phase as overlay of immobilized micelles (top), and of a surface after KYE28 adsorption
(bottom). Scalebars are A-B) 400 nm, and D-E) 200 nm. C) Axis length is 2 µm, and F)
axis length is 1 µm.
The increased phase shift in AFM micrographs showed that after KYE28 adsorption, the
micelles remained more attractive to the AFM tip than the surrounding areas. (Figure
4.9A and C and 4.10D and F). However, compared to surfaces with immobilized bare
micelles, for which the average phase was around 30-35◦, the overall phase was reduced to
20◦, i.e., exhibited less attractive forces after KYE28 decoration (Figure 4.9A,C). Height
images revealed the structures on the surface to be in a similar size range (Figure 4.9B
and D and 4.10B and E). Further, upon peptide adsorption, the surface lost parts of
its previous flexibility as indicated by the overall lower phase. Similar effects were found
for peptide loaded on surface-bound microgels.275 It is possible that the peptide incorpo-
rated between the outer hydrophilic polymer blocks in the micelle and thereby hampered
flexibility. Furthermore, KYE28 decoration led to a slight increased water contact angle of
78◦, i.e., an increase in hydrophobicity of the surface possibly results from the amphiphilic
nature of the peptide. In addition, ellipsometry revealed a slight decrease in thickness to
15.2 nm upon KYE28 adsorption (Figure 4.7). This decrease is likely due to a reduced
water content resulting from the incorporation of the amphiphilic AMP.276
X-Ray photoelectron spectroscopy (XPS) was further employed to analyze the chemical
composition of the different surfaces. XPS of thiol-functionalized, immobilized micelles,
and KYE28-decorated, immobilized micelles revealed the presence of O, N, C, and Si
(Figure 4.13A). On surfaces with immobilized bare or KYE28 decorated micelles the
N 1s peak was detected. It represents the nitrogen in the PMOXA block of the triblock
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Figure 4.11: A) HPLC elugram. The grey area was collected. B) Linear positive MALDI-
ToF spectra of the collected KYE28.
copolymer, and additionally, the nitrogen in the peptide in case of the KYE28-loaded
surface. Accordingly, the nitrogen concentration was 3.6 and 7.3 atomic percent (at. %)
(Table 4.2). A corresponding peak of low intensity (0.8 at. %) was also found on the
thiolated surface (Figure 4.13B), reflecting nitrogen adsorption from the atmosphere.
Surface modification N [at. %] C [at. %] O [at. %] Si [at. %]
Thiolated 0.8 20.3 41.9 37.0
Immobilized micelles 3.6 47.7 27.1 21.6
Immobilized miecelles with
adsorbed KYE28
7.3 57.7 21.7 13.3
Table 4.2: Atomic percent (at. %) calculated from XPS measurements.
Moreover, this surface showed some metal impurities at binding energies of 796 eV, 781
eV for cobalt and 228 eV for molybdenum, which were absent on both micelle-derived sur-
faces. These metal impurities came from the solvent (ethanol) used to wash the surfaces
after thiol functionalization. However, the surfaces with immobilized micelles were rinsed
with H2O and thus, metal impurities were washed away.
The surface analysis by XPS showed changes in the C 1s core level spectra for each surface,
proofing the chemical difference between them. The high resolution spectra were deconvo-
luted into three components for the surfaces with immobilized micelles. The peak at 289
eV, not seen for thiolated surfaces, is characteristic of guanidine and carboxylic acid groups
(Figure 4.13C). For the peptide decorated surface, the peak broadened towards higher
binding energies due to Histidine, Arginine, and Glutamic acid (287 eV, 289 eV).277 A
long peptide with various different amino acids increases the complexity of the peak with
many different contributions and therefore more components at different binding energies
are needed to model it. Thus, the broadening was explained by a deconvolution using five
components. Two components corresponding to guanidine and imidazole (289 eV, 287 eV)
were added in comparison to bare micelles (Figure 4.13C and Figure 4.14).277 KYE28
adsorption on the surface-attached micelles was further supported by a 2-fold increase
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Figure 4.12: HPLC elugram of the KYE28 solution before immersing the micelle immo-
bilized surface in it (black) and after immersing the surface in it (red) to let the peptide
adsorb onto the immobilized micelles.
of nitrogen amount due to the peptide backbone and nitrogen containing amino acids.
Furthermore, the relative amount of carbon increased to 57.7 at. % and oxygen decreased
to 21.7 at. % (Table 4.2). These results clearly demonstrate the immobilization of the
micelle and their decoration with KYE28, the latter localized to a large extent in the
periferal corona of the immobilized micelles based on hydrophobic interactions.
QCM-D experiments monitored the immobilization of maleimide exposing micelles and
the subsequent adsorption of KYE28 in real time (Figure 4.15). First, a stable base-
line was established on thiol functionalized QCM chips. After injecting micelles into the
QCM-D chamber, the resonance frequency immediately dropped (∆F = ( -123 ± 14, -
119 ± 14, -114 ± 13) Hz for the 5th, 7th, and 9th overtone, respectively) relative to the
mass accumulation on the chip (Figure 4.15A,B,E,F). At the same time, the dissipa-
tion increased (∆D = (9.7 ± 1.1, 9.9 ± 1.5, and 9.7 ± 1.3) *10−6 for the 5th, 7th, and
9th overtone, respectively) indicating increased viscoelastic properties (Figure 4.15C-F).
Based on viscoelastic models, which are fed by the frequencies and dissipations measured,
a density of 2.6 mg mm−2 was estimated for micelles immobilized on the sensor surface.
It is important to note that this value does not correspond to the dry micelle density
but to hydrated micelles which include associated H2O oscillationg with the chip during
the measurements.276 After micelle adsorption, the surface was rinsed with water. The
shift in frequency and dissipation indicated the removal of non-covalently attached mi-
celles upon rinsing. The viscoelastic model showed a mass reduction to 2.2 mg mm−2,
which corresponds to a mass reduction of 15 %. When KYE28 solution was applied to
immobilized micelles on the QCM-D chip, the frequency increased (∆F to -104 ± 2, -102
± 3, and -100 ± 2 Hz for the 5th, 7th, and 9th overtone, respectively) and therefore,
the mass decreased to 2.1 mg mm−2, corresponding to a further mass reduction of 5 %.
Furthermore, a drop in dissipation was observed (Figure 4.15). Similar frequency shifts
after peptide addition have been reported in QCM-D studies on the interaction of AMPs
with lipid membranes.278,279 Furthermore, an increase in frequency resulting in an under-
estimation of protein adsorption has been reported for thick polymer surfaces with low
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Figure 4.13: XPS spectra of thiolated surfaces (blue), surfaces with immobilized micelles
(orange), and surfaces with KYE28-decorated micelles (green). A) Wide-scan XPS spectra
with vertical shift, B) Overlapped, fitted and normalized curves for N 1s, and C) C 1s.
viscosity. It has been suggested that the adsorption of the protein leads to a partial col-
lapse of the polymer strains and water is squeezed out.276 We believe that a similar effect
of peptide adsorption occurs in our system. Specifically, peptide binding is expected to
result in osmotic deswelling, and hence in the release of trapped hydration water. Consis-
tent with this notion, KYE28 loaded into anionic poly(acrylic acid)-based microgels has
been found to result in an increase of frequency, associated with a drop in mass due to
the removal of adsorbed water.194 Despite such complications in mass quantification for
KYE28-decorated micelles, the QCM-D experiments revealed that micelle immobilization
and decoration were fast processes, occurring within minutes.
4.4.7 Antimicrobial Activity of Peptide-Modified Micelle Surfaces
The KYE28-decorated nanostructured surface was tested for its antimicrobial potential
using a static biofilm formation assay.280 Different surfaces were immersed in an E. coli
inoculum (5 *104 CFU mL−1) and adhering bacteria were allowed to proliferate in bacteria
growth medium overnight at 37◦C. After 20 h, surfaces were stained with a LIVE/DEAD
cell staining kit and imaged by CLSM to qualitatively assess the growth of bacteria
(Figure 4.16A-C). Initial biofilm formation was found on thiol-functionalized wafers.
Note that there is always a small fraction of dead bacteria in E. coli inoculum, and there-
fore, a fraction of dead bacteria was present on all surfaces, including bare Si-wafers and
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Figure 4.14: XPS O 1s, N 1s, and C 1s core level spectra of thiolated, micelle immobilized
and peptide decorated surfaces. Measurements are displayed in a semi-transparent line
while the fitted sum of the components is in black. The components for O 1s, N 1s, and
C 1s, are in red, blue, and grey, respectively.
thiol-functionalized wafers. On surfaces with immobilized micelles or KYE28 decorated
micelles, small bacteria agglomerations and single bacteria were observed. The adsorption
of KYE28 to micelles, clearly reduced the number of adhering bacteria. These data are in
line with findings for KYE28 loaded surface bound anionic microgels reported by Nyström
et al.193 To quantitatively assess the number of surviving celles, bacteria were detached
from the surfaces by sonication and spotted on LB-Agar plates for CFU counting after 24 h
(Figure 4.16D). E. coli were able to adhere and proliferate better on non-functionalized
Si-wafers or thiolated surfaces, compared to surfaces with bare micelles. On the latter, E.
coli survival was reduced by more than half to 43 % compared to non-functionalized wafers
and to 35 % compared to thiol-functionalized surfaces. This reduction of bacteria survival
demonstrates the efficacy of the passive strategy based on surface attached PMOXA-b-
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Figure 4.15: QCM-D measurements of surface deposition and KYE28-loading of micelles.
Simultaneous changes in frequency and dissipation were recorded at 3 overtones (n=5, 7, 9)
as a function of time. A) Frequency diagram and C) dissipation diagram of a representative
QCM-D experiment. E and F) Additional QCM-D diagrams where the blue colors show
the frequencies of the 5th, 7th, 9th overtone while the red colors show the dissipations
of the same overtones. While applying continuous flow (50 µL/min), equilibration of the
chip with H2O followed by (i) injection of micelles dispersed in H2O, (ii) 1
st washing with
H2O, (iii) injection of KYE28 dissolved in H2O, and (iv) 2
nd washing with H2O. Diagrams
represent the averaged shifts in B) frequency and D) dissipation for the 7th overtone.
71
PhD Thesis Serena Rigo
Figure 4.16: Static biofilm assay. The surfaces were visualized by CLSM after staining
the adhering bacteria with the LIVE/DEAD stain. Bacteria with a damaged membrane
were stained with propidium iodine (red, dead), whereas bacteria with intact membranes
were stained with cell-permeable Syto9 (green, alive). A) thiolated surface, B) immobi-
lized micelles, and C) immobilized micelles with adsorbed KYE28. Scale bars, 10 µm.
D) CFU counting for the 10−3 dilution. Black bars represent the average values of the
measurements (Welch’s t-test, ** p < 0.01, *** p < 0.001, **** p < 0.0001, n ≥ 3).
PDMS-b-PMOXA micelles. The adsorption of KYE28 to the micelles further reduced the
adherence and survival of bacteria on the surface to 16 % compared to non-functionalized
wafers and to 13 % compared to thiol-functionalized surfaces. Thus, the passive defense
by the nanostructured surface was enhanced and the overall antimicrobial properties of
the surface were improved by decorating micelles with the active component KYE28.
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4.5 Conclusions
Passive and active approaches were combined for the efficacious prevention of bacterial
growth. The passive strategy consisted of nanostructured surfaces that were successfully
designed and generated by immobilizing PDMS-b-PMOXA-b-PDMS micelles on a thiol
functionalized surface by Michael addition. Attachment of micelles which in solution
hardly affected bacterial growth, rendered the surface antibacterial compared to non-
functionalized and thiol-functionalized surfaces. When the antimicrobial peptide KYE28
was incorporated into the surface-bound micelles as an active component, E. coli survival
was further reduced. Thus, the passive defense properties bestowed by immobilized mi-
celles were enhanced by the active module. The dual strategy of the antimicrobial AMPs
(active) and nanostructured surface (passive) allows an optimization of the antimicrobial
efficacy and opens new avenues in the fight against biofilm formation. Importantly, this
design of modular antimicrobial surfaces is straightforward and scalable by few modifica-
tion steps. In addition, the functional properties can be readily changed by the choice of
peptide,281,282 as long as it is able to interact with the micelles while retaining its activity.
Varying the peptide-polymer combination might also result in an increased decoration
efficiency. Future modifications of the active module for example by combining different
AMPs with overlapping bacterial spectra or synergistic antimicrobial effects, or by the
combination of antimicrobial effects with anti-inflammatory effects and other biological







Microstructured surfaces that minimize the risk of infections are widespread in nature.
Research ideas in most disciplines often start by observing nature and trying to mimic
the structures of interest. Further the mimics will then be optimized and improved for
a specific application by adding possible non-natural components. Antibacterial surfaces
can be enriched with antibiotic agents. Despite the possible cytotoxicity of silver, sil-
vernanopraticles (AgNPs) are considered a safe reservoir of antimicrobial silver cations.
AgNPs are very effective in killing bacteria by releasing silver ions. Antiseptic creams con-
taining silver are on the market as well as materials (e.g., wind instrument heads, medical
devices) with protective silver coatings.283 Immobilization of AgNPs seems to increase the
antimicrobial potential compared to free AgNPs in solution.228
Cephalexin is a cephalosporin that belongs to the class of β-lactam antibiotics like the peni-
cillins. Its action is based on the disruption of the bacterial cell wall synthesis and it is ef-
fective against S. aureus, S. epidermidis, E. coli and P. mirabilis.153,154 Cephalexin can be
produced enzymatically by the enzyme penicillin acylase (PA) which catalyses the conden-
sation of phenylglycinmethylester (PGME) and 7-aminodesacetoxycephalosporanic acid
(7-ADCA). Due to the broad substrate specificity and the high regio-, stereo-, and chemos-
electivity, PA is able to resolve racemic mixtures. In addition to condenstation reactions
the enzyme also hydrolyses the acyl side chains of penicillins and cephalosporins.284,285
PA is used in industry to produce 6-aminopenicillanic acid or 7-ADCA, the starting ma-
terials for various semi-synthetic β-lactam antibiotics.286 The catalytic pocket uses only
one single amino acid, a serine, for the catalytic centre.287
The outer membrane pore F (OmpF) is a bacterial membrane protein which allows the
passive diffusion of molecules up to about 600 Da.138 The susceptibility to β-lactam antibi-
otics or also fluoroquinolones is dependent on non-specific porins like the OmpF for entry
of these drugs into the bacteria. It is an important pore also for the creation of antibiotic
resistances as bacterial mutations can hinder the entry of antibiotics into the bacteria,
by slightly changing the pore structure and/or by reducing the amount of pores in the
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bacterial membrane.288 The OmpF channel is asymmetric, meaning the pore has different
characteristics at the outer and inner face of the membrane. Because penicillins have a
size similar to the narrowest part of the pore, they can occlude the OmpF during their
passage through the pore. However, interactions between pore wall and the antibiotic can
help to let the antibiotic pass through the pore. Important for these mostly electrostatic
interactions are the charges and therefore, the pH of the solution.289–291 Mahendran et al.
showed that negatively charged compounds translocated more efficiently through the pore
than zwitterionic ones.292
Certain short peptides can also arrange them self in the membrane to create a pore.
Melittin (GIGAVLKVLTTGLPALISWIKRKRQQ), a 26 amino acid peptide, is such a
pore producing peptide. It is the main pain producing substance in bee venom, pre-
sumably due to its strong interactions with cell membranes and its pore forming abili-
ties.293 While melittin translocates through the membrane, it forms short lived pores294
for which a toroidal pore model has been suggested.295 The peptide:lipide ratio influences
the pore size; higher ratios leads to bigger pores.294 Interestingly, melittin has also an-
tibacterial properties.293 MelP5 (GIGAVLKVLATGLPALISWIKAAQQL) is a melittin
where 5 amino acids have been changed to make the peptide less charged (+3 instead
of +6) and thereby more hydrophobic. MelP5 was more effective in pore formation as a
lower peptide concentration already resulted in pore formation and the pores were larger
and sometimes longer lasting.296
5.2 Scope of this chapter
There is a huge interest in smart surfaces that successfully fight bacterial colonization.
Therefore, the aim of the research presented in this chapter was to create microstruc-
tured, smart antimicrobial surfaces where passive and active antimicrobial strategies are
combined. The active strategy involving the production and immobilization of cephalexin
producing nanoreactors was developed and examined in our laboratory at the University
of Basel whereas the microstructured surfaces exhibiting passive defense properties were
designed and provided by the collaborating research group of Prof. Jian Xu from the
Chinese Academy of Science, Institute of Chemistry (Figure 5.1).
This chapter focuses the design and development of an antimicrobial producing nanoreac-
tor permeabilized by OmpF or melittin. Furthermore, the characterization and antimicro-
bial testing of several materials and surfaces for possible passive strategies are presented.
The aim is to further advance the knowledge in the field of smart antimicrobial surfaces
by achieving the following goals:
(i) Characterization of a microstructured surface designed to allow for a passive
antimicrobial strategy.
(ii) Encapsulation of enzymes into polymersomes to create nanoreactors.
(iii) Nanoreactor permeabilization for antibiotic release.
(iv) Nanoreactor immobilization on a microstructured surface.
The dual antimicrobial approach contemplated in this chapter is based on the careful char-
acterization of the surfaces and the nanoreactors. Furthermore, two different nanoreactor
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permeabilization strategies were studied.




Polypropylene and cotton based materials as well as organosilica covered glass and sil-
ica surfaces were prepared by the research group of Prof. Dr. Jian Xu. Bacterial
tryptone, yeast extract, agar, and soytone were from Becton Dickinson; potassium phos-
phate dibasic (K2HPO4) was purchased from AppliChem; sodiumchlorid (NaCl), sodium
phosphate dibasic (Na2HPO4) from Merck, D-glucose monohydrate, and zinc chloride
from Fluka; Potassiumchlorid (KCl), Cephalexin hydrate, sodium carbonate (Na2CO3),
sodium hydrogen carbonate (NaHCO3), sodium hydroxid (NaOH), horseradish peroxidase
(HRP), (R)-(-)-2-phenylglycine methyl ester hydrochlorid (PGME), 7-Aminodesacetoxy-
cephalosporanic acid (7-ADCA), HPLC grade trifluoroacetic acid (TFA), Sepharose 2B,
D-Sorbitol, Atto488-NHS, 5(6)-carboxyfluorescein (CF), and melittin from Sigma Aldrich;
HPLC grade acetonitrile (ACN) from Scharlau; E. coli penicillin acylase (PA) (MW = 70
kDa) from ASA Spezialenzyme GmbH; octyl glucopyranoside (OG), and Triton X-100 from
Anatrace; and bodipy630/650, and 3,3’,5,5’-tetramethylbenzidin (TMB) from Thermo Sci-
entific. Purified OmpF was kindly provided by Andrea Belluati,122 PMOXA6-b-PDMS43-b-
PMOXA6 and azid terminated PMOXA7-b-PDMS40-b-PMOXA7 by Dr. Samuel Lörcher.
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5.3.2 Microstructured surface - passive strategy
The antimicrobial activity was assessed by the Japan industrial standard (JIS) test. 50
µL E. coli inoculum (8.3·105 CFU mL−1) was added to the surface of interest and covered
with a sterile square of parafilm. The surface was kept overnight at 37◦C in a humid
environment. The next day, the surface including the parafilm was placed in a 15 mL
falcon tube containing 3 mL 1% tryptic soy broth (TSB) (1.7 g bacterial tryptone, 0.3 g
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soytone, 0.25 g of D-Glucose monohydrate, 0.5 g NaCl, 0.25 g K2HPO4, 100 mL H2O) in
PBS (137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.8 mM KH2PO4, pH = 7.4) and
sonicated for 5 min to remove all attached bacteria. The resulting bacteria suspension was
serially diluted (100, 10−1, 10−2, 10−3) in PBS and 50 µL of each dilution was spotted in
triplicate on LB-Agar (5 g bacterial tryptone, 2.5 g yeast extract, 5 g NaCl, 7.5 g agar,
500 mL H2O) plates and incubated overnight at 37
◦C. Colony forming units (CFUs) were
counted the next day. Static water contact angles (KSV, instruments, CAM100 Version
2.1.1) were measured for at least 3 surfaces.
Surfaces with adsorbed organosilica microparticles were sputtered with platinum and char-
acterized by scanning electron microscopy (SEM) (Hitach S-4800) with an acceleration
voltage of 5000 V at a working distance of 3.4 mm. In addition, the surface covered with 1
µm particles was imaged by atomic force microscopy (AFM) (JPK Nanowizard 3, Version
6.0.63) in air. A Tap300 Al-G cantilever (Budget Sensors, resonance frequency 300 kHz,
force constant 40 N m−1) was used for AC mode measurements. Images were analyzed
with the JPK data processing software (Version spm 6.0.63).
Bacterial attachment was studied by immersing the surface of interest in 2 mL E. coli
inoculum (5·105 CFU mL−1) per well of a 12-well plate. The 12-well plate was shaken
horizontally at 60 rpm at 37◦C. After 30 min, 3 hours, or 6 hours the surface was washed
by removing the bacteria suspension and adding 2 mL 1% TSB in PBS. Then the surface
was transferred to a 15 mL falcon tube containing 1 mL 1% TSB in PBS and sonicated for
5 min to remove attached bacteria. The obtained bacteria suspension was serially diluted
(100, 10−1, 10−2, 10−3, 10−4, 10−5, 10−6) in PBS and 50 µL of each dilution was spotted in
triplicate on LB-Agar plates. CFUs were counted after an overnight incubation at 37◦C.
5.3.3 Cephalexin producing nanoreactors - active strategy
Cephalexin was detected by a sorbitol-zinc assay similar to the spectrocolorimetric assay
developed by Bundgaard to quantify aminopenicillines.297 Briefly, 20 % sorbitol in an 0.2
M carbonate (0.04 M Na2CO3, 0.16 M NaHCO3) buffer containing 0.15 µg mL
−1 Zn2+
ions at pH = 9.2 was prepared. A 50 µL sample was mixed with 50 µL sorbitol-zinc solu-
tion and heated at 60◦C for 10 min while shaking horizontally (300 rpm). Then, NaOH
solution (1 M, 50 µL) was added. After 10 min incubation at room temperature (rt) 130
µL of the mixture were added to a well of a 96-well plate for UV-Vis measurement on a
SpectraMaxPlus 384 (Molecular Devices, Sunnyvale, USA).
Cephalexin, PGME, and 7-ADCA were identified by high performance liquid chromatog-
raphy (HPLC). The sample was loaded onto a chromolith performance RP-18c 100-4.6
mm column and eluted by a 0.1 % TFA in ACN : water (15 : 85) isocratic gradient at a
flow rate of 0.5 mL min−1 over 15 min. UV-Vis absorbance was simultaneously measured
focusing on λ = 214 nm.
PA was coupled to Atto-488-NHS (Atto-Tec GmbH, Germany) overnight at 4◦C. Free
Atto-488-NHS was removed from labeled PA by dialysis against PBS using a 8-10 kDa
dialysis membrane (Spectra/Por Biotech CE Tubing from spectraLabs.com).
Nanoreactors were self-assembled by thin film rehydration. 0.5 µmol of PMOXA6-b-
PDMS43-b-PMOXA6 in ethanol were mixed with 1 mol% azide-terminated PMOXA7-b-
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PDMS40-b-PMOXA7 and dried to a thin film by rotary evaporation under reduced pressure
(150 mbar). The film was rehydrated with 1 mL of filtered PBS (Durapore membrane
filters 0.45 µm HV, Merck) containing 2.2 mg PA, labeled PA, or HRP. The obtained
suspension was stirred overnight at 4◦C and then extruded 13 times through a 400 nm
pore-size polycarbonate membrane (Nuclepore Trac-Etch membrane, Whatman R©) on a 1
mL syringe extruder. Non-encapsulated enzyme was removed from polymersomes by size
exclusion chromatography (SEC) on a Sepharose 2B column (length: 25 cm, diameter: 1
cm) connected to an ÄKTAprime system. The column was eluted with filtered PBS and
the polymersome containing fraction detected at 280 nm. For CF encapsulated polymer-
somes, 50 mM CF in PBS was used for rehydration. OmpF was added to the polymer
mixture before film formation to create OmpF permeabilized nanoreactors. Negative con-
trols for OmpF permeabilized nanoreactors were prepared by adding dialysed OG instead
of OmpF to the polymer. To obtain melitin permeabilized vesicles, melittin (20 µM) was
added to the nanoreactors or CF encapsulated polymersomes immediatly before use.
For transmission electron microscopy (TEM), 5 µL nanoreactor suspension were adsorbed
to a glow discharged formvar-coated copper grid (400 mesh) for one minute. Excess sample
was blotted off and the grid washed twice with water and once with 2 % uranyl acetate
before negative staining for 10 s with 2 % uranyl acetate. Dry grids were imaged with a
Philips CM100 at an acceleration voltage of 80kV.
PA encapsulation was analyzed by fluorescence correlation spectroscopy (FCS) on a Zeiss
LSM 510 META/Confocor2. 10 µL aliquots of Atto-488-NHS, Atto-488-labeled PA, and
Atto-488-labeled PA encapsulated nanoreactors were placed on a glass slide (0.16-0.19
mm thickness) and excited at 488 nm with a Argon laser. Autocorrelation curves were
recorded using a 40x water-immersion objective (Zeiss C/Apochromat, NA 1.2) and ap-
propriate filter sets. The FCS autocorrelation curves were fitted with either a one com-
ponent curve or a two-component curve where the diffusion time of the first fraction was
fixed to the one obtained for free dye or Atto-488-labeled PA. The fitting was conducted
as previously described.93 Additionally, giant unilamellar vesicles (GUVs) with encapsu-
lated Atto-488-labeled PA were prepared as follows. 30 µL ethanol containing 30 nmol
PMOXA6-b-PDMS43-b-PMOXA6 and 0.3 nmol azide terminated PMOXA7-b-PDMS40-b-
PMOXA7 was added to a plasma cleaned glass vial (2.5 mL) and dried under vacuum
to a thin film. Then, 250 µL sucrose (300 mM) containing Atto-488-labeled PA (2.2 mg
mL−1) were added and pipetted up and down 4 times to induce GUV formation. GUV
preparations were stored at 4◦C until further use. For confocal laser scanning microscopy
(CLSM), the GUV membranes were stained with Bodipy630/650 (50 nM). GUVs were
imaged at 20 ◦C using a water immersion objective (C-Apochromat 40x/1.2W Korr FCS
M27) with an excitation wavelength of 488 nm and 633 nm (each 1 % laser power) and
a mean beam splitter (488/561/633). The pinhole was set to 1 airy unit and the gain to
750 and 500 for the 488 and the 633 channel, respectively. Fluorescence was tracked from
499 - 629 nm (Atto-488-labeled PA) and 638 - 737 nm (Bodipy). Fluorescent images were
processed with Fiji.
Cephalexin production was studied using the sorbitol zinc-assay described above. In brief,
7-ADCA and PGME were mixed in PBS to a concentration of 66 mM and 33 mM, respec-
tively. The pH of the mixture was adjusted to 6.5 and then added to either free PA or PA
encapsulated nanoreactors. The enzymatic reaction was allowed to proceed for different
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periods of time.
The functional insertion of OmpF in nanoreactor membranes was examined by measuring
the enzymatic activity of encapsulated HRP. 500 µL TMB (substrate) were mixed with
500 µL PBS and 5 µL H2O2. 200 µL of this substrate solution were added to 5 µL HRP
encapsulated nanoreactors permeabilized with OmpF in a well of a 96-well plate and the
absorbance was measured at λ = 370 nm for 20 min.
To test the permeability of CF encapsulated polymersomes with and without melittin,
the fluorescence at λEx = 495 nm and λEm = 519 nm was recorded on a spectrafluorome-
ter FP-8200 from Jasco over 4 hours. 10 µL untreated polymersome suspension was added
to 2990 µL PBS in a cuvette and the baseline was monitored. After 20 min, melittin (20
µM) was added and at 3 hours 50 min, 5 µL Triton X-100 (10 % stock solution) were
added to solubilize the membrane and obtain 100 % permeability.
5.4 Results and Discussion
5.4.1 Microstructured surface - passive strategy
To find a passive antimicrobial microstructured surface, several materials prepared by the
research group of Prof. Dr. Jian Xu from the Chinese Academy of Science in Beijing
were tested for their antimicrobial properties. First, polypropylene (PP) and cotton gauze
based materials were tested using the JIS test. A drop of E. coli inoculum was placed on
the respective surface and covered with a parafilm to prevent it from drying out. After
overnight incubation at 37◦C the surface including the drop and the parafilm piece were
added to PBS and sonicated to resuspend all bacteria. CFUs of serial dilutions plated
on LB-agar plates were counted the next day (Figure 5.2A). As expected, the material
modified with AgNPs (B2) shows the best performance and no CFUs could be detected,
while on non-modified PP (B0, C0) and polymer crystal modified PP (C1) surfaces the
most CFUs were counted. The wettability of the different surfaces was characterized by
water contact angle measurements. All surfaces showed a similar hydrophobicity slightly
below 150◦ water contact angle. Only the non-modified cotton gauze was extremely hy-
drophilic and immediately absorbed the water drop, resulting in a water contact angle of
0◦ (Figure 5.2B).
The second, microstructured surfaces from Professor Xu’s group consisted of organosilica
microparticles adsorbed on glass or silica surfaces. The diameters of the microparticles
were 1 µm, 2 µm, and 5 µm. Upon arrival at the University of Basel, the surfaces were
immediately characterized and tested for their passive antimicrobial behavior. SEM anal-
ysis (Figure 5.3) revealed that there were fewer particles on the glass surface than of the
silica, especially in the case of particles with 1 µm in diameter. Silica surfaces appeared to
be more robust as more particles stayed adsorbed during the shipping. However, the silica
surfaces did change during the shipping as well. There were less homogeneous as when im-
aged in Beijing before the shipping. Some particles detached as visible on SEM pictures as
light rings, where organosilica particles were most likely adsorbed to the surface previously
(Figure 5.4A). In some areas the surface was covered relatively homogeneously with one
layer of particles (Figure 5.4B), but in other areas the particles got stacked creating
several layers (Figure 5.4C). AFM of the silica surface covered with 1 µm sized particles
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Figure 5.2: A) E. coli CFU count on polypropylene (PP) non woven-fabrics modified
with polydopamine (B1), polydopamine and AgNPs (B2), polymer crystal (C1) and cot-
ton cause modified with paraffin wax (D1). The corresponding ’0’ surfaces are the non-
modified control samples. The ? indicates statistical significance (p < 0.05, n=3) in
relation to B0, in accordance to the t-test. B) Water contact angle measurements of the
surfaces tested in A.
Figure 5.3: SEM of microstructured surfaces: organosilica microparticles (diameters: 1
µm, 2 µm, and 5 µm) adsorbed on glass (upper panels) and on silica (lower panels).
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Figure 5.4: A-C) SEM of 1 µm organosilica particles adsorbed to a silica surface at dif-
ferent magnifications. D) AFM image of the height channel of 1 µm organosilica particles
adsorbed to silica surface (left panel). The height profile along the black line is shown on
the right.
confirmed the size and spherical structure of the particles on the surface (Figure 5.4D).
Finally, the passive antimicrobial activity was tested by studying bacterial attachment.
The microstructured surfaces created with the different sized organosilica microparticles
were compared to non-, NH2-, or DBCO-functionalized silica surfaces or nanostructured
surfaces created by the SPAAC immobilization (described in chapter 3) of soft, spherical
polymersomes. For testing attachment, the surfaces were immersed in an E. coli inoculum
and incubated while shaking horizontally for 30 min, 3 h, or 6 h at 37 ◦C. To quantify bac-
terial adhesion, the surfaces were transferred to fresh PBS and sonicated to resuspend the
attached bacteria. The bacteria suspension was plated on LB-Agar plates, where the CFUs
were counted the next day (Figure 5.5). At 6 hours of immersion during which the bacte-
ria had time to adhere, the antibacterial properties of the different surfaces varied. DBCO
functionalized silica surfaces reduced bacterial attachment compared to non-functionalized
silica surfaces. The microstructured surface with 5 µm sized organisilica particles clearly
reduced bacterial attachment when compared to all other surfaces at 6 hours. The least
significance with p = 0.07 is obtained when it was compared to nanostructured surfaces
with immobilized polymersomes. On the other hand, the data comparison was enlarged
to the shorter immersion times, where the 5 µm sized organisilica particles still showed
significantly less bacterial attachment when compared to the amino functionalized silica
surface immersed for only 3 hours (p = 0.04).
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Figure 5.5: Bacterial attachment study. Surfaces were immersed in an E. coli inoculum
(5·107 CFU mL−1). The surfaces were sonicated in PBS to resuspend surface attached
bacteria. This bacteria suspension was collected and plated on LB-agar plates at different
dilutions for CFU counting. The black bars represent 0.5 h, the red bars 3 h, and the blue
bars 6 h immersion in the E. coli inoculum. The p values obtained by the student t-test
from comparison to the 5 µm organosilica particle surface are indicated in grey. (n=3)
5.4.2 Cephalexin producing nanoreactors - active strategy
The active strategy was pursued by designing a cephalexin producing nanoreactor based
on PMOXA6-b-PDMS43-b-PMOXA6 mixed together with azide-terminated PMOXA7-b-
PDMS40-b-PMOXA7 triblock copolymer for future immobilization on the microstructured
surface. The antibiotic cephalexin can be enzymatically produced in situ by PA. First,
a method to detect cephalexin independent of the substrates PGME and 7-ADCA was
applied. A colorimetric method to quantify aminopenicillins which contain, apart from
the β-lactamring, an amino side chain (Figure 5.6, marked in red) was developed by
Bundgaard.297 The reaction involves heating the reaction in an alkaline buffer contain-
ing sorbitol and zinc(II)-cations that catalyse the degradation of penicillines. In Bun-
gaard’s study ampicillin (1) forms with sorbitol the corresponding penicilloyl ester, the α-
aminobenzylpenicilloyl ester (2). This ester undergoes intramolecular aminolysis to form
a piperazine-2,5-dione derivative (3). Like ampicillin, Cephalexin (4) has a β-lactamring
with an amino side chain that is required to undergo esterification and subsequent in-
tramolecular aminolysis to form a piperazine-2,5-dione derivative (6). This derivative has
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Figure 5.6: A) Scheme of Ampicillin (1) and Cephalexin (4) reacting with sorbitol
(RO−) to the corresponding esters (2 and 5), which after intramolecular aminolysis form
piperazine-2,5-dione derivatives (3 and 6). B and C) Detection of enzymatic cephalexin
production by the sorbitol-zinc colorimetric assay. B) Absorbance spectra form 350 nm
- 600 nm. The negative controls are PBS alone (black and light grey at different time
points) and the substrate mix (PGME (7) and 7-ADCA (8)) with only PBS (light green).
The positive control is cephalexin in PBS (olive). The other recordings represent the sub-
strate mix with PA in PBS with different incubation times. C) Absorbance at 470 nm
over the course of 24 hours of the enzymatic cephalexin production (black), PBS mixed
with only PA (red) or only the substrate mix without enzyme (blue) as negative controls,
and cephalexin alone as positive control (pink).
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an absorbance maximum around λ = 470 nm (Figure 5.6). When the substrate mix
(consisting of PGME and 7-ADCA) was incubated with PA, the reaction with sorbitol
and zinc(II)-cations produced a color change to yellow that was accompanied by an ab-
sorbance at 470 nm. After 10 min of incubation, a slight increase in absorbance over the
negative controls was observed, (Figure 5.6A) indicating the PA catalyzed condensation
of PGME and 7-ADCA to cephalexin. After about 5 hours, the cephalexin production
reached a plateau and only marginally increased from then on (Figure 5.6B). However,
no colorimetric effect was detected for the negative control where sorbitol and zinc were
incubated with the substrate mix. This is due to the molecular separation of the two
required moieties: the β-lactamring is only present in 7-ADCA while the amino side chain
only in PGME. Similarly, the enzyme PA alone did not produce a color change.
HPLC offers another way to distinguish cephalexin from PGME and 7-ADCA.286,298
When 5 µg of each compound were injected on the analytical column (chromolith per-
formance RP-18c 100-4.6 mm) with a mobile phase of 85% water, 15% ACN, and 0.1%
TFA, cephalexin showed the longest retention time while the educts PGME and 7-ADCA
were eluted earlier and close to each other (Figure 5.7A). Decreasing the flow rate by
half approximately doubled the corresponding retention times and therefore, the separa-
tion between the educts and cephalexin increased. Enzymatic cephalexin production was
also monitored by HPLC (Figure 5.7B). Heating to 80◦C, in order to stop the reaction
by inactivating the enzyme at specific time points, did not affect the peaks. Again, after
10 min reaction time a small peak for cephalexin was detected, proofing the enzymatic
production of cephalexin by PA.
Figure 5.7: A) Injection of 5 µg cephalexin (black), 7-ADCA (red) and PGME (blue).
Flow rate: 1 mL min−1 B) Reaction mixtures after different reaction times. The reaction
was stopped by heating the reaction mixture to 80◦C. Cephalexin alone, as a positive
control, was injected after heating to 80◦C. Flow rate: 0.5 mL min−1
The enzymatic production of cephalexin could be followed by both detection methods.
The advantage of HPLC is that besides cephalexin, residual substrates can be individ-
ually detected and only little sample volumes are needed. However, HPLC is too time
consuming when many samples have to be tested and generates lots of solvent waste. The
sorbitol-zinc assay on the other hand requires larger sample volumes but many samples
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can be tested in parallel generating less solvent waste. Taking these considerations into
account, further analyses were generally done by the sorbitol-zinc assay.
Figure 5.8: A) SEC of PA encapsulated nanoreactors with OmpF (OmpF) and witout
OmpF (OG control) to separate them from non-encapsulated PA (free PA). B) TEM of PA
encapsulated nanoreactors, scale bar: 500 nm. C) Sorbitol-zinc assay of PA encapsulated
nanoreactors with OmpF (black), and without OmpF (OG control) (red), and free PA
eluate from SEC (blue). D) HRP activity assay of HRP encapsulated nanoreactors with
OmpF (black) and without OmpF (OG control) (red).
As a next step towards the in situ production of cephalexin, nanoreactors were self-
assembled in the presence of PA by thin film rehydration. To prepare nanoreactors that
lend themselves to immobilization by the SPAAC reaction222 a thin film of PMOXA6-b-
PDMS43-b-PMOXA6 mixed with azide terminated PMOXA7-b-PDMS40-b-PMOXA7 poly-
mers were prepared. After film rehydration in PBS in the presence of PA, self-assembled
nanoreactors were purified from non-encapsulated PA by extrusion and SEC (Figure
5.8A). The nanoreactor membrane enclosing the PA needs to be made permeable to
PGME, 7-ADCA and cephalexin. Therefore, OmpF was incorporated. Purified OmpF is
solubilized in 3% OG which interferes with the self-assembly of the polymersomes. Thus,
the detergent was reduced to a minimum by dialysis against PBS prior to adding the
OmpF to the polymer solution used for film formation. Because residual OG could still
influence self-assembly, a 3% OG solution was dialysed in parallel against PBS and added
as control in corresponding polymersome preparations (OG control). TEM micrographs
confirmed the vesicular structure of the nanoreactors and the OG control polymersomes
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(Figure 5.8B). More force was needed for the extrusion of PA encapsulated nanoreactors
compared to the pure polymersomes self-assembled in chapter 3. Because sometimes it
was not possible to extrude through 200 nm membranes, samples were mostly extruded
through 400 nm.
To study PA encapsulation, the enzyme was labeled with Atto488-NHS and encapsulated
in polymersomes and GUVs assembled with 1 mol% azide-terminated polymer (Figure
5.9). Due to their size, GUVs can be examined by CLSM. Bodipy, a hydrophobic flu-
orophore that non-specifically interacts with membranes, was used to visualize the hy-
drophobic polymer membranes (Figure 5.9A, middle). Atto-488 labeled PA was de-
tected in the green channel. Corresponding fluorescence images showed that PA did not
specifically interact with the GUV membrane but is evenly distributed throughout the
GUV’s cavity (Figure 5.9A, left). PA encapsulation in polymersomes was quantified
by FCS (Figure 5.9B and Table 5.1). FCS autocorrelation curves of free Atto488-NHS
(black curve) compared to Atto-488 labeled PA (blue curve) showed an shift to higher
diffusion times for the labeled enzyme. The fitting showed that about half of the dye was
attached to the enzyme while the other half was still free in solution. Higher diffusion times
indicate that the fluorescent species diffuses across the confocal volume at lower speed and
thus, represents a slow moving, i.e. bigger/heavier molecule or particle. Comparing the
counts per molecule (CPM) of samples with a comparable count rate (CR) allowed the
calculation of the number of dye molecules per PA or the number of encapsulated PA
molecules (Table 5.1). Corresponding calculations revealed 1-2 dye molecules per labeled
PA. As expected, encapsulation of labeled PA in polymersomes resulted in a clear shift
to higher diffusion times. This slow diffusing fraction was close to 100%, indicating good
purification after encapsulation resulting in very low non-encapsulated labeld PA left in
solution. On average, each N3 exposing polymersomes had encapsulated 30 labeled PA
molecules.
CPM [kHz] CR [kHz] τD [µs] Fraction [%]
Atto-488 NHS 0.9 ± 0.2 43 ± 2 64 ± 20 100
Labeled PA 1.3 ± 0.2 27 ± 2 385 ± 243 51
encapsulated labeled PA 38.5 ± 17 27 ± 3 13638 ± 3533 99
Table 5.1: FCS fitting parameters to estimate PA encapsulation efficiency.
To test the activity of PA encapsulated in nanoreactors, the in situ production of cepha-
lexin was analyzed by the sorbitol-zinc assay. The free PA fraction collected from SEC
purification of the nanoreactors (Figure 5.8A) responded to the sorbitol-zinc treatment
with a clear color change, demonstrating that the enzyme stayed active during nanoreactor
formation and purification (Figure 5.8C). The membrane permeabilization by OmpF re-
constitution was tested with established HPR nanoreactors that were prepared in parallel
to the PA nanoreactors using the same mixture of polymers. While HRP nanoreactors
showed increased absorbance, hence activity, over control nanoreactors without OmpF
(OG control) after adding the substrates for the HRP reaction (TMB and H2O2, Figure
5.8D) OmpF permeabilized PA nanoreactors did not show activity. Only when free PA
was present, the absorbance peak at λ = 470 nm occurred. After different preparation
methods failed to produce functional PA nanoreactors, other ways to render the mem-
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Figure 5.9: A) CLSM of 1 mol% N3 exposing GUVs with encapsulated Atto488-PA. The
membrane was stained with Bodipy. Left: green channel revealing Atto-488-PA, middle:
red channel showing Bodipy630/650, right: bright field image B) Normalized FCS auto-
correlation curves of free Atto-488-NHS (black), Atto-488 labeled PA (blue), Atto-488-
labeled PA encapsulated in polymersomes (red). Raw data are represented by squares
while the fitted autocorrelation curves by a solid line.
branes permeable were sought.
Melittin, a peptide present in bee toxin, was tested for its ability to form functional pores in
PA encapsulated polymersomes. Because CF has a similar molecular weight to cephalexin,
it was chosen as a model molecule to monitor melittin-mediated permeabilization. First,
CF encapsulated polymersomes were used to study membrane permeabilization by melit-
tin (Figure 5.10A). At high concentrations, encpasulated CF is self quenching, but when
diluted (i.e. able to diffuse out of the polymersome) it dequenches and fluorescence oc-
curs.272 As shown in Figure 5.10A, the addition of melittin to a final concentration of
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20 µM nearly instantly permeabilized 90 ± 4 % of CF encapsulated polymersomes (black
lines). Because melittin was dissolved in ethanol, control experiments were performed
with the corresponding volume of ethanol added to the polymersomes (red lines). In this
case only 5 ± 4 % of the polymersomes were permeabilized. Hence, the permeabilization
is mainly caused by the melittin and not by the ethanol.
Figure 5.10: A) Permeabilization of CF encapsulated polymersomes by melittin. After 20
min of equilibration, melittin (20 µM final concentration, black lines) or the same volume
of ethanol (1% final concentration, red lines) was added. After 3 hours and 40 min Triton
X-100 is added to completely solubilize the polymersome membranes. B) Sorbitol-zinc
activity assay of PA nanoreactors. Only the free PA showed an absorbance peak around
470 nm while nanoreactors to which melittin or ethanol were added from the outside as
well as nanoreactors with melittin added during film formation did not. C) Sorbitol-zinc
activity assay of Triton X-100 lysed PA nanoreactors. The total reaction volume was
constant while the substrate and nanoreactor (NR) concentration was changed.
To further explore melittin as permeablization agent, melittin (black line) or corresponding
volumes of ethanol (red line) was added to the outside of the PA encapsulated polymer-
somes. In addition melittin was also added during film rehydration (pink line) to create
melittin pores already during self-assembly (Figure 5.10B). In addition, free PA obtained
by collecting the PA fraction from SEC purification served as a positive control (blue line).
Absorbance at λ = 470 nm indicated that the free PA catalyzed cephalexin production.
In contrast, similar to the negative control (EtOH), addition of melittin from the outside
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or during film rehydration did not lead to a color change suggesting that there was no
cephalexin production by the nanoreactors.
To assess if enough nanoreactors with enough PA are in the mixture, different volumes
of nanoreactor solution in which the nanoreactors were completely lysed with 5 µL Tri-
ton X-100 were mixed with different volumes of the substrate solution. The total volume
was kept constant at 175 µL (Figure 5.10C). The presence of only 20 µL of nanoreac-
tors seemed too little to obtain a detectable color change. Similarly, 160 µL nanoreactor
with 4.7 µM PGME and 2.35 µM 7-ADCA did not yield a color change, suggesting a too
small amount of substrate. However, successful cephalexin production was detected after
sorbitol-zinc treatment when 70 - 120 µL lysed nanoreactor solution were incubated with
23.5 - 47 µM PGME and 11.75 - 23.5 µM 7-ADCA.
5.5 Conclusions
The microstructured surface with 5 µm sized organosilica microparticles adsorbed on silica
showed the most promising passive antimicrobial behavior. Two independent methods, a
fast colorimetric method involving sorbitol and zinc and HPLC, were found to be suitable
to detect cephalexin. The fast sorbitol zinc assay is practical to screen many different
parameters to design the nanoreactors. Having a working system, the HPLC, which is
more time consuming, offers the possibility to quantitatively monitor all substrates simul-
taneously. PA was encapsulated in polymersomes where it kept its activity. However, for
PA encapsulated nanoreactors that were permeabilized by OmpF or melittin cephalexin
production could not be detected. The issue could not be found in the OmpF reconsti-
tution or melittin permeabilization. HRP encapsulated nanoreactors self-assembled from
the same polymers allowed the diffusion of the corresponding substrates (i.e.: TMB and
H2O2) through OmpF. CF, even having a slightly higher molecular weight than cephalexin,
was able to pass through the membrane of CF encapsulated polymersomes self-assembled
from the same polymers upon melittin addition. This led to the conclusion that either
the substrates PGME or 7-ADCA or the antibiotic cephalexin, or a combination thereof,
could not pass through the OmpF and melittin pore. Therefore, other permeabilization
techniques need to be found which allow the passage of cephalexin, PGME, and 7-ADCA
through the nanoreactors membrane.
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Chapter 6
General conclusions and Outlook
Antibiotic resistance is a term that is gaining attention, visible in the general public by
regular newspaper or TV-channel reports. The future outlook does not look bright. An-
tibiotic overuse favors antibiotic resistance, which is a threat to our achieved medical
improvements over the last century. So far easily curable infections can again become
life-threatening and surgeries would come with a higher risk due to possible exposure to
antibiotic resistant bacteria. The demand and need to find new antibiotics, new ways,
and new strategies to fight bacteria infections is indisputable. This global need gave
the motivation for this thesis in which possible new ways and strategies were researched.
Particularly, the coimmobilization of polymeric nano-assemblies on a solid support as
well as the decoration with an antimicrobial peptide was studied and characterized by
their physical chemical properties as well as their antibacterial performance. This thesis
describes the self-assembly of PMOXA-PDMS-PMOXA block copolymers. A new and
easy polymersome-immobilization technique has been developed with the already known
SPAAC reaction avoiding possible toxic catalysts. Coimmobilization was obtained by
the simultaneous immobilization of polymeric nanostructures by the SPAAC reaction and
the established thiol-ene immobilization reaction. Furthermore, patterns were created by
micro-contact printing polymersomes onto a solid support. The immobilization was stud-
ied by a combination of SEM, AFM, and LSM. A possible next step would be to load
different antibiotic agents into the immobilized polymersomes and micelles. The antibi-
otics would be released when needed by an external trigger (e.g., UV) or internal trigger
(e.g, pH, temperature, enzymes) by incorporating a unit sensitive to the trigger in the
polymersomes or micelles. Having a nanostructured surface created by the immobiliza-
tion of the nano-assemblies with multiple loaded antibiotics could help the fight against
bacteria through the local release of antibiotic where needed which also might reduce the
used amount of antibiotics.
To decorate immobilized micelles with antimicrobial activity, the AMP KYE28 was chosen.
The synthesis of the AMP was optimized on a microwave assisted peptide synthesizer and
the thiol-maleimide Michael addition, as an additional micelle immobilization technique,
was studied. A nanostructured surface was obtained by the immobilzation of micelles.
This surface reduced bacteria growth on it and therefore, displayed a passive antimicro-
bial strategy. The synthesized KYE28 was characterized for its antimicrobial properties
(i.e. the MIC and MBC) and represents an active antimicrobial strategy. These two
strategies were combined by adding the AMP on the nanostructured surfaces, decorating
the immobilized micelles which further reduced bacterial growth on the surface. These
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surfaces were thoroughly characterized by a combination of AFM, LSM, XPS, and QCM-
D for their physical chemical properties. The lyophilized peptide has been shown to be
stable over at least 1.5 years. However, the next step would be to evaluate the long-term
stability of the AMP on the surface as well as release properties. Therefore, the surface’s
performance would need to be evaluated under various conditions (e.g., pH, temperature,
ionic strength). Further research could study the micelle decoration with a combination
of different AMPs for synergistic antimicrobial or anti-infection properties.
Additional research for the combination of active and passive strategies has been done.
The collaborating research group of Prof. Jian Xu developed microstructured surfaces
as passive antimicrobial surfaces. The antimicrobial test performed suggested the sur-
face with adsorbed 5 µm sized particles to be most effective. Furthermore, we studied
cephalexin producing nanoreactors as the active strategy to create smart antimicrobial
surfaces by its immobilization onto the microstructured surface designed by the collabo-
rating research group. The cephalexin producing enzyme PA has been encapsulated into
the aqueous lumen of the polymersomes as proven by FCS and LSM studies. High enough
PA concentration has been encapsulated for cephalexin production. However OmpF or
melittin was not suitable to allow the passage of either the produced cephalexin or the
needed educts (i.e., PGME and 7-ADCA) through the membrane. Nevertheless, OmpF
and melittin were successfully reconstituted into the polymersome membrane as shown
by the active HRP encapsulated nanoreactor or the release of CF from CF encapsulated
polymersomes, respectively. As a future step, the nanoreactor would need to be further
optimized with other permeabilization techniques to be found.
Overall, the aim of the thesis has been achieved. A passive and active antibacterial
strategy have been combined by the immobilization of polymeric micelles with further
decoration by the active AMP KYE28. This designed antibacterial surface acts locally.
However, a smart antibacterial surface including triggered release and production of an-
tibiotics could not be finished.
A question which has to be answered when developing such surfaces for any biomedi-
cal application is about the sterilization: How can these surfaces be sterilized or kept
sterile without destroying the polymeric self-assembled structures and maintaining the
active module (i.e, enzyme, peptide, antibiotic) intact? As a further step for all surfaces,
these questions must be addressed. Sterilization with ethanol is not an option as the poly-
meric assemblies are not stable in ethanol. UV-irradiation might be a possible sterilization
method for certain polymers and active agents. Additional sterilization methods have to
be researched and studied.
Surfaces consisting of immobilized soft polymeric nano-assemblies combined with active
agents as studied within this thesis are build in a straight forward modular way. This
allows high versatility and easy adaption to various bacterial threats through coimmo-
bilization of different antibiotic loaded self-assembled structures or the decoration with
several amphiphilic AMPs or other potent peptides. Such surfaces are promising in fu-
ture applications of wound healing concepts, where the surface supports the would healing
locally. Furthermore such a surface could also be developed for contact lenses where its
main task is to protect the lens from bacteria colonization and biofilm formation and
therefore the eye from infection. Here the surface would be applied preventive with the
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aim to never obtain an infection while in the former mentioned wound healing application
it would only be applied when there is already a wound that needs protection and support
to heal. In both suggested applications the surface acts locally from the outside of the
body while being in contact with a humid environment either of the ichor or the tear fluid.
Additionally, the surface could also be applied on urinary catheters where the surface is in
contact with soft tissue and urine. Here, the surface would be applied on a device which is
temporary placed in the body. The surface would further regularly be flushed with urine
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B. thailandensis Burkholderia thailandensis
CF carboxyfluoerescein
CFU colony forming units
clavA clavanin A
CLSM confocal laser scanning microscopy
CMC critical micelle concentration
CPM counts per molecule
CR count rate
CuAAC copper (I) catalyzed alkyne azide click
CVC central venous catheter
D dispersity




DF-PEG dibenzaldehyde-functionalized polyethylene glycol
DIC N,N’-Diisopropylcarbodiimide
DIEA diisopropylethylamine







E. coli Escherichia coli
EPS extracellular polymeric substances
FCS fluorescent correlation spectroscopy
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GUV giant unilamellar vesicle
HEMA 2-hydroxyethyl methacrylate
HGF human-gingival-fibroblasts
HPLC high-performance liquid chromatography
HRP horseradish peroxidase
IOP iron oxide-encapsulating polymersome
JIS japan industrial standard
LS light scattering
M. bovis-BCG M. bovis-attenuated Bacillus Calmette-Guérin
M. marinum Mycobacterium marinum
M. tuberculosis Mycobacterium tuberculosis
MBC minimum bactericidal concentration
MBEC minimal biofilm eradication concentration
MIC minimal inhibition concentration
Mn number average molecular weight
mPEG-PDLLA methoxypoly(ethelyne glycol)-poly(D)-(L)-lactic acid
MSSA methicillin-Sensitive S. Aureus
Mw weight average molecular weight




OmpF outer membrane pore F
P packing parameter
P. gingivalis Porphyromonas gingivalis







PDPA poly[2-(diisopropylamino) ethyl methacrylate]
PEG polyethylene glycol
PGME phenylglycine methyl ester
PLLA poly(L-lactic acid)
PMEO 2 MA-b-PTA poly[2-(2-methoxyethoxy)ethyl methacrylate]-Poly[2-(tert-butylaminoethyl) methacrylate]
PMOXA poly(2-methyl-2-oxazoline)
PMOXA-b-PDMS-b-PMOXA poly(2-methyloxazoline)-block-poly(dimethylsiloxane-block-poly(2-methyloxazoline)
PMPC poly[2-(methacryloyloxy) ethyl phosphorylcholine]
PMPI p-maleimidophenyl isocyanate
PP polypropylene
PSD particle size distribution
PVA polyvinyl alcohol
QCM-D quarz crystal microbalance with dissipation monitoring
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RAFT reversible addition-fragmentation chain transfer
RDH ribitol dehydrogenase
ROS reactive oxygen species





ROP ring opening polymerization
rt room temperature
S. aureus Staphylococcus aureus
S. epidermidis Staphylococcus epidermidis
SA-CS-Ti sulfuric acid treated titanium surface with immobilized chitosan
SA-Ti sulfuric acid treated titanium surface
SEC size exclusion chromatography
SEM scanning electron microscopy
SLS static light scattering
SPAAC strain promoted azide alkyne click
SPION superparamagnetic iron oxide nanoparticle
SRB sulforhodamine B
TCEP tris(2-carboxyethyl)phosphine
TEM transmission electron microscopy
TFA Trifluoroacetic acid




TSB tryptic soy broth
µCP micro-contact printing
Un-Ti untreated titanium surface
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